<SEC-DOCUMENT>0000950170-24-042789.txt : 20240409
<SEC-HEADER>0000950170-24-042789.hdr.sgml : 20240409
<ACCEPTANCE-DATETIME>20240409070530
ACCESSION NUMBER:		0000950170-24-042789
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20240408
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240409
DATE AS OF CHANGE:		20240409

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acrivon Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001781174
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				825125532
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41551
		FILM NUMBER:		24831097

	BUSINESS ADDRESS:	
		STREET 1:		480 ARSENAL WAY, SUITE 100
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-207-8979

	MAIL ADDRESS:	
		STREET 1:		480 ARSENAL WAY, SUITE 100
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>acrv-20240408.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-04-09T07:03:22.9540+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:acrv="http://acrivon.com/20240408" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_f5ec1587-dd91-4b31-9c42-e65b566258a3" name="dei:EntityCentralIndexKey" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6">0001781174</ix:nonNumeric><ix:nonNumeric id="F_b0cb3a43-bf84-42e6-9042-b90497e8083b" name="dei:AmendmentFlag" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="acrv-20240408.xsd"/></ix:references><ix:resources><xbrli:context id="C_89b67c7e-1d96-4982-8bed-140402994bc6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001781174</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-08</xbrli:startDate><xbrli:endDate>2024-04-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="min-height:0.5in;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_098315aa-39d0-4866-9654-ab55aa43a0f0" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_5b3c9fee-7c48-4eaf-b60f-ecf82de0dc26" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">April 08, 2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7cff70b9-fb9f-4085-be6b-20f8258c2bed" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">Acrivon Therapeutics, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;"/>
    <td style="width:1%;"/>
    <td style="width:20%;"/>
    <td style="width:18%;"/>
    <td style="width:41%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2d587c30-14eb-482d-bc06-745a52700127" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d6522c86-197d-4e33-ab28-78d8b617806b" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">001-41551</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_208dde73-cf07-4d09-9a55-5211d63f15a1" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">82-5125532</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_fc9bbd50-a7c6-4cc9-8b3b-3d1dac9358e4" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">480 Arsenal Way</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_3664105e-3b82-447c-a2cc-10debf06f2f8" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Suite 100</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2bdebbe3-da97-47c7-b961-9a1e403b766c" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Watertown</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_1bdb1305-1b99-4918-ae90-c9e8dcc2b97d" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_4d181283-b8e3-442e-9e4e-19ff832ad227" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">02472</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_77f61c6a-5a20-4544-a29d-66b415eb9357" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">617</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_2fa84d5d-ba5b-4be9-9ca6-b03cfd1a681b" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">207-8979</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1feffdb5-2bd5-4b39-a33a-024aa435efda" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Not Applicable </span></ix:nonNumeric></span><span></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_792a9a6f-5c1b-4d6a-b9cd-9c705937ade2" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f615747f-9948-47f1-a50f-45bc89924b08" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_520f8bc8-5291-4722-9b8a-021a7de447e8" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fce15ef6-181d-4b12-ae9c-75f58340829c" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;"/>
    <td style="width:1%;"/>
    <td style="width:15%;"/>
    <td style="width:1%;"/>
    <td style="width:45%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_602a7d44-3c14-4ef2-89fc-e2387329a03f" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common Stock, par value $0.001 per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_87b6409f-5135-4b0e-b1c7-c10192852a7b" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">ACRV</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_dd3140f1-77d0-4b36-a4a5-1cbd6b1b071a" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_7365e258-d46e-4dd7-a45a-4273449da500" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_946617d4-d309-4495-8862-b535794bf58a" contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1.01 Entry into a Material Definitive Agreement.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Securities Purchase Agreement</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 8, 2024, Acrivon Therapeutics, Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) for a private placement (the &#8220;Private Placement&#8221;) with certain institutional and accredited investors (each, a &#8220;Purchaser&#8221; and collectively, the &#8220;Purchasers&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Purchase Agreement, the Company agreed to issue and sell to the Purchasers an aggregate of (i) 8,235,000 shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), at a purchase price of $8.50 per share, and (ii) pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase up to an aggregate of 7,060,000 shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;) at a purchase price of $8.499 per Pre-Funded Warrant, which represents the per share purchase price of the Shares less the $0.001 per share exercise price for each Pre-Funded Warrant. The Pre-Funded Warrants will be exercisable at any time after the date of issuance and will not expire.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Pre-Funded Warrants will have an exercise price of $0.001 per share of Common Stock, subject to proportional adjustments in the event of stock splits or combinations or similar events, be immediately exercisable on the date of issuance and remain exercisable until exercised in full. The holders of Pre-Funded Warrants may not exercise a Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. The holders of Pre-Funded Warrants may increase or decrease such percentage not in excess of 19.99%, in the case of an increase, by providing at least 61 days&#8217; prior notice to the Company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The aggregate gross proceeds for the Private Placement will be approximately $130 million, before deducting offering expenses and excluding any proceeds the Company may receive upon exercise of the Pre-Funded Warrants, and the Private Placement is expected to close on April 11, 2024, subject to customary closing conditions. The Company intends to use the net proceeds from the Private Placement to fund the continued advancement of its pipeline, including ACR-368, ACR-2316, and its undisclosed cell cycle regulatory program, to fund research and development to broaden its use and applications of its AP3 platform, to leverage its vast proprietary data sets through artificial intelligence and machine learning, and for other general corporate purposes.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Jefferies LLC acted as the sole placement agent for the Private Placement. The Company has agreed to pay customary placement fees and reimburse certain expenses of the placement agent.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Purchase Agreement, the Company has agreed not to issue (or enter into any agreement to issue) any shares of Common Stock or Common Stock equivalents, subject to certain exceptions, until the earlier of (a) the date the Registration Statement (defined below) is declared effective by the Securities and Exchange Commission (the &#8220;SEC&#8221;) and (b) 60 days after the closing of the Private Placement (such period, the "Lock-Up Period").</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Purchase Agreement contains customary representations, warranties and agreements by the Company, indemnification obligations of the Company and the Purchasers, including for liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and other obligations of the parties. The representations, warranties and covenants contained in the Purchase Agreement were made only for purposes of such Purchase Agreement and are made as of specific dates; are solely for the benefit of the parties (except as specifically set forth therein); may be subject to qualifications and limitations agreed upon by the parties in connection with negotiating the terms of the Purchase Agreement, instead of establishing matters as facts; and may be subject to standards of materiality and knowledge applicable to the contracting parties that differ from those applicable to the investors generally. Investors should not rely on the representations, warranties and covenants or any description thereof as characterizations of the actual state of facts or condition of the Company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The foregoing descriptions of the Purchase Agreement and the Pre-Funded Warrants do not purport to be complete and are qualified in their entirety by reference to such agreements, copies of which are filed as Exhibits 10.1 and 4.1 hereto, respectively, and incorporated by reference herein.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Registration Rights Agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 8, 2024, the Company entered into a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;) with the Purchasers, pursuant to which the Company agreed to register for resale under the Securities Act the Shares and the Pre-Funded Warrant Shares held by the Purchasers (the &#8220;Registrable Securities&#8221;). Under the Registration Rights Agreement, the Company has agreed to prepare and file a registration statement with the SEC (the &#8220;Registration Statement&#8221;), covering the resale of the Registrable Securities by no later than May 11, 2024 (the &#8220;Filing Deadline&#8221;). The Company has also agreed to use reasonable best efforts to cause such registration statement to become effective as soon as practicable, but in any event no later than the earlier of (i) the 5th business day after the date the Company is notified by the SEC that the Registration Statement will not be "reviewed" or (ii) the 75th day following the filing of the registration statement in the event of a &#8220;review&#8221; by the SEC (the &#8220;Effectiveness Deadline&#8221;), subject to specified exceptions, and suspension and deferral rights as are set forth in the Registration Rights Agreement.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company also agreed to use reasonable best efforts to keep such registration statement effective until the earlier of (a) the date on which the Investors shall have resold all the Registrable Securities covered thereby; and (b) the date on which the Registrable Securities may be resold by the Purchasers without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144 promulgated under the Securities Act (&#8220;Rule 144&#8221;), without the requirement for the Company to be in compliance with the current public information requirement under Rule 144 under the Securities Act or any other rule of similar effect. The Company has agreed to be responsible for all fees and expenses incurred in connection with the registration of the Registrable Securities. In addition, certain liquidated damages provisions will apply to the Company in the event of registration failures, as described in the Registration Rights Agreement.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has granted the Purchasers customary indemnification rights in connection with the registration statement. The Purchasers have also granted the Company customary indemnification rights in connection with the registration statement.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the form of the Registration Rights Agreement, which is attached hereto as Exhibit 10.2 and incorporated herein by reference.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Letter Agreements</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Private Placement, the Company has agreed to enter into certain letter agreements with the lead Purchaser in the Private Placement (&#8220;Investor&#8221;) as discussed below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the first letter agreement, at any time following the closing date of the Private Placement when Investor owns at least 50% of the number of Pre-Funded Warrants it purchased in the Private Placement (or the underlying shares of Common Stock issued upon exercise thereof) Investor shall have the right to one (1) non-voting board observer who shall have the right to attend and participate in all board and committee meetings, with certain customary exceptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the second letter agreement, the Company agreed to enter into the Affiliate Registration Rights Agreement in certain circumstances, as more further described below.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The foregoing descriptions of the letter agreements do not purport to be complete and are qualified in their entirety by reference to the forms of such agreements, copies of which are filed as Exhibits 10.3 and 10.4, respectively, and incorporated by reference herein.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Affiliate Registration Rights Agreement</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the second letter agreement, the Company has agreed to enter into a registration rights agreement (the &#8220;Affiliate Registration Rights Agreement&#8221;) with Investor upon request from Investor following such time that Investor may be deemed an affiliate of the Company, pursuant to which Investor is entitled to certain resale registration rights with respect to shares of the Common Stock held by Investor (the &#8220;Affiliate Registrable Securities&#8221;). Under the Affiliate Registration Rights Agreement, following a request by Investor, the Company is obligated to file a resale registration statement on Form S-3, or other appropriate form, covering the Affiliate Registrable Securities. The Company has agreed to file such resale registration statement as promptly as reasonably practicable following such request, and in any event within 60 days of such request. The Company&#8217;s obligations to file such registration statement are subject to specified exceptions, and suspension and deferral rights as are set forth in the Affiliate Registration Rights Agreement. Under specified circumstances, the Company may also include securities of the Company in any such registration statement. Under the Affiliate Registration Rights Agreement, Investor also has the right to one underwritten offering per calendar year, but no more than three underwritten offerings in total and not more than two underwritten offerings or &#8220;block trades&#8221; (as defined in the Affiliate Registration Rights Agreement) in any twelve-month period, to effect the sale or distribution of the Affiliate Registrable Securities, subject to certain exceptions, conditions and limitations.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The foregoing description of the Affiliate Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the form of the Affiliate Registration Rights Agreement, which is attached as Exhibit A to the second letter agreement and incorporated herein by reference.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 3.02 Unregistered Sales of Equity Securities.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To the extent required by Form 8-K, the disclosures in Item 1.01 above are incorporated herein by reference. The securities to be issued and sold to the Purchasers under the Purchase Agreement are not registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and are being sold in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act. The Company relied on this exemption from registration based in part on representations made by the Purchasers. The securities may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Neither this Current Report on Form 8-K nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy shares of common stock or other securities of the Company.</span></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 8, 2024, the Company issued a press release announcing the Private Placement. A copy of this press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company&#8217;s filing with the SEC made by the Company, regardless of any general incorporation language in such filings, except to the extent expressly set forth by reference in such filing.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.08%;"/>
    <td style="width:2.02%;"/>
    <td style="width:90.9%;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="acrv-ex4_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Pre-Funded Warrant</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.1*</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="acrv-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Securities Purchase Agreement, dated April 8, 2024, by and among Acrivon Therapeutics, Inc. and each of the purchasers as party thereto</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.2*</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="acrv-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Registration Rights Agreement</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.3*</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="acrv-ex10_3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Letter Agreement, dated April 8, 2024, by and among Acrivon Therapeutics, Inc. and each of the persons party thereto</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.4*</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="acrv-ex10_4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Letter Agreement, dated April 8, 2024, by and among Acrivon Therapeutics, Inc. and each of the persons party thereto</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="acrv-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press Release dated April 8, 2024</span><span style="color:#0000ff;white-space:pre-wrap;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">* Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.</span></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;"/>
    <td style="width:44%;"/>
    <td style="width:4%;"/>
    <td style="width:46%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Acrivon Therapeutics, Inc.</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">April 9, 2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Rasmus Holm-Jorgensen</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rasmus Holm-Jorgensen<br/>Chief Financial Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>acrv-ex4_1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<html>
 <head>
  <title>EX-4.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 4.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">		</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> 	  Number of Shares: [            ]<br>(subject to adjustment)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant No. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">   </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">	Original Issue Date: April [    ], 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Acrivon Therapeutics, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [    ] or its registered assigns (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), is entitled, subject to the terms set forth below, to purchase from the Company up to a total of [    ] shares of common stock, $0.001 par value per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), of the Company (each such share, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Share</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and all such shares, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) at an exercise price per share equal to $0.001 (as adjusted from time to time as provided in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> herein, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) at any time and from time to time on or after the date hereof (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Original Issue Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), subject to the following terms and conditions:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. For purposes of this Warrant, the following terms shall have the following meanings:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any Person directly or indirectly controlled by, controlling or under common control with, a Holder, but only for so long as such control shall continue. For purposes of this definition, &#x201c;control&#x201d; (including, with correlative meanings, &#x201c;controlled by&#x201d;, &#x201c;controlling&#x201d; and &#x201c;under common control with&#x201d;) means, with respect to a Person, possession, direct or indirect, of (i) the power to direct or cause direction of the management and policies of such Person (whether through ownership of securities or partnership or other ownership interests, by contract or otherwise), or (ii) at least 50% of the voting securities (whether directly or pursuant to any option, warrant or other similar arrangement) or other comparable equity interests.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attribution Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, collectively, the following Persons and entities: (i) any direct or indirect Affiliates of the Holder, (ii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any Attribution Parties and (iii) any other Persons whose beneficial ownership of the Company&#x2019;s Common Stock would or could be aggregated with the Holder&#x2019;s and/or any other Attribution Parties for purposes of Section 13(d) or Section 16 of the Exchange Act. For clarity, the purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.</font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Closing Sale Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, for any security as of any date, the last trade price for such security on the Principal Trading Market for such security, as reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended hours basis and does not designate the last trade price, then the last trade price of such security prior to 4:00 P.M., New York City time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets. If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the Board of Directors of the Company shall use its good faith judgment to determine the fair market value. The Board of Directors&#x2019; determination shall be binding upon all parties absent demonstrable error. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the United States Securities and Exchange Commission.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Securities Exchange Act of 1934, as amended.</font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Group</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall have the meaning ascribed to it in Section 13(d) of the Exchange Act, and all related rules, regulations and jurisprudence.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof.</font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(g) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Principal Trading Market</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the national securities exchange or other trading market on which the Common Stock is primarily listed on and quoted for trading, which, as of the Original Issue Date, shall be the Nasdaq Global Market.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(h) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Securities Act of 1933, as amended.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Standard Settlement Period</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the standard settlement period, expressed in a number of Trading Days, for the Principal Trading Market with respect to the Common Stock that is in effect on the date of delivery of an applicable Exercise Notice, which as of the Original Issue Date was &#x201c;T+2.&#x201d;</font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(j) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trading Day</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any weekday on which the Principal Trading Market is normally open for trading.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(k) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Transfer Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means Equiniti Trust Company, LLC, the Company&#x2019;s transfer agent and registrar for the Common Stock, and any successor appointed in such capacity.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Issuance of Securities; Registration of Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall register ownership of this Warrant, upon records to be maintained by the Company for that purpose (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Register</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee to which this Warrant is permissibly assigned hereunder) from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Registration of Transfers</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to compliance with all applicable securities laws, the Company shall, or will cause its Transfer Agent to, register the transfer of all or any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, and payment for all applicable transfer taxes (if any). Upon any such registration or transfer, a new warrant to purchase Common Stock in substantially the form of this Warrant (any such new warrant, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">New Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) evidencing the portion of this Warrant so transferred shall be issued to the transferee, and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company shall, or will cause its Transfer Agent to, prepare, issue and deliver at the Company&#x2019;s own expense any New Warrant under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 3</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Until due presentment for registration of transfer, the Company may treat the registered Holder hereof as the owner and holder for all purposes, and the Company shall not be affected by any notice to the contrary.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Exercise of Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) All or any part of this Warrant shall be exercisable by the registered Holder in any manner permitted by this Warrant (including Section 11) at any time and from time to time on or after the Original Issue Date, and such rights shall not expire.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) The Holder may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Schedule 1</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> hereto (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise Notice</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant Shares as to which this Warrant is being exercised (which may take the form of a &#x201c;cashless exercise&#x201d; if so indicated in the Exercise Notice pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> below), and the date on which the last of such items is delivered to the Company (as determined in accordance with the notice provisions hereof) is an </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;Exercise Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.&#x201d; The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number of Warrant Shares, if any.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Delivery of Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;" id="ole_link1"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font id="ole_link2"></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Upon exercise of this Warrant, the Company shall promptly (but in no event later than the number of Trading Days comprising the Standard Settlement Period following the Exercise Date), upon the request of the Holder, credit such aggregate number of shares of Common Stock specified by the Holder in the Exercise Notice and to which the Holder is entitled pursuant to such exercise (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) to the Holder&#x2019;s or its designee&#x2019;s balance account with The Depository Trust Company (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DTC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) through its Deposit Withdrawal At Custodian system, or if the Transfer Agent is then a participant in the DTC Fast Automated Securities Transfer</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Program (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FAST Program</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or the resale of such Warrant Shares by the Holder or (B) the Exercise Shares are eligible for resale by the Holder without volume or manner-of-sale restrictions pursuant to Rule 144 promulgated under the Securities Act (assuming cashless exercise of this Warrant).  If the Transfer Agent is not a member of the FAST Program or if (A) and (B) above are not true, the Transfer Agent will either (i) record the Exercise Shares in the name of the Holder or its designee on the certificates reflecting the Exercise Shares with an appropriate legend regarding restriction on transferability, which shall be issued and dispatched by overnight courier to the address as specified in the Exercise Notice, and on the Company&#x2019;s share register or (ii) issue such Exercise Shares in the name of the Holder or its designee in restricted book-entry form in the Company&#x2019;s share register. The Holder, or any Person so designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date, irrespective of the date such Warrant Shares are credited to the Holder&#x2019;s DTC account, the date of the book entry positions or the date of delivery of the certificates evidencing such Exercise Shares, as the case may be.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) If the Company fails to deliver to the Holder or its designee Exercise Shares in the manner required pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 5(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> within the Standard Settlement Period following the Exercise Date and the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Buy-In</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) but did not receive within the Standard Settlement Period, then the Company shall, within two (2) Trading Days after the Holder&#x2019;s request and in the Holder&#x2019;s sole discretion, promptly honor its obligation to deliver to the Holder or its designee the Exercise Shares pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 5(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and pay cash to the Holder in an amount equal to the excess (if any) of Holder&#x2019;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased in the Buy-In, less the product of (A) the number of shares of Common Stock purchased in the Buy-In, times (B) the Closing Sale Price of a share of Common Stock on the Exercise Date.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) To the extent permitted by law and subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company&#x2019;s obligations to issue and deliver Warrant Shares in accordance with and subject to the terms hereof (including the limitations set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 11</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> below) are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance that might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, nothing herein shall limit the Holder&#x2019;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#x2019;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Charges, Taxes and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Issuance and delivery of shares of Common Stock upon exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense (excluding any applicable stamp duties) in respect of the issuance of such shares, all of which taxes and expenses shall be paid by the Company; </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any Warrant Shares or the Warrants in a name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Replacement of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and reasonable contractual indemnity, if requested by the Company. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company&#x2019;s obligation to issue the New Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;" id="ole_link4"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8. </font><font id="ole_link3"></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reservation of Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company covenants that it will, at all times while this Warrant is outstanding, reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares that are initially issuable and deliverable upon the exercise of this entire</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder (taking into account the adjustments and restrictions of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">). The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized, issued and fully paid and non-assessable. The Company will take all such action as may be reasonably necessary to assure that such shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation system upon which the Common Stock may be listed. The Company further covenants that it will not, without the prior written consent of the Holder, take any actions to increase the par value of the Common Stock at any time while this Warrant is outstanding.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Certain Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Number of Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) are subject to adjustment from time to time as set forth in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock Dividends and Splits</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock or otherwise makes a distribution on any class of capital stock issued and outstanding on the Original Issue Date and in accordance with the terms of such stock on the Original Issue Date or as amended, that is payable in shares of Common Stock, (ii) subdivides its outstanding shares of Common Stock into a larger number of shares of Common Stock, (iii) combines its outstanding shares of Common Stock into a smaller number of shares of Common Stock or (iv) issues by reclassification of shares of capital stock any additional shares of Common Stock of the Company, then in each such case the Number of Warrant Shares shall be multiplied by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding immediately after such event and the denominator of which shall be the number of shares of Common Stock outstanding immediately before such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not fully paid on the date fixed therefor, the Number of Warrant Shares shall be recomputed accordingly as of the close of business on such record date and thereafter the Number of Warrant Shares shall be adjusted pursuant to this paragraph as of the time of actual payment of such dividends. Any adjustment pursuant to clause (ii), (iii) or (iv) of this paragraph shall become effective immediately after the effective date of such subdivision, combination or issuance.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pro Rata Distributions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If, on or after the Original Issue Date, the Company shall declare or make any dividend or other pro rata distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property, options, evidence of indebtedness or any other assets by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction, but, for the avoidance of doubt, excluding any distribution of shares of Common Stock subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, any distribution of Purchase Rights (as defined below) subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and any Fundamental Transaction (as defined below) subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9(d))</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without limitation, the Maximum Percentage (as defined below)) immediately before the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, that to the extent that the Holder&#x2019;s right to participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to such extent (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution (and beneficial ownership) to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Purchase Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  If at any time on or after the Original Issue Date, the Company grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property, in each case pro rata to the record holders of any class of Common Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Purchase Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issuance or sale of such Purchase Rights (provided, that to the extent that the Holder&#x2019;s right to participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership of such Common Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and such Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such time or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase Right to be held similarly in abeyance) to the same extent as if there had been no such limitation). As used in this Section 9(c), (i) &#x201c;Options&#x201d; means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities and (ii) &#x201c;Convertible Securities&#x201d; mean any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock.</font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fundamental Transactions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If, at any time while this Warrant is outstanding (i) the Company effects any merger or consolidation of the Company with or into another Person, in which the Company is not the surviving entity or in which the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly, at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii) the Company effects any sale to another Person of all or substantially all of its assets in one or a series of related transactions, (iii) pursuant to any tender offer or exchange offer (whether by the Company or another Person), holders of capital stock tender shares representing more than 50% of the voting power of the capital stock of the Company and the Company or such other Person, as applicable, accepts such tender for payment, (iv) the Company consummates a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the voting power of the capital stock of the Company (except for any such transaction in which the stockholders of the Company immediately prior to such transaction maintain, in substantially the same proportions, the voting power of such Person immediately after the transaction) or (v) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> above) (in any such case, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fundamental Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then following such Fundamental Transaction the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard to any limitations on exercise contained herein (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Alternate Consideration</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The Company shall not effect any Fundamental Transaction in which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person unless (i) the Alternate Consideration is solely cash and the Company provides for the simultaneous &#x201c;cashless exercise&#x201d; of this Warrant pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> below or (ii) prior to or simultaneously with the consummation thereof, any successor to the Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume the obligation to deliver to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and the other obligations under this Warrant. The provisions of this paragraph (c) shall similarly apply to subsequent transactions analogous of a Fundamental Transaction type.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Number of Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Simultaneously with any adjustment to the Number of Warrant Shares pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Exercise Price shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the increased or decreased Number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.  Notwithstanding the foregoing, in no event may the Exercise Price be adjusted below the par value of the Common Stock then in effect.</font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Calculations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All calculations under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shall be made to the nearest one-tenth of one cent or the nearest share, as applicable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(g) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notice of Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Upon the occurrence of each adjustment pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company at its expense will, at the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the Company&#x2019;s transfer agent.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(h) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notice of Corporate Events</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If, while this Warrant is outstanding, the Company (i) declares a dividend or any other distribution of cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants to subscribe for or purchase any capital stock of the Company or any subsidiary, (ii) authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company, then the Company shall deliver to the Holder a notice of such transaction at least ten (10) days prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote with respect to such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice. In addition, if while this Warrant is outstanding, the Company authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction contemplated by </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9(d)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, other than a Fundamental Transaction under clause (iii) of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> 9(d), the Company shall deliver to the Holder a notice of such Fundamental Transaction at least thirty (30) days prior to the date such Fundamental Transaction is consummated. Holder agrees to maintain any information disclosed pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9(h)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> in confidence until such information is publicly available, and shall comply with applicable law with respect to trading in the Company&#x2019;s securities following receipt of any such information.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Payment of Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a &#x201c;cashless exercise&#x201d;, in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">X = Y [(A-B)/A]</font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">where:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;X&#x201d; equals the number of Warrant Shares to be issued to the Holder;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;Y&#x201d; equals the total number of Warrant Shares with respect to which this Warrant is then being exercised;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;A&#x201d; equals the Closing Sale Price of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;B&#x201d; equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a &#x201c;cashless exercise&#x201d; transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If the Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that, in accordance with Section 3(a)(9) of the Securities Act, the Exercise Shares issued in such exercise shall take on the registered characteristics of the Warrants being exercised and may be tacked on to the holding period of the Warrants being exercised. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Limitations on Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) Notwithstanding anything to the contrary contained herein, the Company shall not effect the exercise of any portion of this Warrant, and the Holder of the Warrant shall not have the right to exercise any portion of the Warrant, and any such exercise shall be null and void ab initio and treated as if the exercise had not been made, to the extent that immediately prior to or following such exercise, the Holder, together with the Attribution Parties, beneficially owns or would beneficially own as determined in accordance with Section 13(d) of the Exchange Act and the rules promulgated thereunder, in excess of 4.99% (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Maximum Percentage</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of the Common Stock that</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;" id="ole_link5"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">would be issued and outstanding following such exercise. For purposes of calculating beneficial ownership for determining whether the Maximum Percentage is or will be exceeded, the aggregate number of shares of Common Stock held and/or beneficially owned by the Holder</font><font id="ole_link6"></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> together with the Attribution Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, shall include the number of shares of Common Stock held and/or beneficially owned by the Holder  together with the Attribution Parties plus the number of shares of Common Stock issuable upon exercise of the relevant Warrant with respect to which the determination is being made but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, unexercised Warrant held and/or beneficially owned by the Holder or the Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company held and/or beneficially owned by such Holder or any Attribution Party (including, without limitation, any convertible notes, convertible stock or warrants) that are subject to a limitation on conversion or exercise analogous to the limitation contained herein. For purposes of this Paragraph 11(a), beneficial ownership of the Holder or the Attribution Parties shall, except as set forth in the immediately preceding sentence, be calculated and determined in accordance with Section 13(d) of the Exchange Act and the rules promulgated thereunder. For purposes of the Warrant, in determining the number of outstanding shares of Common Stock, a Holder of the Warrant may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company&#x2019;s most recent Form 10-K, Form 10-Q, Current Report on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Company&#x2019;s transfer agent setting forth the number of shares of Common Stock outstanding (such issued and outstanding shares, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reported Outstanding Share Number</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). For any reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding.  </font><font id="ole_link7"></font><font id="ole_link8"></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Holder shall disclose to the Company the number of shares of Common Stock that it, together with the Attribution Parties holds and/or beneficially owns and has the right to acquire through the exercise of derivative securities and any limitations on exercise or conversion analogous to the limitation contained herein contemporaneously or immediately prior to submitting an Exercise Notice for the relevant Warrant. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> If the Company receives an Exercise Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder&#x2019;s, together with the Attribution Parties&#x2019;, beneficial ownership, as determined pursuant to this Section 11(a), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the &#x201c;Reduction Shares&#x201d;) and (ii) as soon as reasonably practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction Shares.  In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and the Attribution Parties since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results in the Holder, together with the Attribution Parties, being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the Exchange Act), the number of shares so issued by which the Holder&#x2019;s, together with the Attribution Parties&#x2019;, aggregate beneficial ownership exceeds the Maximum Percentage (the &#x201c;Excess Shares&#x201d;) shall be deemed null and void and shall be cancelled ab initio, and the Holder and/or the Attribution Parties shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the Holder the exercise price paid by the Holder for the Excess Shares. By written notice to the Company, a Holder of the Warrant may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 19.99% specified in such notice; provided that any increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company and shall not negatively affect any partial exercise effected prior to such change.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) This </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 11</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shall not restrict the number of shares of Common Stock which a Holder or the  Attribution Parties may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder or the Attribution Parties may receive in the event of a Fundamental Transaction as contemplated in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of this Warrant. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder or the Attribution Parties for any purpose including for purposes of Section 13(d) of the Exchange Act and the rules promulgated thereunder or Section 16 of the Exchange Act and the rules promulgated thereunder, including Rule 16a-1(a)(1). No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">applicability of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 11</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to the extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 11</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of this Warrant.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">12. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">No Fractional Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next whole number and the Company shall pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such fractional shares.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered confirmed e-mail at the e-mail address specified in the books and records of the Transfer Agent prior to 5:30 P.M., New York City time, on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via confirmed e-mail at the e-mail address specified in the books and records of the Transfer Agent on a day that is not a Trading Day or later than 5:30 P.M., New York City time, on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service specifying next business day delivery, or (iv) upon actual receipt by the Person to whom such notice is required to be given, if by hand delivery.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">14. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Warrant Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall initially serve as warrant agent under this Warrant. Upon thirty (30) days&#x2019; notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&#x2019;s last address as shown on the Warrant Register.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Miscellaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No Rights as a Stockholder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Except as otherwise set forth in this Warrant, the Holder, solely in such Person&#x2019;s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&#x2019;s capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Authorized Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. (i) Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate or articles of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (a) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (b) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant, and (c) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ii) Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Successors and Assigns</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may not be assigned by the Company without the written consent of the Holder, except to a successor in the event of a Fundamental Transaction. This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and assigns.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amendment and Waiver</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Except as otherwise provided herein, the provisions of the Warrants may be amended and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Acceptance</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Governing Law; Jurisdiction</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(g) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(h) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby, and the Company and the Holder will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12%;"></td>
    <td style="width:1%;"></td>
    <td style="width:87%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">ACRIVON THERAPEUTICS, INC.</font></p></td>
   </tr>
   <tr style="height:12.25pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="margin-left:0.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.139%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SCHEDULE 1</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FORM OF EXERCISE NOTICE</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">[To be executed by the Holder to purchase shares of Common Stock under the Warrant]</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ladies and Gentlemen:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(1) The undersigned is the Holder of Warrant No. __ (the &#x201c;Warrant&#x201d;) issued by Acrivon Therapeutics, Inc., a Delaware corporation (the &#x201c;Company&#x201d;). Capitalized terms used herein and not otherwise defined herein have the respective meanings set forth in the Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(2) The undersigned hereby exercises its right to purchase Warrant Shares pursuant to the Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(3) The Holder intends that payment of the Exercise Price shall be made as (check one):</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:0.046%;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.841%;"></td>
    <td style="width:3.841%;"></td>
    <td style="width:92.318%;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash Exercise</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:0.046%;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.841%;"></td>
    <td style="width:3.841%;"></td>
    <td style="width:92.318%;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;Cashless Exercise&#x201d; under Section 10 of the Warrant</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(4) If the Holder has elected a Cash Exercise, the Holder shall pay the sum of $ in immediately available funds to the Company in accordance with the terms of the Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(5) Pursuant to this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in accordance with the terms of the Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(6) By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby the Holder will not beneficially own in excess of the number of shares of Common Stock (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned under Section</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11(a) of the Warrant to which this notice relates.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:33%;"></td>
    <td style="width:1%;"></td>
    <td style="width:66%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dated:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.007in;border-bottom:1pt solid #000000;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;border-bottom:1pt solid #ffffff03;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name of Holder:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.007in;border-bottom:1pt solid #000000;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;border-bottom:1pt solid #ffffff03;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.007in;border-bottom:1pt solid #000000;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;border-bottom:1pt solid #ffffff03;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.007in;border-bottom:1pt solid #000000;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;border-bottom:1pt solid #ffffff03;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.007in;border-bottom:1pt solid #000000;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;border-bottom:1pt solid #ffffff03;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Signature must conform in all respects to name of Holder as specified on the face of the Warrant)</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>acrv-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES PURCHASE AGREEMENT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">BY AND AMONG</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ACRIVON THERAPEUTICS, INC.,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">AND</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">THE PURCHASERS</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">AS SET FORTH HEREIN</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">April 8, 2024</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">TABLE OF CONTENTS</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:11.16%;"></td>
    <td style="width:85.54%;"></td>
    <td style="width:3.3%;"></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;vertical-align:top;"><p style="text-indent:-21.6pt;padding-left:21.6pt;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Definitions</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;vertical-align:top;"><p style="text-indent:-21.6pt;padding-left:21.6pt;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Purchase and Sale of Securities</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.1</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Purchase and Sale</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Closing</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;vertical-align:top;"><p style="text-indent:-21.6pt;padding-left:21.6pt;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Representations and Warranties of the Company</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.1</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Organization and Power</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalization</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.3</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Registration Rights</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.4</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Authorization</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.5</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Valid Issuance</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.6</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">No Conflict</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Consents</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.8</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">SEC Filings; Financial Statements</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.9</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Absence of Changes</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.10</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Absence of Litigation</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.11</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Compliance with Law; Permits</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.12</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intellectual Property</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.13</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Employee Benefits</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.14</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Taxes</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.15</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Environmental Laws</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.16</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.17</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Insurance</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.18</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq Stock Market</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.19</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sarbanes-Oxley Act</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.20</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Clinical Data and Regulatory Compliance</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.21</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Compliance with Health Care Laws</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.22</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounting Controls and Disclosure Controls and Procedures</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.23</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Price Stabilization of Common Stock</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.24</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Investment Company Act</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.25</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">General Solicitation; No Integration or Aggregation</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.26</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Brokers and Finders</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.27</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reliance by the Purchasers</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.28</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">No Disqualification Events</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.29</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">No Additional Agreements</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.30</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Anti-Bribery and Anti-Money Laundering Laws</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.31</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cybersecurity</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.32</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Compliance with Data Privacy Laws</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.33</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Transactions with Affiliates and Employees</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.34</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reliance</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.35</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shell Company Status.</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;vertical-align:top;"><p style="text-indent:-21.6pt;padding-left:21.6pt;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Representations and Warranties of Each Purchaser</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">i</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:11.16%;"></td>
    <td style="width:85.54%;"></td>
    <td style="width:3.3%;"></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.1</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Organization</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Authorization</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.3</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">No Conflict</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.4</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Residency</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.5</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Brokers and Finders</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.6</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Investment Representations and Warranties</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intent</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.8</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Investment Experience; Ability to Protect Its Own Interests and Bear Economic Risks</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.9</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Independent Investment Decision</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.10</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Securities Not Registered; Legends</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.11</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Placement Agent</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.12</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">No General Solicitation</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.13</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Access to Information</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.14</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Certain Trading Activities</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.15</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Disqualification Event</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;vertical-align:top;"><p style="text-indent:-21.6pt;padding-left:21.6pt;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Covenants</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.1</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Further Assurances</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Listing</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.3</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Disclosure of Transactions</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.4</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Integration</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.5</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Removal of Legends</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.6</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Withholding Taxes</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.7</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fees and Taxes</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.8</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">No Conflicting Agreements</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.9</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reporting Status</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.10</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Indemnification.</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.11</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Subsequent Equity Sales</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.12</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reservation of Common Stock</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;vertical-align:top;"><p style="text-indent:-21.6pt;padding-left:21.6pt;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Conditions of Closing</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.1</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Conditions to the Obligation of the Purchasers</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Conditions to the Obligation of the Company</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;vertical-align:top;"><p style="text-indent:-21.6pt;padding-left:21.6pt;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Termination</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.1</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Termination</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Notice</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;vertical-align:top;"><p style="text-indent:-21.6pt;padding-left:21.6pt;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Miscellaneous Provisions</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.1</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Public Statements or Releases</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interpretation</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.3</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Notices</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.4</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Severability</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.5</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Governing Law; Submission to Jurisdiction; Venue; Waiver of Trial by Jury</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.6</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Waiver</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.7</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expenses</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ii</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:11.16%;"></td>
    <td style="width:85.54%;"></td>
    <td style="width:3.3%;"></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.8</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Assignment</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.9</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Confidential Information</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.10</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reliance by and Exculpation of Placement Agent</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.11</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Third Parties</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">33</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.12</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Independent Nature of Purchasers&#x2019; Obligations and Right</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">33</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.13</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Counterparts</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">33</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.14</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Entire Agreement; Amendments</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.15</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Survival</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.16</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Mutual Drafting</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:54pt;vertical-align:top;"><p style="margin-left:21.6pt;text-indent:-32.4pt;padding-left:32.4pt;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.17</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Additional Matters</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibits</font></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A	Purchasers</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit B	Form of Registration Rights Agreement</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit C	Form of Pre-Funded Warrant</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">iii</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES PURCHASE AGREEMENT</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> (this &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is dated as of April 8, 2024, by and among Acrivon Therapeutics, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and each of the entities listed on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> attached to this Agreement (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Purchaser</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and together, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Purchasers</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the Company and the Purchasers are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;);</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the Company desires to sell to the Purchasers, and each Purchaser desires to purchase from the Company, severally and not jointly, upon the terms and subject to the conditions stated in this Agreement, (A) shares (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock, par value $0.001 per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and/or (B) the pre-funded warrants to purchase shares of Common Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) substantially in the form attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit C</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">; and</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, contemporaneously with the sale of the Shares and the Pre-Funded Warrants, the parties hereto will execute and deliver a Registration Rights Agreement, substantially in the form attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, pursuant to which the Company will agree to provide certain registration rights in respect of the Shares and the Pre-Funded Warrant Shares (as defined below) under the Securities Act and applicable state securities laws.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">NOW THEREFORE</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, in consideration of the mutual agreements, representations, warranties and covenants herein contained, the Company and each Purchaser, severally and not jointly, agree as follows:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">1.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. As used in this Agreement, the following terms shall have the following respective meanings:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2024 SEC Reports</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean (a) the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and (b) any Quarterly Reports on Form 10-Q or any Current Reports on Form 8-K filed or furnished (as applicable) by the Company after December 31, 2023 and prior to the Business Day immediately preceding the date hereof, together in each case with any documents incorporated by reference therein or exhibits thereto.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean, with respect to any Person, any other Person that, directly or indirectly through one or more intermediates, controls, is controlled by or is under common control with such Person.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in the recitals hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Amended and Restated Certificate of Incorporation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the Certificate of Incorporation of the Company, as currently in effect.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Amended and Restated Bylaws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the Bylaws of the Company, as currently in effect.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Benefit Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Benefit Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean employee benefit plans as defined in Section 3(3) of ERISA and all other employee benefit practices or arrangements, including, without limitation, any such practices or arrangements providing severance pay, sick leave, vacation pay, salary continuation for disability, retirement benefits, deferred compensation, bonus pay, incentive pay, stock options or other stock-based compensation, hospitalization insurance, medical insurance, life insurance, scholarships or tuition reimbursements, maintained by the Company or to which the Company or any of its Subsidiaries is obligated to contribute for employees or former employees of the Company and its Subsidiaries.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the board of directors of the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Business Day</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Closing</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Closing Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.03pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the Internal Revenue Code of 1986, as amended.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in the recitals hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Common Stock Equivalents</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any securities of the Company which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in the recitals hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Data</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.31</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disclosure Document</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 5.3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Drug Regulatory Agency</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the United States Food and Drug Administration (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FDA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) or other foreign, state, local or comparable governmental authority responsible for regulation of the research, development, testing, manufacturing, processing, storage, labeling, sale, marketing, advertising, distribution and importation or exportation of drug or biological products and drug or biological product candidates.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Environmental Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.15</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ERISA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the U.S. Employee Retirement Income Security Act of 1974, as amended.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the Securities Exchange Act of 1934, as amended, and all of the rules and regulations promulgated thereunder.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Financial Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.8(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">GAAP</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.8(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">GDPR</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.32</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Governmental Authorizations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.11</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Health Care Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.21</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">HIPAA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.31</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Intellectual Property</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.12</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">IT Systems</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.31</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Material Adverse Effect</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean any change, event, circumstance, development, condition, occurrence or effect that, individually or in the aggregate, (a) was, is, or would reasonably be expected to be, materially adverse to the business, financial condition, properties, assets, liabilities, stockholders&#x2019; equity or results of operations of the Company and its Subsidiaries, taken as a whole, or (b) materially delays or materially impairs the ability of the Company to comply, or prevents the Company from complying, with its obligations under this Agreement, the other Transaction Agreements, or with respect to the Closing or would reasonably be expected to do so; provided, however, that none of the following will be deemed in themselves, either alone or in combination, to constitute, and that none of the following will be taken into account in determining whether there has been or will be, a Material Adverse Effect under subclause (a) of this definition:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(i)	any change generally affecting the economy, financial markets or political, economic or regulatory conditions in the United States or any other geographic region in which the Company conducts business, provided that the Company is not disproportionately affected thereby;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(ii)	general financial, credit or capital market conditions, including interest rates or exchange rates, or any changes therein, provided that the Company is not disproportionately affected thereby;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iii)	any change that generally affects industries in which the Company and its Subsidiaries conduct business, provided that the Company is not disproportionately affected thereby;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iv)	earthquakes, hurricanes, tsunamis, tornadoes, floods, mudslides, fires or other natural disasters, weather conditions, global pandemics, including the COVID-19 pandemic and related strains, epidemic or similar health emergency, and other force majeure events in the United States or any other location, provided that the Company is not disproportionately affected thereby;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(v)	national or international political or social conditions (or changes in such conditions), whether or not pursuant to the declaration of a national emergency or war, or the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">occurrence of any military or terrorist attack, provided that the Company is not disproportionately affected thereby;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(vi)	material changes in laws after the date of this Agreement; and</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(vii)	in and of itself, any material failure by the Company to meet any published or internally prepared estimates of revenues, expenses, earnings or other economic performance for any period ending on or after the date of this Agreement (it being understood that the facts and circumstances giving rise to such failure may be deemed to constitute, and may be taken into account in determining whether there has been, a Material Adverse Effect to the extent that such facts and circumstances are not otherwise described in clauses (i)-(v) of this definition).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Nasdaq</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Nasdaq Stock Market LLC.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">National Exchange</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question, together with any successor thereto: the NYSE American, The New York Stock Exchange, the Nasdaq Global Market, the Nasdaq Global Select Market and the Nasdaq Capital Market.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Per Share Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means $8.50.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Per Warrant Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means $8.499.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture or any other entity or organization.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Personal Data</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.31</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Placement Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means Jefferies LLC.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in the recitals hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Privacy Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.32</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Privacy Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.32</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Process</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Processing</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.32</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Purchaser</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Purchasers</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; have the meanings set forth in the recitals hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Registration Rights Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 6.1(j)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Regulatory Agencies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.20 </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">hereof.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Rule 144</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same effect as such Rule.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the United States Securities and Exchange Commission.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SEC Reports</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.8(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in the recitals hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in the recitals hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Short Sales</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; include, without limitation, (i) all &#x201c;short sales&#x201d; as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the box, and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, short sales, swaps, &#x201c;put equivalent positions&#x201d; (as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements (including on a total return basis), and (ii) sales and other transactions through non-U.S. broker dealers or non-U.S. regulated brokers (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Subsidiaries</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Tax Returns</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean returns, reports, information statements and other documentation (including any additional or supporting material) filed or maintained, or required to be filed or maintained, in connection with the calculation, determination, assessment or collection of any Tax and shall include any amended returns required as a result of examination adjustments made by the Internal Revenue Service or other Tax authority.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Tax</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean any and all federal, state, local, foreign and other taxes, levies, fees, imposts, duties and charges of whatever kind (including any interest, penalties or additions to the tax imposed in connection therewith or with respect thereto), whether or not imposed on the Company, including, without limitation, taxes imposed on, or measured by, income, franchise, profits or gross receipts, and also ad valorem, value added, sales, use, service, real or personal property, capital stock, license, payroll, withholding, employment, social security, workers&#x2019; compensation, unemployment compensation, utility, severance, production, excise, stamp, occupation, premium, windfall profits, transfer and gains taxes and customs duties.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Transaction Agreements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean this Agreement, the Pre-Funded Warrants, and the Registration Rights Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Transfer Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean, with respect to the Common Stock, Equiniti Trust Company, LLC, or such other financial institution that provides transfer agent services as the Company may engage from time to time.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Transfer Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean all real property transfer, sales, use, value added, stamp, documentary, recording, registration, conveyance, stock transfer, intangible property transfer,</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">personal property transfer, gross receipts, registration, duty, securities transactions or similar fees or Taxes (together with any interest, penalty, or addition thereto) incurred in connection with the transactions contemplated by this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Purchase and Sale of Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Purchase and Sale</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.   On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $130,000,440 of Securities (as defined below), with a purchase price per Share equal to the Per Share Price and a purchase price per Pre-Funded Warrant equal to the Per Warrant Price. Subject to and upon the terms and conditions set forth in this Agreement, at the Closing, the Company shall issue and sell to each Purchaser, and each Purchaser, severally and not jointly, shall purchase from the Company, (A) that number of Shares equal to (x) the dollar amount set forth opposite such Purchaser&#x2019;s name on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> under the heading &#x201c;Share Purchase Price&#x201d; divided by (y) the Per Share Price, rounded down to the nearest whole share, and/or (B) a Pre-Funded Warrant exercisable for a number of shares of Common Stock equal to (x) the dollar amount set forth opposite such Purchaser&#x2019;s name on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> under the heading &#x201c;Pre-Funded Warrant Purchase Price&#x201d; divided by (y) the Per Warrant Price, rounded down to the nearest whole share.  The Shares and the Pre-Funded Warrants to be issued in the Closing (as defined below) are collectively referred to herein as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.&#x201d;</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Closing</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Subject to the satisfaction or waiver of the conditions set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 5.6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> of this Agreement, the closing of the purchase and sale of the Securities (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Closing</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and the date on which the Closing occurs, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Closing Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) shall occur remotely via the exchange of documents and signatures at such time as agreed to by the Company and the Purchasers but (i) in no event earlier than the second Business Day after the date hereof and (ii) in no event later than the fifth Business Day after the date hereof.  At the Closing, the Shares shall be issued and registered in the name of such Purchaser, or in such nominee name(s) as designated by such Purchaser, representing the number of Shares to be purchased by such Purchaser at such Closing as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, in each case against payment to the Company of the purchase price therefor (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Aggregate Purchase Amount</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) in full, by wire transfer to the Company of immediately available funds, at or prior to the Closing, in accordance with wire instructions provided by the Company to the Purchasers prior to the Closing. At the Closing, the Company shall deliver to such Purchaser (or such Purchaser&#x2019;s designated custodian per its delivery instructions), or in such nominee name(s) as designated by such Purchaser, a Pre-Funded Warrant exercisable for a number of shares of Common Stock as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> with respect to such Purchaser, in each case against payment to the Company of the purchase price therefor in full, by wire transfer to the Company of immediately available funds, at or prior to the Closing, in accordance with wire instructions provided by the Company to the Purchasers prior to the Closing. On the Closing Date, the Company will cause the Transfer Agent to issue the Shares in book-entry form, free and clear of all restrictive and other legends (except as expressly provided in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 4.10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof) and the Company shall provide evidence of such issuance from the Company&#x2019;s Transfer Agent as of the Closing Date to each Purchaser. In the event that the Closing has not occurred within one Business Day of after the expected Closing Date, unless otherwise agreed by the Company and such Purchaser, the Company shall promptly (but no later than one Business Day thereafter) return the previously wired Aggregate Purchase Amount to each respective Purchaser by wire transfer of United States dollars in immediately available funds to the account</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">specified by each Purchaser, and any book entries for the Securities shall be deemed cancelled; provided that, unless this Agreement has been terminated pursuant to Section 7, such return of funds shall not terminate this Agreement or relieve such Purchaser of its obligation to purchase, or the Company of its obligation to issue and sell, the Securities at the Closing.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Representations and Warranties of the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company hereby represents and warrants to each of the Purchasers and the Placement Agent that the statements contained in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> are true and correct as of the date hereof and as of the Closing Date (except for the representations and warranties that speak as of a specific date, which shall be made as of such date):</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Organization and Power</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, has the requisite power and authority to own, lease and operate its properties and to carry on its business as now conducted and described in the 2024 SEC Reports and is qualified to do business in each jurisdiction in which the character of its properties or the nature of its business requires such qualification, except where such failure to be in good standing or to have such power and authority or to so qualify would not reasonably be expected to have a Material Adverse Effect. As of the date hereof, the Company has the following subsidiaries: Acrivon AB, a joint stock company incorporated under the laws of Sweden, and Acrivon Securities Corporation, a Massachusetts corporation (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Subsidiaries</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  Each of the  Subsidiaries is duly incorporated and validly existing and in good standing under the laws of the  jurisdiction of its incorporation  and has the requisite power and authority to carry on their business as now conducted and to own or lease its properties.  Each of the Subsidiaries is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which such qualification is required unless the failure to so qualify has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Capitalization</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The authorized capital stock of the Company consists of 500,000,000 shares of Common Stock and 10,000,000 shares of preferred stock, par value $0.001 per share. The Company&#x2019;s disclosure of its issued and outstanding capital stock in the 2024 SEC Reports containing such disclosure was accurate in all material respects as of the date indicated in such 2024 SEC Reports. All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued and are fully paid and non-assessable. None of the outstanding shares of capital stock of the Company were issued in violation of any preemptive or other similar rights of any securityholder of the Company which have not been waived, and such shares were issued in compliance in all material respects with applicable state and federal securities law and any rights of third parties.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Registration Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Except as set forth in the Transaction Agreements or as disclosed in the 2024 SEC Reports, the Company is presently not under any obligation, and has not granted any rights, to register under the Securities Act any of the Company&#x2019;s presently outstanding securities or any of its securities that may hereafter be issued that have not expired or been satisfied or waived.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Authorization</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company has all requisite corporate power and authority to enter into the Transaction Agreements and to carry out and perform its obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">7</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">under the terms of the Transaction Agreements, including the issuance and sale of the Securities and the issuance of the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  All corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization of the Shares and the Pre-Funded Warrant Shares, the authorization, execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated herein, including the issuance and sale of the Securities and the Pre-Funded Warrant Shares, has been taken.  This Agreement has been duly executed and delivered by the Company and assuming the due authorization, execution and delivery by each Purchaser and that this Agreement constitutes the legal, valid and binding agreement of each Purchaser, this Agreement constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws relating to or affecting creditors generally or by general equity principles (regardless of whether such enforceability is considered in a proceeding in equity or at law). Upon its execution by the Company and the other parties thereto and assuming that it constitutes legal, valid and binding agreements of the other parties thereto, the Registration Rights Agreement will constitute a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws relating to or affecting creditors generally or by general equity principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Valid Issuance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Shares being purchased by the Purchasers hereunder have been duly and validly authorized and, upon issuance pursuant to the terms hereof, against full payment therefor in accordance with the terms of this Agreement, will be duly and validly issued, fully paid and non-assessable and will be issued free and clear of any liens or other restrictions (other than those as provided in the Transaction Agreements or restrictions on transfer under applicable state and federal securities laws) and the holder of the Shares shall be entitled to all rights accorded to a holder of Common Stock. The Pre-Funded Warrant Shares have been duly and validly authorized and reserved for issuance and, upon issuance pursuant to the terms of the Pre-Funded Warrants, against full payment therefor in accordance with the terms of the Pre-Funded Warrants, will be duly and validly issued, fully paid and non-assessable and will be issued free and clear of any liens or other restrictions (other than those as provided in the Transaction Agreements or restrictions on transfer under applicable state and federal securities laws) and the holder of the Pre-Funded Warrant Shares shall be entitled to all rights accorded to a holder of Common Stock. Subject to the accuracy of the representations and warranties made by the Purchasers in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof, the offer and sale of the Securities to the Purchasers is and will be in compliance with applicable exemptions from (i) the registration and prospectus delivery requirements of the Securities Act and (ii) the registration and qualification requirements of applicable securities laws of the states of the United States.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No Conflict</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The execution, delivery and performance of the Transaction Agreements by the Company, the issuance and sale of the Securities and the consummation of the other transactions contemplated by the Transaction Agreements will not (i) violate any provision of the Amended and Restated Certificate of Incorporation or Amended and Restated Bylaws of the Company, (ii) conflict with or result in a violation of or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">obligation, a change of control right or to a loss of a benefit under any agreement or instrument, credit facility, franchise, license, judgment, order, statute, law, ordinance, rule or regulations, applicable to the Company or any Subsidiary or their respective properties or assets, or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or any Subsidiary is subject (including federal and state securities laws and regulations) and the rules and regulations of any self-regulatory organization to which the Company or its securities are subject, or by which any property or asset of the Company or any Subsidiary is bound or affected, except, in the case of clauses (ii) and (iii), as would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.7	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Consents</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Assuming the accuracy of the representations and warranties of the Purchasers, no consent, approval, authorization, filing with or order of or registration with, any court or governmental agency or body is required in connection with the authorization, execution or delivery by the Company of the Transaction Agreements, the issuance and sale of the Securities and the performance by the Company of its other obligations under the Transaction Agreements, except such as (a) have been or will be obtained or made under the Securities Act or the Exchange Act, (b) the filing of any requisite notices and/or application(s) to the National Exchange for the issuance and sale of the Shares or the Pre-Funded Warrant Shares and the listing of the Shares or the Pre-Funded Warrant Shares for trading or quotation, as the case may be, thereon in the time and manner required thereby, (c) customary post-closing filings with the SEC or pursuant to state securities laws in connection with the offer and sale of the Shares or the Pre-Funded Warrant Shares by the Company in the manner contemplated herein, which will be filed on a timely basis, and (d) the filing of the registration statement required to be filed by the Registration Rights Agreement, or (e) such that the failure of which to obtain would not have a Material Adverse Effect. All notices, consents, authorizations, orders, filings and registrations which the Company is required to deliver or obtain prior to the Closing pursuant to the preceding sentence have been obtained or made or will be delivered or obtained or effected, and shall remain in full force and effect, on or prior to the Closing.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.8	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SEC Filings; Financial Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	The Company has timely filed or furnished, as applicable, all forms, statements, certifications, reports and documents required to be filed or furnished by it with the SEC under the Exchange Act or the Securities Act for the one year preceding the date hereof (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SEC Reports</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  As of the time it was filed with, or furnished to, the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing), each of the SEC Reports complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act (as the case may be), and the rules and regulations promulgated thereunder, and, as of the time they were filed or furnished, none of the SEC Reports contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. There are no outstanding or unresolved comments from the SEC staff with respect to the SEC Reports. None of the SEC Reports is the subject of an ongoing SEC review.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">9</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	The financial statements of the Company included in the SEC Reports (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Financial Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing (or to the extent corrected by a subsequent restatement) and fairly present in all material respects the financial position of the Company as of the dates indicated, and the results of its operations and cash flows for the periods therein specified, all in accordance with United States generally accepted accounting principles (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">GAAP</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) (except as otherwise noted therein, and in the case of unaudited financial statements, as permitted by Form 10-Q of the SEC, and except that the unaudited financial statements may not contain footnotes and are subject to normal and recurring year-end adjustments) applied on a consistent basis unless otherwise noted therein throughout the periods therein specified. Except as set forth in the Financial Statements filed prior to the date hereof, the Company has not incurred any liabilities, contingent or otherwise, except (i) those incurred in the ordinary course of business, consistent with past practices since the date of such financial statements or (ii) liabilities not required under GAAP to be reflected in the Financial Statements, in either case, none of which, individually or in the aggregate, have had or would reasonably be expected to have a Material Adverse Effect.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.9	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Absence of Changes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Except as otherwise stated or disclosed in the 2024 SEC Reports, between December 31, 2023 and the date of this Agreement, (a) the Company has conducted its business only in the ordinary course of business and there have been no material transactions entered into by the Company (except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto); (b) no material change to any material contract or arrangement by which the Company is bound or to which any of its assets or properties is subject has been entered into that has not been disclosed in the 2024 SEC Reports; and (c) there has not been any other event or condition of any character that has had or would reasonably be expected to have a Material Adverse Effect.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.10	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Absence of Litigation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  There is no action, suit, proceeding, arbitration, claim, investigation or inquiry pending or, to the Company&#x2019;s knowledge, threatened against the Company or any Subsidiary which, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect, nor are there any orders, writs, injunctions, judgments or decrees outstanding of any court or government agency or instrumentality and binding upon the Company or any Subsidiary that have had or would reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary, nor to the knowledge of the Company, any director or officer of the Company or any Subsidiary, is, or within the last ten years has been, the subject of any action involving a claim of violation of or liability under federal or state securities laws relating to the Company or such Subsidiary or a claim of breach of fiduciary duty relating to the Company or such Subsidiary.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.11	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Compliance with Law; Permits</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  None of the Company or any Subsidiary is in violation of, or has received any notices of violations with respect to, any laws, statutes, ordinances, rules or regulations of any governmental body, court or government agency or instrumentality, except for violations which, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect.  The Company and its Subsidiaries have all required licenses, permits, certificates and other authorizations (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Governmental Authorizations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) from such federal, state or local government or governmental agency, department or body that are currently necessary for the operation of the business of the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">10</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company and its Subsidiaries as currently conducted, except where the failure to possess currently such Governmental Authorizations has not had and is not reasonably expected to have a Material Adverse Effect.  None of the Company or any Subsidiary has received any written (or, to the Company&#x2019;s knowledge, oral) notice regarding any revocation or material modification of any such Governmental Authorization, which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, has or would reasonably be expected to result in a Material Adverse Effect.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.12	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Intellectual Property</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company and its Subsidiaries own, or have rights to use, all material inventions, patent applications, patents, trademarks, trade names, service names, service marks, copyrights, trade secrets, know how (including unpatented and/or unpatentable proprietary of confidential information, systems or procedures) and other intellectual property as described in the 2024 SEC Reports  necessary for, or used in the conduct of their respective businesses (including as described in the 2024 SEC Reports) (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Intellectual Property</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), except where any failure to own, possess or acquire such Intellectual Property has not had, and would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.  The Intellectual Property of the Company and its Subsidiaries has not been adjudged by a court of competent jurisdiction to be invalid or unenforceable, in whole or in part.  To the Company&#x2019;s knowledge: (i) there are no third parties who have rights to any Intellectual Property, including no liens, security interests, or other encumbrances; and (ii) there is no infringement by third parties of any Intellectual Property.  No action, suit, or other proceeding is pending, or, to the Company&#x2019;s knowledge, is threatened: (A) challenging the Company&#x2019;s or its Subsidiaries&#x2019; rights in or to any Intellectual Property; (B) challenging the validity, enforceability or scope of any Intellectual Property; or (C) alleging that the Company or any of its Subsidiaries infringes, misappropriates, or otherwise violates any patent, trademark, trade name, service name, copyright, trade secret or other proprietary rights of others, except, in each case, which, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect.  The Company and its Subsidiaries have complied in all material respects with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or any of its Subsidiaries in all material respects, and to the Company&#x2019;s knowledge all such agreements are in full force and effect.  To the Company&#x2019;s knowledge, there are no material defects in any of the patents or patent applications included in the Intellectual Property.  The Company and its Subsidiaries have taken all reasonable steps to protect, maintain and safeguard their Intellectual Property.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.13	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Employee Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Except as would not be reasonably likely to result in a Material Adverse Effect, each Benefit Plan has been established and administered in accordance with its terms and in compliance with the applicable provisions of ERISA, the Code, the Patient Protection and Affordable Care Act of 2010, as amended, and other applicable laws, rules and regulations.  The Company and its Subsidiaries are in compliance with all applicable federal, state and local laws, rules and regulations regarding employment, except for any failures to comply that are not reasonably likely, individually or in the aggregate, to have a Material Adverse Effect.  There is no labor dispute, strike or work stoppage against the Company or its Subsidiaries pending or, to the knowledge of the Company, threatened which may interfere with the business activities of the Company, except where such dispute, strike or work stoppage is not reasonably likely, individually or in the aggregate, to have a Material Adverse Effect.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">11</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.14	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company and its Subsidiaries have filed all federal, state and foreign income Tax Returns and other Tax Returns required to have been filed under applicable law (or extensions have been duly obtained) and have paid all Taxes required to have been paid by them, except for those which are being contested in good faith and except where failure to file such Tax Returns or pay such Taxes would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. No assessment in connection with United States federal tax returns has been made against the Company. The charges, accruals and reserves on the books of the Company in respect of any income and corporation tax liability for any years not finally determined are adequate to meet any assessments or reassessments for additional income tax for any years not finally determined, except to the extent of any inadequacy that would not result in a Material Adverse Effect. No audits, examinations, or other proceedings with respect to any material amounts of Taxes of the Company and its Subsidiaries are presently in progress or have been asserted or proposed in writing without subsequently being paid, settled or withdrawn.  There are no liens on any of the assets of the Company.  The Company, at all times since inception, has been and continues to be each classified as a corporation for U.S. federal income tax purposes.  Neither the Company nor any of its Subsidiaries has been a United States real property holding corporation within the meaning of Code Section 897I(2) during the period specified in Code Section 897(c)(1)(A)(ii).</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.15	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Environmental Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company and its Subsidiaries (i) are in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Environmental Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), (ii) have received all permits and other Governmental Authorizations required under applicable Environmental Laws to conduct its business and (iii) are in compliance with all terms and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.  None of the Company or any Subsidiary has received since January 1, 2023, any written notice or other communication (in writing or otherwise), whether from a governmental authority or other Person, that alleges that the Company or any Subsidiary is not in compliance with any Environmental Law and, to the knowledge of the Company, there are no circumstances that may prevent or interfere with the Company&#x2019;s or any Subsidiary&#x2019;s compliance in any material respects with any Environmental Law in the future, except where such failure to comply would not reasonably be expected to have a Material Adverse Effect.  To the knowledge of the Company: (i) no current or (during the time a prior property was leased or controlled by the Company) prior property leased or controlled by the Company or any Subsidiary has received since January 1, 2023, any written notice or other communication relating to property owned or leased at any time by the Company, whether from a governmental authority, or other Person, that alleges that such current or prior owner or the Company or any Subsidiary is not in compliance with or violated any Environmental Law relating to such property and (ii) the Company has no material liability under any Environmental Law.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.16	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Title</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Each of the Company and its Subsidiaries has good and marketable title to all personal property owned by it that is material to the business of the Company, free and clear of all liens, encumbrances and defects except such as do not materially affect the value of such property and do not interfere with the use made and proposed to be made of such property by</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">12</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company or its Subsidiaries, as the case may be.  Any real property and buildings held under lease by the Company or its Subsidiaries is held under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company or its Subsidiaries, as the case may be.  The Company does not own any real property.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.17	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Insurance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company carries or is entitled to the benefits of insurance in such amounts and covering such risks that is customary for comparably situated companies and is adequate for the conduct of its business and the value of its properties (owned or leased) and assets, and each of such insurance policies is in full force and effect and the Company is in compliance in all material respects with the terms thereof.  Other than customary end of policy notifications from insurance carriers, since January 1, 2023, the Company has not received any notice or other communication regarding any actual or possible: (i) cancellation or invalidation of any insurance policy or (ii) refusal or denial of any coverage, reservation of rights or rejection of any material claim under any insurance policy.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.18	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Nasdaq Stock Market</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The issued and outstanding shares of Common Stock are registered pursuant to Section 12(b) of the Exchange Act and are listed for trading on the Nasdaq Global Market under the symbol &#x201c;ACRV&#x201d;. The Company is in compliance with all applicable listing requirements of Nasdaq applicable to the Company. As of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company by Nasdaq or the SEC, respectively, to prohibit or terminate the listing of the Common Stock on the Nasdaq Global Market or to deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date hereof that is designed to terminate the registration of the Common Stock under the Exchange Act.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.19	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Sarbanes-Oxley Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company is, and since January 1, 2023 has been, in compliance with all applicable requirements of the Sarbanes-Oxley Act of 2002 and applicable rules and regulations promulgated by the SEC thereunder.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.20	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Clinical Data and Regulatory Compliance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Except as would not reasonably be expected to result in a Material Adverse Effect: (i) the preclinical tests and clinical trials, and other studies used to support regulatory approval (collectively, &#x201c;studies&#x201d;) being conducted by the Company that are described in, or the results of which are referred to in, 2024 SEC Reports were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; (ii) each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its Subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the 2024 SEC Reports; (iii) the Company and its Subsidiaries have made all such filings and obtained all such approvals as may be required by the FDA or from any other U.S. federal, state or local government or foreign government or Drug Regulatory Agency, or Institutional Review Board, each having jurisdiction over biopharmaceutical products (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Regulatory Agencies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) for the conduct of its business as described in the 2024 SEC Reports; (iv) neither the Company nor any of its Subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination or suspension of or imposing any clinical hold on</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">13</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">any clinical trials that are described or referred to in the 2024 SEC Reports; and (v) the Company and its Subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.21	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Compliance with Health Care Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company and its Subsidiaries are in compliance in all material respects with all Health Care Laws to the extent applicable to the Company&#x2019;s current business and research use only products.  For purposes of this Agreement, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Health Care Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means: (i) the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Section 301 et seq.) and the Public Health Service Act (42 U.S.C. Section 201 et seq.), and the regulations promulgated thereunder; (ii) all applicable federal, state, local and foreign health care fraud and abuse laws, including, without limitation, the Anti-Kickback Statute (42 U.S.C. Section 1320a-7b(b)); (iii) HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. Section 17921 et seq.); (iv) the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010; (v) the European Union (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">EU</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) Clinical Trials Regulation (Regulation (EU) No. 536/2014); (vi) the EU Regulation regarding community procedures for authorization and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Regulation (EC) No. 726/2004); (vii) licensure, quality, safety and accreditation requirements under applicable federal, state, local or foreign laws or regulatory bodies; (viii) all other local, state, federal, national, supranational and foreign laws, relating to the regulation of the Company or its Subsidiaries, and (ix) the regulations promulgated pursuant to such statutes and any state or non-U.S. counterpart thereof.  Neither the Company nor any of its Subsidiaries has received written or, to the Company&#x2019;s knowledge, oral notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental or regulatory authority or third party alleging that any product operation or activity is in material violation of any Health Care Laws nor, to the Company&#x2019;s knowledge, is any such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action threatened.  The Company and its Subsidiaries have filed, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Health Care Laws, and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and accurate on the date filed in all material respects (or were corrected or supplemented by a subsequent submission).  Neither the Company nor any of its Subsidiaries is a party to any corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority.  Additionally, neither the Company, any of its Subsidiaries nor any of their respective employees, officers, directors, or, to the knowledge of the Company, agents has been excluded, suspended or debarred from participation in any U.S. federal health care program or human clinical research or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension, or exclusion.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.22	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Accounting Controls and Disclosure Controls and Procedures</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance (i) that the Company maintains records that in reasonable detail</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">14</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">accurately and fairly reflect the Company&#x2019;s transactions and dispositions of assets, (ii) that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, (iii) that receipts and expenditures are made only in accordance with authorizations of management and the Board and (iv) regarding prevention or timely detection of the unauthorized acquisition, use or disposition of the Company&#x2019;s assets that could have a material effect on the Company&#x2019;s financial statements.  Except as disclosed in the Company&#x2019;s SEC Reports filed prior to the date hereof, the Company has not identified any material weaknesses in the design or operation of the Company&#x2019;s internal control over financial reporting. The Company&#x2019;s &#x201c;disclosure controls and procedures&#x201d; (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) are designed to provide reasonable assurance that all information (both financial and non-financial) required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such information is accumulated and communicated to the Company&#x2019;s management as appropriate to allow timely decisions regarding required disclosure.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.23	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Price Stabilization of Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company has not taken, nor will it take, directly or indirectly, any action designed to stabilize or manipulate the price of the Common Stock to facilitate the sale or resale of the Shares or the Pre-Funded Warrant Shares.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.24	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Investment Company Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company is not, and immediately after receipt of payment for the Common Stock will not be, an &#x201c;investment company&#x201d; within the meaning of the Investment Company Act of 1940, as amended.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.25	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">General Solicitation; No Integration or Aggregation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Neither the Company nor any other person or entity authorized by the Company to act on its behalf has engaged in a general solicitation or general advertising (within the meaning of Regulation D of the Securities Act) of investors with respect to offers or sales of Common Stock pursuant to this Agreement.  The Company has not, directly or indirectly, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act) which, to its knowledge, is or will be (i) integrated with the Securities sold pursuant to this Agreement for purposes of the Securities Act or (ii) aggregated with prior offerings by the Company for the purposes of the rules and regulations of the Nasdaq Global Market. Assuming the accuracy of the representations and warranties of the Purchasers set forth in Section 4, neither the Company nor any of its Affiliates, its subsidiaries nor any Person acting on their behalf has, directly or indirectly, made any offers or sales of any Company security or solicited any offers to buy any Company security, under circumstances that would adversely affect reliance by the Company on Section 4(a)(2) for the exemption from registration for the transactions contemplated hereby.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.26	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Brokers and Finders</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Other than the Placement Agent, neither the Company nor any other Person authorized by the Company to act on its behalf has retained, utilized or been represented by any broker or finder in connection with the transactions contemplated by this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.27	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Reliance by the Purchasers</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company acknowledges that each of the Purchasers will rely upon the truth and accuracy of, and the Company&#x2019;s compliance with, the representations, warranties, agreements, acknowledgements and understandings of the Company set forth herein.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">15</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.28	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No Disqualification Events</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Neither the Company nor any of its (i) predecessors, (ii) affiliates, (iii) directors, (iv) executive officers, (v) non-executive officers participating in the placement contemplated by this Agreement, (vi) beneficial owners of 20% or more of its outstanding voting equity securities (calculated on the basis of voting power), (vii) promoters, or (viii) investment managers (including any of such investment managers&#x2019; directors, executive officers or officers participating in the placement contemplated by this Agreement) or general partners or managing members of such investment managers (including any of such general partners&#x2019; or management members&#x2019; directors, executive officers or officers participating in the placement contemplated by this Agreement) is subject to the disqualification provisions of Rule 506(d) of Regulation D under the Securities Act.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.29	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No Additional Agreements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  To the knowledge of the Company, there are no agreements or understandings with any Purchaser with respect to the transactions contemplated by the Transaction Agreements other than (i) as specified in the Transaction Agreements and (ii) any side letter agreements with any of the Purchasers, which side letters the Company has shared with any Purchaser that has so requested.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.30	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Anti-Bribery and Anti-Money Laundering Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Each of the Company, its Subsidiaries and, to the knowledge of the Company, any of their respective officers, directors, supervisors, managers, agents, or employees are and have at all times been in compliance with and its participation in the offering will not violate: (A) anti-bribery laws, including but not limited to, any applicable law, rule, or regulation of any locality, including but not limited to any law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or any other law, rule or regulation of similar purposes and scope or (B) anti-money laundering laws, including, but not limited to, applicable federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money laundering, including, without limitation, Title 18 US. Code sections 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international anti-money laundering principles or procedures by an intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering, of which the United States is a member and with which designation the United States representative to the group or organization continues to concur, all as amended, and any executive order, directive, or regulation pursuant to the authority of any of the foregoing, or any orders or licenses issued thereunder.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.31	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Cybersecurity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company and its Subsidiaries&#x2019; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">IT Systems</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) are adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Company and its Subsidiaries as currently conducted, and are free and clear of all material Trojan horses, time bombs, malware and other malicious code. The Company and its Subsidiaries have implemented and maintained commercially reasonable physical, technical and administrative controls designed to maintain and protect the confidentiality, integrity, availability, privacy and security of all sensitive, confidential or regulated data (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Data</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) used or maintained in connection with their businesses and Personal Data (defined below), and the integrity, availability continuous operation, redundancy and security of all IT Systems. &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Personal Data</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the following data used in connection with the Company&#x2019;s and its Subsidiaries&#x2019; businesses and in their possession or</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">16</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">control: (i) a natural person&#x2019;s name, street address, telephone number, e-mail address, photograph, social security number or other tax identification number, driver&#x2019;s license number, passport number, credit card number or bank information; (ii) information that identifies or may reasonably be used to identify an individual; (iii) any information that would qualify as &#x201c;protected health information&#x201d; under the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">HIPAA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;); and (iv) any information that would qualify as &#x201c;personal data,&#x201d; &#x201c;personal information&#x201d; (or similar term) under the Privacy Laws. To the Company&#x2019;s knowledge, there have been no breaches, outages or unauthorized uses of or accesses to the Company&#x2019;s IT Systems, Confidential Data, or Personal Data that would require notification under Privacy Laws (as defined below).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.32	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Compliance with Data Privacy Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company and its Subsidiaries are, and at all prior times were, in material compliance with all applicable state, federal and foreign data privacy and security laws and regulations regarding the collection, use, storage, retention, disclosure, transfer, disposal, or any other processing (collectively &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Process</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Processing</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of Personal Data, including without limitation HIPAA, the EU General Data Protection Regulation (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">GDPR</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) (Regulation (EU) No. 2016/679), all other local, state, federal, national, supranational and foreign laws relating to the regulation of the Company or its Subsidiaries, and the regulations promulgated pursuant to such statutes and any state or non-U.S. counterpart thereof (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Privacy Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). To ensure material compliance with the Privacy Laws, the Company and its Subsidiaries have in place, comply with, and take all appropriate steps necessary to ensure compliance in all material respects with their policies and procedures relating to data privacy and security, and the Processing of Personal Data and Confidential Data (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Privacy Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The Company and its Subsidiaries have, except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, at all times since inception provided accurate notice of its Privacy Statements then in effect to its customers, employees, third party vendors and representatives. None of such disclosures made or contained in any Privacy Statements have been materially inaccurate, misleading, incomplete, or in material violation of any Privacy Laws.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.33	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Transactions with Affiliates and Employees</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. No relationship, direct or indirect, exists between or among the Company, on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company, on the other hand, that is required to be described in the SEC Reports that is not so described.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.34	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Reliance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company has a reasonable basis for making each of the representations set forth in this Section 3. The Company acknowledges that the Purchaser is relying upon the accuracy and truthfulness of the foregoing representations made by the Company hereunder and hereby consents to such reliance.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3.35	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Shell Company Status</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company is not, and has never been, an issuer identified in Rule 144(i)(1).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Representations and Warranties of Each Purchaser</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Each Purchaser, severally for itself and not jointly with any other Purchaser, represents and warrants to the Company and the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">17</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Placement Agent that the statements contained in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> are true and correct as of the date hereof and the Closing Date:</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Organization</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Such Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization and has the requisite power and authority to own, lease and operate its properties and to carry on its business as now conducted.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Authorization</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Such Purchaser has all requisite corporate or similar power and authority to enter into this Agreement and the other Transaction Agreements to which it will be a party and to carry out and perform its obligations hereunder and thereunder.  All corporate, member or partnership action on the part of such Purchaser or its stockholders, members or partners necessary for the authorization, execution, delivery and performance of this Agreement and the other Transaction Agreements to which it will be a party and the consummation of the other transactions contemplated herein has been taken. The signature of the Purchaser on this Agreement is genuine and the signatory to this Agreement, if the Purchaser is an individual, has the legal competence and capacity to execute the same or, if the Purchaser is not an individual, the signatory has been duly authorized to execute the same on behalf of the Purchaser. Assuming this Agreement constitutes the legal and binding agreement of the Company, this Agreement constitutes a legal, valid and binding obligation of such Purchaser, enforceable against such Purchaser in accordance with its respective terms, except as such enforceability may be limited or otherwise affected by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and/or similar laws relating to or affecting the rights of creditors generally or by general equity principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No Conflict</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s.  The execution, delivery and performance of the Transaction Agreements by such Purchaser, the purchase of the Securities in accordance with their terms and the consummation by such Purchaser of the other transactions contemplated hereby will not conflict with or result in any violation of, breach or default by such Purchaser (with or without notice or lapse of time, or both) under, conflict with, or give rise to a right of termination, cancellation or acceleration of any obligation, a change of control right or to a loss of a material benefit under (i) any provision of the organizational documents of such Purchaser, including, without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable or (ii) any agreement or instrument, undertaking, credit facility, franchise, license, judgment, order, ruling, statute, law, ordinance, rule or regulations, applicable to such  Purchaser or its respective properties or assets, except, in the case of clause (ii), as would not, individually or in the aggregate, be reasonably expected to materially delay or hinder the ability of such Purchaser to perform its obligations under the Transaction Agreements.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Residency</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Such Purchaser&#x2019;s residence (if an individual) or offices in which its investment decision with respect to the Securities was made (if an entity) are located at the address immediately below such Purchaser&#x2019;s name on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, except as otherwise communicated by such Purchaser to the Company.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">18</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Brokers and Finders</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Such Purchaser has not retained, utilized or been represented by any broker or finder in connection with the transactions contemplated by this Agreement whose fees the Company would be required to pay.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Investment Representations and Warranties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Each Purchaser hereby represents and warrants that, it (i) as of the date hereof is, if an entity, a &#x201c;qualified institutional buyer&#x201d; (as defined in Rule 144A under the Securities Act) or an institutional &#x201c;accredited investor&#x201d; as that term is defined in Rule 501(a) under Regulation D promulgated pursuant to the Securities Act; or (ii) if an individual, is an &#x201c;accredited investor&#x201d; as that term is defined in Rule 501(a) of Regulation D of the Securities Act and has such knowledge and experience in financial and business matters as to be able to protect its own interests in connection with an investment in the Securities. Each Purchaser further represents and warrants that (x) it is capable of evaluating the merits and risk of such investment, and (y) that it has not been organized for the purpose of acquiring the Securities and is an &#x201c;institutional account&#x201d; as defined by FINRA Rule 4512(c). Such Purchaser understands and agrees that the offering and sale of the Securities has not been registered under the Securities Act or any applicable state securities laws and is being made in reliance upon federal and state exemptions for transactions not involving a public offering which depend upon, among other things, the bona fide nature of the investment intent and the accuracy of such Purchaser&#x2019;s representations as expressed herein.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.7	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Intent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Each Purchaser is purchasing the Securities solely for investment purposes, for such Purchaser&#x2019;s own account and not for the account of others, and not with a view to the resale or distribution of any part thereof in violation of the Securities Act, and the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same in violation of the Securities Act without prejudice, however, to the Purchaser&#x2019;s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable federal and state securities laws.  Notwithstanding the foregoing, if such Purchaser is purchasing the Securities as a fiduciary or agent for one or more investor accounts, such Purchaser has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account. Each Purchaser has no present arrangement to sell the Securities to or through any person or entity. Each Purchaser understands that the Securities must be held indefinitely unless such Securities are resold pursuant to a registration statement under the Securities Act or an exemption from registration is available. Nothing contained herein shall be deemed a representation or warranty by such Purchaser to hold the Securities for any period of time.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.8	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Investment Experience; Ability to Protect Its Own Interests and Bear Economic Risks</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Each Purchaser acknowledges that it can bear the economic risk and complete loss of its investment in the Securities and has knowledge and experience in finance, securities, taxation, investments and other business matters as to be capable of evaluating the merits and risks of investments of the kind described in this Agreement and contemplated hereby, and the Purchaser has had an opportunity to seek, and has sought, such accounting, legal, business and tax advice as such Purchaser has considered necessary to make an informed investment decision.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Each Purchaser acknowledges that such Purchaser (i) is a sophisticated investor, experienced in investing in private placements of equity securities and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">19</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">involving a security or securities and (ii) has exercised independent judgment in evaluating its participation in the purchase of the Securities. Each Purchaser acknowledges that such Purchaser is aware that there are substantial risks incident to the purchase and ownership of the Securities, including those set forth in the Company&#x2019;s filings with the SEC. Alone, or together with any professional advisor(s), such Purchaser has adequately analyzed and fully considered the risks of an investment in the Securities and determined that the Securities are a suitable investment for the Purchaser. Each Purchaser is, at this time and in the foreseeable future, able to afford the loss of such Purchaser&#x2019;s entire investment in the Securities and such Purchaser acknowledges specifically that a possibility of total loss exists.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.9	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Independent Investment Decision</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Such Purchaser understands that nothing in the Transaction Agreements or any other materials presented by or on behalf of the Company to such Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice. Such Purchaser has consulted such legal, tax and investment advisors as it, in their sole discretion, has deemed necessary or appropriate in connection with its purchase of the Securities.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.10	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Securities Not Registered; Legends</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Such Purchaser acknowledges and agrees that the Securities are being offered in a transaction not involving any public offering within the meaning of the Securities Act, and such Purchaser understands that the Securities have not been registered under the Securities Act, by reason of their issuance by the Company in a transaction exempt from the registration requirements of the Securities Act, and that the Securities must continue to be held and may not be offered, resold, transferred, pledged or otherwise disposed of by such Purchaser unless a subsequent disposition thereof is registered under the Securities Act or is exempt from such registration and in each case in accordance with any applicable securities laws of any state of the United States.  Such Purchaser understands that the exemptions from registration afforded by Rule 144 (the provisions of which are known to it) promulgated under the Securities Act depend on the satisfaction of various conditions including, but not limited to, the time and manner of sale, the holding period and on requirements relating to the Company which are outside of such Purchaser&#x2019;s control and which the Company may not be able to satisfy, and that, if applicable, Rule 144 may afford the basis for sales only in limited amounts. Such Purchaser acknowledges and agrees that it has been advised to consult legal counsel prior to making any offer, resale, transfer, pledge or disposition of any of the Securities. Such Purchaser acknowledges that no federal or state agency has passed upon or endorsed the merits of the offering of the Securities or made any findings or determination as to the fairness of this investment.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Each Purchaser understands that any certificates or book entry notations evidencing the Shares may bear one or more legends in substantially the following form and substance:</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;SECURITIES ACT&#x201d;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT, (II) SUCH SECURITIES MAY BE SOLD PURSUANT TO RULE 144, (III) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">20</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">THAT SUCH TRANSFER MAY LAWFULLY BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT, OR (IV) THE SECURITIES ARE TRANSFERRED WITHOUT CONSIDERATION TO AN AFFILIATE OF SUCH HOLDER OR A CUSTODIAL NOMINEE (WHICH FOR THE AVOIDANCE OF DOUBT SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY OF AN OPINION).&#x201d;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">In addition, the Securities may contain a legend regarding affiliate status of the Purchaser, if applicable.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.11	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Placement Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Each Purchaser hereby acknowledges and agrees that (a) the Placement Agent is acting solely as placement agent in connection with the execution, delivery and performance of the Transaction Agreements and the issuance of the Securities to Purchaser and neither the Placement Agent nor any of its affiliates have acted as an underwriter or in any other capacity and is not and shall not be construed as a fiduciary or financial advisor for such Purchaser, the Company or any other person or entity in connection with the execution, delivery and performance of the Transaction Agreements and the issuance and purchase of the Securities, (b) the Placement Agent has not made and does not make any representation or warranty, whether express or implied, of any kind or character, or has not provided any advice or recommendation in connection with the execution, delivery and performance of the Transaction Agreements or with respect to the Securities, nor is such information or advice necessary or desired, (c) the Placement Agent will not have any responsibility with respect to (i) any representations, warranties or agreements made by any person or entity under or in connection with the execution, delivery and performance of the Transaction Agreements, or the execution, legality, validity or enforceability (with respect to any person) thereof, or (ii) the business, affairs, financial condition, operations, properties or prospects of, or any other matter concerning the Company, and (d) the Placement Agent will not have any liability or obligation (including without limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements incurred by such Purchaser, the Company or any other person or entity), whether in contract, tort or otherwise, to such Purchaser, or to any person claiming through it, in respect of the execution, delivery and performance of the Transaction Agreements, except in each case for such party&#x2019;s own gross negligence, willful misconduct or bad faith. No disclosure or offering document has been prepared by the Placement Agent or any of its affiliates in connection with the offer and sale of the Securities. Neither the Placement Agent nor any of its affiliates have made or make any representation as to the quality or value of the Securities and the Placement Agent and any its affiliates may have acquired non-public information with respect to the Company which Purchaser agrees need not be provided to it.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.12	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No General Solicitation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Purchaser acknowledges and agrees that the Purchaser is purchasing the Securities directly from the Company. Purchaser became aware of this offering of the Securities solely by means of direct contact from the Placement Agent or directly from the Company as a result of a pre-existing, substantive relationship with the Company or the Placement Agent, and/or their respective advisors (including, without limitation, attorneys, accountants, bankers, consultants and financial advisors), agents, control persons, representatives, affiliates, directors, officers, managers, members, and/or employees, and/or the representatives of such persons. The Securities were offered to Purchaser solely by direct contact between Purchaser and the Company, the Placement Agent and/or their respective representatives. Purchaser did not become aware of this offering of the Securities, nor were the Securities offered to Purchaser, by</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">21</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">any other means, and none of the Company, the Placement Agent and/or their respective representatives acted as investment advisor, broker or dealer to Purchaser. The Purchaser is not purchasing the Securities as a result of any general or public solicitation or general advertising, or publicly disseminated advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television, radio or the internet or presented at any seminar or any other general solicitation or general advertisement, including any of the methods described in Section 502(c) of Regulation D under the Securities Act.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.13	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Access to Information</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. In making its decision to purchase the Securities, Purchaser has relied solely upon independent investigation made by Purchaser, upon the SEC Reports and upon the representations, warranties and covenants set forth herein. The Purchaser acknowledges and agrees that the Purchaser has received such information as the Purchaser deems necessary in order to make an investment decision with respect to the Securities, including, with respect to the Company. Without limiting the generality of the foregoing, each Purchaser acknowledges that copies of the 2024 SEC Reports are available on EDGAR at www.sec.gov. The Purchaser acknowledges and agrees that the Purchaser and the Purchaser&#x2019;s professional advisor(s), if any, have had the opportunity to ask such questions, receive such answers and obtain such information from the Company regarding the Company, its business and the terms and conditions of the offering of the Securities as the Purchaser and such Purchaser&#x2019;s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Securities and that the Purchaser has independently made its own analysis and decision to invest in the Company. Neither such inquiries nor any other due diligence investigation conducted by such Purchaser shall modify, limit or otherwise affect such Purchaser&#x2019;s right to rely on the Company&#x2019;s representations and warranties contained in this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.14	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Certain Trading Activities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Other than consummating the transaction contemplated hereby, the Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser was first contacted by the Company or any other Person regarding the transaction contemplated hereby and ending immediately prior to the date hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#x2019;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#x2019;s assets, the representation set forth above shall only apply with respect to the portion of the assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement and to its advisors and agents who had a need to know such information, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">22</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4.15	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disqualification Event</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. To the extent the Purchaser is one of the covered persons identified in Rule 506(d)(1), the Purchaser represents that no disqualifying event described in Rule 506(d)(1)(i-viii) of the Securities Act (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disqualification Event</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is applicable to the Purchaser or any of its Rule 506(d) Related Parties (as defined below), except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. The Purchaser hereby agrees that it shall notify the Company promptly in writing in the event a Disqualification Event becomes applicable to the Purchaser or any of its Rule 506(d) Related Parties, except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. For purposes of this Section, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Rule 506(d) Related Party</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean a person or entity that is a beneficial owner of the Purchaser&#x2019;s securities for purposes of Rule 506(d) of the Securities Act.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Covenants</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Further Assurances</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Each party agrees to cooperate with each other and their respective officers, employees, attorneys, accountants and other agents, and, generally, do such other reasonable acts and things in good faith as may be necessary to effectuate the intents and purposes of this Agreement, subject to the terms and conditions hereof and compliance with applicable law, including taking reasonable action to facilitate the filing of any document or the taking of reasonable action to assist the other parties hereto in complying with the terms hereof. Each Purchaser acknowledges that the Company and the Placement Agent will rely on the acknowledgments, understandings, agreements, representations and warranties contained in this Agreement. Prior to the Closing, the Purchaser agrees to promptly notify the Company if any of the acknowledgments, understandings, agreements, representations and warranties set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> of this Agreement are no longer accurate.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Listing</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall use commercially reasonable efforts to maintain the listing and trading of its Common Stock on the Nasdaq Global Market and, in accordance therewith, will use reasonable best efforts to comply in all material respects with the Company&#x2019;s reporting, filing and other obligations under the rules and regulations of Nasdaq.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disclosure of Transactions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	The Company shall, by 9:00 a.m., New York City time, on the first (1st) Business Day immediately following the date hereof, file with the SEC a Current Report on Form 8-K (including all exhibits thereto, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disclosure Document</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) disclosing all material terms of the transactions contemplated hereby and by the other Transaction Agreements and attaching this Agreement and the other Transaction Documents as exhibits to such Disclosure Document.  Notwithstanding anything in this Agreement to the contrary, the Company shall not publicly disclose the name of any Purchaser or any of its affiliates or advisers, or include the name of any Purchaser or any of its affiliates or advisers in any press release or filing with the SEC (other than any registration statement contemplated by the Registration Rights Agreement) or any regulatory agency, without the prior written consent of such Purchaser, except (i) as required by the federal securities law in connection with (A) any registration statement contemplated by the Registration Rights Agreement and (B) the filing of final Transaction Agreements with the SEC or pursuant to other routine proceedings of regulatory authorities, or (ii) to the extent such</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">23</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">disclosure is required by law, at the request of the staff of the SEC or regulatory agency or under the regulations of the Nasdaq Global Market.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	No later than June 4, 2024, the Company shall issue a press release and/or a Current Report on Form 8-K (the actual date of such press release and/or Current Report on Form 8-K, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disclosure Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) disclosing all material non-public information concerning the Company disclosed to the Purchasers. Following the Disclosure Date, no Purchaser shall be in possession of any material non-public information received from the Company, its subsidiaries or any of their respective officers, directors, employees or agents (including the Placement Agents).</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Integration</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that will be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities to the Purchasers, or that will be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any National Exchange such that it would require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Removal of Legends</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	In connection with any sale, assignment, transfer or other disposition of the Shares or Pre-Funded Warrant Shares by a Purchaser pursuant to Rule 144 or pursuant to any other exemption under the Securities Act such that the purchaser acquires freely tradable shares and upon compliance by the Purchaser with the requirements of this Agreement, if requested by the Purchaser by notice to the Company, the Company shall request the Transfer Agent to remove any restrictive legends related to the book entry account holding such shares and make a new, unlegended entry for such book entry shares sold or disposed of without restrictive legends as soon as reasonably practicable following any such request therefor from such Purchaser, provided that the Company has timely received from the Purchaser customary representations and other documentation reasonably acceptable to the Company in connection therewith. The Company shall be responsible for the fees of its Transfer Agent and its legal counsel associated with such legend removal.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	Subject to receipt from the Purchaser by the Company and the Transfer Agent of customary representations and other documentation reasonably acceptable to the Company and the Transfer Agent in connection therewith, upon the earliest of such time as the Shares or Pre-Funded Warrant Shares (i) have been registered under the Securities Act pursuant to an effective registration statement or (ii) have been sold pursuant to Rule 144, the Company shall, in accordance with the provisions of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 5.5(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> and as soon as reasonably practicable following any request therefor from a Purchaser accompanied by such customary and reasonably acceptable documentation referred to above, (A) deliver to the Transfer Agent irrevocable instructions that the Transfer Agent shall make a new, unlegended entry for such book entry shares, and (B) cause its counsel to deliver to the Transfer Agent one or more opinions to the effect that the removal of such legends in such circumstances may be effected under the Securities Act if</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">24</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;" id="swireturnhere"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">required by the Transfer Agent to effect the removal of the legend in accordance with the provisions of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Withholding Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Each Purchaser agrees to furnish the Company with any information, representations and forms as shall reasonably be requested by the Company from time to time to assist the Company in complying with any applicable tax law (including any withholding obligations).</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.7	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Fees and Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company shall be solely responsible for the payment of any placement agent&#x2019;s fees, financial advisory fees, or broker&#x2019;s commissions (other than for Persons engaged by a Purchaser) relating to or arising out of the transactions contemplated hereby, including, without limitation, any fees or commissions payable to the Placement Agent.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.8	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No Conflicting Agreements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company will not take any action, enter into any agreement or make any commitment that would conflict or interfere in any material respect with the Company&#x2019;s obligations to the Purchasers under the Transaction Agreements.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.9	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Reporting Status</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company shall timely file all reports required to be filed with the SEC pursuant to the Exchange Act, and the Company shall not terminate its status as an issuer required to file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would otherwise permit such termination.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.10	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Indemnification.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	The Company agrees to indemnify and hold harmless each Purchaser and its Affiliates, and their respective directors, officers, trustees, members, managers, employees, investment advisers and agents, from and against any and all losses, claims, damages, liabilities and expenses (including without limitation reasonable and documented attorney fees and disbursements and other documented out-of-pocket expenses reasonably incurred in connection with investigating, preparing or defending any action, claim or proceeding, pending or threatened and the costs of enforcement thereof) to which such Person may become subject as a result of any breach of representation, warranty, covenant or agreement made by or to be performed on the part of the Company under the Transaction Agreements, and will reimburse any such Person for all such amounts as they are incurred by such Person solely to the extent such amounts have been finally judicially determined not to have resulted from such Person&#x2019;s fraud or willful misconduct.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Any person entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party; provided that any person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of such person unless (a) the indemnifying party has agreed in writing to pay such fees or expenses, (b) the indemnifying party shall have failed to assume the defense of such claim and employ counsel reasonably satisfactory to such person or (c) in the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">25</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">indemnifying party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such person); and provided, further, that the failure of any indemnified party to give written notice as provided herein shall not relieve the indemnifying party of its obligations hereunder, except to the extent that such failure to give notice shall materially adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or expenses of more than one separate firm of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party, which consent shall not be unreasonably withheld, conditioned or delayed, consent to entry of any judgment or enter into any settlement unless such judgment or settlement (i) imposes no liability or obligation on, (ii) includes as an unconditional term thereof the giving of a complete, explicit and unconditional release from the party bringing such indemnified claims of all liability of the indemnified party in respect of such claim or litigation in favor of, and (iii) does not include any admission of fault, culpability, wrongdoing, or wrongdoing or malfeasance by or on behalf of, the indemnified party. No indemnified party will, except with the consent of the indemnifying party, which consent shall not be unreasonably withheld, conditioned or delayed, consent to entry of any judgment or enter into any settlement.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.11	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Subsequent Equity Sales</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  From the date hereof until the earlier of (a) sixty (60) days after the Closing Date and (b) the Business Day immediately following the effective date of the registration statement filed pursuant to the Registration Rights Agreement, the Company shall not (A) issue shares of Common Stock or Common Stock Equivalents, (B) effect a reverse stock split, recapitalization, share consolidation, reclassification or similar transaction affecting the outstanding Common Stock or (C) file with the SEC a registration statement under the Securities Act relating to any shares of Common Stock or Common Stock Equivalents, except pursuant to the terms of the Registration Rights Agreement. Notwithstanding the foregoing, the provisions of this Section 5.11 shall not apply to (i) the issuance of the Securities hereunder, (ii) the issuance of Common Stock or Common Stock Equivalents upon the conversion, exercise or vesting of any securities of the Company outstanding on the date hereof or outstanding pursuant to clause (iii) below, (iii) the issuance of any Common Stock or Common Stock Equivalents pursuant to any Company stock-based compensation plans or in accordance with Nasdaq Stock Market Rule 5635(c)(4), or (iv) the filing of a registration statement on Form S-8 under the Securities Act to register the offer and sale of securities on an equity incentive plan or employee stock purchase plan.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5.12	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Reservation of Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue the Pre-Funded Warrant Shares that are issuable upon the exercise of the Pre-Funded Warrants.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Conditions of Closing</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Conditions to the Obligation of the Purchasers</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The several obligations of each Purchaser to consummate the transactions to be consummated at the Closing, and to purchase</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">26</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and pay for the Securities being purchased by it at the Closing pursuant to this Agreement, are subject to the satisfaction or waiver in writing of the following conditions precedent:</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Representations and Warranties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The representations and warranties of the Company contained herein shall be true and correct in all material respects, except for those representation and warranties qualified by materiality or Material Adverse Effect, which shall be true and correct in all respects, as of the date hereof and as of the Closing Date, as though made on and as of such date, except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and correct in all material respects as of such earlier date, except for those representations and warranties qualified by materiality or Material Adverse Effect, which shall be true and correct in all respects as of such earlier date.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Performance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall have performed in all material respects the obligations and conditions herein required to be performed or observed by the Company on or prior to the Closing Date.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(c)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No Injunction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The purchase of and payment for the Securities by each Purchaser shall not be prohibited or enjoined by any law or governmental or court order or regulation and no such prohibition shall have been threatened in writing.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(d)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Consents</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall have obtained any and all consents, permits, approvals, registrations and waivers necessary for the consummation of the purchase and sale of the Securities, all of which shall be in full force and effect.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(e)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Transfer Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall have furnished all required materials to the Transfer Agent to reflect the issuance of the Shares at the Closing.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(f)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Adverse Changes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Since the date hereof, no event or series of events shall have occurred that has had or would reasonably be expected to have a Material Adverse Effect.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(g)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Opinion of Company Counsel</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company shall have delivered to the Purchasers and the Placement Agent the opinion of Sidley Austin LLP, dated as of the Closing Date, in customary form and substance to be reasonably agreed upon with the Purchasers and addressing such legal matters as the Purchasers and the Company reasonably agree.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(h)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Compliance Certificate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. An authorized officer of the Company shall have delivered to the Purchasers at the Closing Date a certificate certifying that the conditions specified in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Sections 6.1(a) (Representations and Warranties)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.1(b) (Performance)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.1(c) (No Injunction)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.1(d) (Consents)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.1(e) (Transfer Agent)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.1(f) (Adverse Changes)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.1(k) (Listing Requirements)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.1(l)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> of this Agreement have been fulfilled.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(i)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Secretary&#x2019;s Certificate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Secretary of the Company shall have delivered to the Purchasers at the Closing Date a certificate certifying (i) the Amended and Restated Certificate of Incorporation; (ii) the Amended and Restated Bylaws; and (iii) resolutions of the Company&#x2019;s Board of Directors (or an authorized committee thereof) approving this</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">27</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Agreement, the other Transaction Agreements, the transactions contemplated by this Agreement and the issuance of the Securities.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(j)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Registration Rights Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall have executed and delivered the Registration Rights Agreement in the form attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Registration Rights Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) to the Purchasers.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(k)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Listing Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. No stop order or suspension of trading shall have been imposed by Nasdaq, the SEC or any other governmental or regulatory body with respect to public trading in the Common Stock. The Common Stock shall be listed on a National Exchange and shall not have been suspended, as of the Closing Date, by the SEC or the National Exchange from trading thereon nor shall suspension by the SEC or the National Exchange have been threatened, as of the Closing Date, in writing by the SEC or the National Exchange; and the Company shall have filed with Nasdaq a Notification Form: Listing of Additional Shares for the listing of the Shares and the Pre-Funded Warrant Shares.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(l)	No judgment, writ, order, injunction, award or decree of or by any court, or judge, justice or magistrate, including any bankruptcy court or judge, or any order of or by any Governmental Entity, shall have been issued, and no action or proceeding shall have been instituted by any Governmental Entity, enjoining or preventing the consummation of the transactions contemplated hereby or in the other Transaction Agreements.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Conditions to the Obligation of the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The obligation of the Company to consummate the transactions to be consummated at the Closing, and to issue and sell to each Purchaser the Common Stock to be purchased by it at the Closing pursuant to this Agreement, is subject to the satisfaction or waiver in writing of the following conditions precedent:</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Representations and Warranties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The representations and warranties of each Purchaser in Section 4 hereto shall be true and correct on and as of the Closing Date, with the same force and effect as though made on and as of the Closing Date and consummation of the Closing shall constitute a reaffirmation by the Purchaser of each of the representations, warranties, covenants and agreements of the Purchaser contained in this Agreement as of the Closing Date.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Performance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Each Purchaser shall have performed or complied with in all material respects all obligations and conditions herein required to be performed or observed by such Purchaser on or prior to the Closing Date.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(c)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Injunction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The purchase of and payment for the Securities by each Purchaser shall not be prohibited or enjoined by any law or governmental or court order or regulation.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(d)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Registration Rights Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Each Purchaser shall have executed and delivered the Registration Rights Agreement to the Company in the form attached as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(e)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall have received payment, by wire transfer of immediately available funds, in the full amount of the purchase price for the number of Securities being purchased by each Purchaser at the Closing as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">28</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">7.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">7.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.The obligations of the Company, on the one hand, and the Purchaser, on the other hand, to effect the Closing shall terminate as follows:</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(i)	Upon the mutual written consent of the Company and the Purchaser prior to the Closing;</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(ii)	By the Company if any of the conditions set forth in Section 6.2 shall have become incapable of fulfillment, and shall not have been waived by the Company;</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iii)	By the Purchaser if any of the conditions set forth in Section 6.1 shall have become incapable of fulfillment, and shall not have been waived by the Purchaser; or</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iv)	By either the Company or the Purchaser if the Closing has not occurred on or prior to the fifth Business Day following the date of this Agreement;</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided, however, that, except in the case of clauses (ii) and (iii) above, the party seeking to terminate its obligation to effect the Closing shall not then be in breach of any of its representations, warranties, covenants or agreements contained in the Transaction Agreements if such breach has resulted in the circumstances giving rise to such party&#x2019;s seeking to terminate its obligation to effect the Closing.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">7.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notice</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  In the event of termination by the Company or the Purchaser of its obligations to effect the Closing pursuant to Section 7.1, written notice thereof shall be given to the other party. Nothing in this Section 7 shall be deemed to release any party from any liability for any breach by such party of the other terms and provisions of the Transaction Agreements or to impair the right of any party to compel specific performance by any other party of its other obligations under the Transaction Agreements.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Miscellaneous Provisions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Public Statements or Releases</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Except as set forth in Section 5.3, neither the Company nor any Purchaser shall make any public announcement with respect to the existence or terms of this Agreement or the transactions provided for herein without the prior consent of the other party (which consent shall not be unreasonably withheld).  Notwithstanding the foregoing, and subject to compliance with Section 5.3, nothing in this Section 8.1 shall prevent any party from making any public announcement it considers necessary in order to satisfy its obligations under the law, including applicable securities laws, or under the rules of any national securities exchange or securities market, in which case the Company shall allow the Purchaser reasonable time to comment on such release or announcement in advance of such issuance. The Company shall not include the name of the Purchaser in any press release or public announcement (which, for the avoidance of doubt, shall not include any filing with the SEC) without the prior written consent of the Purchaser, except as otherwise required by law or the applicable rules or regulations of any securities exchange or securities market, in which case the Company shall allow the Purchaser, to the extent reasonably practicable in the circumstances, reasonable time to comment on such release or announcement in advance of such issuance.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">29</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Interpretation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The words &#x201c;hereof,&#x201d; &#x201c;herein&#x201d; and &#x201c;hereunder&#x201d; and words of similar import when used in this Agreement will refer to this Agreement as a whole and not to any particular provision of this Agreement, and section and subsection references are to this Agreement unless otherwise specified.  The headings in this Agreement are included for convenience of reference only and will not limit or otherwise affect the meaning or interpretation of this Agreement.  Whenever the words &#x201c;include,&#x201d; &#x201c;includes&#x201d; or &#x201c;including&#x201d; are used in this Agreement, they will be deemed to be followed by the words &#x201c;without limitation.&#x201d;  The phrases &#x201c;the date of this Agreement,&#x201d; &#x201c;the date hereof&#x201d; and terms of similar import, unless the context otherwise requires, will be deemed to refer to the date set forth in the first paragraph of this Agreement.  The meanings given to terms defined herein will be equally applicable to both the singular and plural forms of such terms.  All matters to be agreed to by any party hereto must be agreed to in writing by such party unless otherwise indicated herein.  References to agreements, policies, standards, guidelines or instruments, or to statutes or regulations, are to such agreements, policies, standards, guidelines or instruments, or statutes or regulations, as amended or supplemented from time to time (or to successors thereto).</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Any notices or other communications required or permitted to be given hereunder shall be in writing and shall be deemed to be given (a) when delivered if personally delivered to the party for whom it is intended, (b) when delivered, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient&#x2019;s next Business Day, (c) three (3) days after having been sent by certified or registered mail, return-receipt requested and postage prepaid, or (d) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt:</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	If to the Company, addressed as follows:</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Acrivon Therapeutics, Inc.<br>480 Arsenal Way, Suite 100</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Watertown, Massachusetts<br>Attention: Peter Blume-Jensen; Rasmus Holm-Jorgensen; Mary-Alice Miller<br>Email: pblumejensen@acrivon.com; rholmjorgensen@acrivon.com; mmiller@acrivon.com</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:26.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">with a copy (which shall not constitute notice):</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Sidley Austin LLP.<br>787 Seventh Avenue</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">New York, NY 10019</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Attention: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Asher Rubin; Istvan Hajdu<br>Email:  arubin@sidley.com; ihajdu@sidley.com</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	If to any Purchaser, at its address set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or to such e-mail address, or address as subsequently modified by written notice given in accordance with this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 8.3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">30</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Any Person may change the address to which notices and communications to it are to be addressed by notification as provided for herein.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. If any part or provision of this Agreement is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction, the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Agreement shall remain binding upon the parties hereto.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Governing Law; Submission to Jurisdiction; Venue; Waiver of Trial by Jury</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York without regard to choice of laws or conflicts of laws provisions thereof that would require the application of the laws of any other jurisdiction, except to the extent that mandatory principles of Delaware law may apply.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	The Company and each of the Purchasers  hereby irrevocably and unconditionally:</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(i)	submits for itself and its property in any legal action or proceeding relating solely to this Agreement or the transactions contemplated hereby, to the general jurisdiction of the any state court or United States Federal court sitting in the City of New York in the State of New York;</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(ii)	consents that any such action or proceeding may be brought in such courts, and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same to the extent permitted by applicable law;</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iii)	agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to the party, as the case may be, at its address set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 8.3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or at such other address of which the other party shall have been notified pursuant thereto;</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iv)	agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction for recognition and enforcement of any judgment or if jurisdiction in the courts referenced in the foregoing clause (i) are not available despite the intentions of the parties hereto;</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(v)	agrees that final judgment in any such suit, action or proceeding brought in such a court may be enforced in the courts of any jurisdiction to which such party is subject by a suit upon such judgment, provided that service of process is effected upon such party in the manner specified herein or as otherwise permitted by law;</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(vi)	agrees that to the extent that such party has or hereafter may acquire any immunity from jurisdiction of any court or from any legal process with respect to itself or its</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">31</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">property, such party hereby irrevocably waives such immunity in respect of its obligations under this Agreement, to the extent permitted by law; and</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(vii)	irrevocably and unconditionally waives trial by jury in any legal action or proceeding in relation to this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Waiver</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. No waiver of any term, provision or condition of this Agreement, whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or be construed as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision or condition of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.7	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Except as expressly set forth in the Transaction Agreements to the contrary, each party shall pay its own out-of-pocket fees and expenses, including the fees and expenses of attorneys, accountants and consultants employed by such party, incurred in connection with the proposed investment in the Securities and the consummation of the transactions contemplated thereby; provided, however, that the Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company), stamp taxes and other taxes (other than income taxes) and duties levied in connection with the delivery of any Securities to the Purchasers. Notwithstanding the foregoing, the Company shall pay the reasonable fees and expenses of Wilmer Cutler Pickering Hale and Dorr LLP, counsel for certain Purchasers, in an amount not to exceed $100,000 in the aggregate. The Company shall pay all Placement Agent fees relating to or arising out of the transactions contemplated by this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.8	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Assignment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. None of the parties may assign its rights or obligations under this Agreement or designate another person (i) to perform all or part of its obligations under this Agreement or (ii) to have all or part of its rights and benefits under this Agreement, in each case without the prior written consent of (x) the Company, in the case of a Purchaser, and (y) the Purchasers, in the case of the Company, provided that a Purchaser may, without the prior consent of the Company, assign its rights to purchase the Securities hereunder to any of its affiliates or to any other investment funds or accounts managed or advised by the investment manager who acts on behalf of such Purchaser (provided each such assignee agrees to be bound by the terms of this Agreement and makes the same representations and warranties set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof).  In the event of any assignment in accordance with the terms of this Agreement, the assignee shall specifically assume and be bound by the provisions of this Agreement by executing a writing agreeing to be bound by and subject to the provisions of this Agreement and shall deliver an executed counterpart signature page to this Agreement and, notwithstanding such assumption or agreement to be bound hereby by an assignee, no such assignment shall relieve any party assigning any interest hereunder from its obligations or liability pursuant to this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.9	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Information</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	Each Purchaser covenants that until such time as the transactions contemplated by this Agreement and any material non-public information provided to such Purchaser are publicly disclosed by the Company, such Purchaser will maintain the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction), other than to such Purchaser&#x2019;s outside attorney, accountant, auditor or</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">32</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">investment advisor only to the extent necessary to permit evaluation of the investment, and the performance of the necessary or required tax, accounting, financial, legal, or administrative tasks and services and other than as may be required by law.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	The Company may request from the Purchasers such reasonable and customary additional information as the Company may deem necessary to evaluate the eligibility of the Purchaser to acquire the Securities, and the Purchaser shall promptly provide such information as may reasonably be requested to the extent readily available; provided, that the Company agrees to keep any such information provided by the Purchaser confidential, except (i) as required by the federal securities laws, rules or regulations and (ii) to the extent such disclosure is required by other laws, rules or regulations, at the request of the staff of the SEC or regulatory agency or under the regulations of Nasdaq. The Purchaser acknowledges that the Company may file a copy of this Agreement and the Registration Rights Agreement with the SEC as exhibit to a periodic report or a registration statement of the Company.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.10	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Reliance by and Exculpation of Placement Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	Each Purchaser agrees for the express benefit of the Placement Agent, its affiliates and its representatives that (i) the Placement Agent, its affiliates and its representatives have not made, and will not make any representations or warranties with respect to the Company or the offer and sale of the Securities, and such Purchaser will not rely on any statements made by the Placement Agent, orally or in writing, to the contrary, (ii) such Purchaser will be responsible for conducting its own due diligence investigation with respect to the Company and the offer and sale of the Securities, (iii) such Purchaser will be purchasing Securities based on the results of its own due diligence investigation of the Company and the Placement Agent and each of its directors, officers, employees, representatives, and controlling persons have made no independent investigation with respect to the Company, the Securities, or the accuracy, completeness, or adequacy of any information supplied to the Purchaser by the Company, (iv) such Purchaser has negotiated the offer and sale of the Securities directly with the Company, and the Placement Agent will not be responsible for the ultimate success of any such investment and (v) the decision to invest in the Company will involve a significant degree of risk, including a risk of total loss of such investment. Each Purchaser further represents and warrants to the Placement Agent that it, including any fund or funds that it manages or advises that participates in the offer and sale of the Securities, is permitted under its constitutive documents (including, without limitation, all limited partnership agreements, charters, bylaws, limited liability company agreements, all applicable side letters with investors, and similar documents) to make investments of the type contemplated by this Agreement. This Section 8.10 shall survive any termination of this Agreement.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	The Company agrees and acknowledges that the Placement Agent may rely on its representations, warranties, agreements and covenants contained in this Agreement and each Purchaser agrees that the Placement Agent may rely on such Purchaser&#x2019;s representations and warranties contained in this Agreement as if such representations and warranties, as applicable, were made directly to the Placement Agent.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(c)	Neither the Placement Agent nor any of its affiliates or representatives (1) shall be liable for any improper payment made in accordance with the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">33</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">information provided by the Company; (2) makes any representation or warranty, or has any responsibilities as to the validity, accuracy, value or genuineness of any information, certificates or documentation delivered by or on behalf of the Company pursuant to the Transaction Agreements or in connection with any of the transactions contemplated therein; or (3) shall be liable (x) for any action taken, suffered or omitted by any of them in good faith and reasonably believed to be authorized or within the discretion or rights or powers conferred upon it by the Transaction Agreements or (y) for anything which any of them may do or refrain from doing in connection with the Transaction Agreements, except in each case for such party&#x2019;s own gross negligence or willful misconduct.</font></p>
  <p style="text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(d)	The Company agrees that the Placement Agent, its affiliates and representatives shall be entitled to (1) rely on, and shall be protected in acting upon, any certificate, instrument, notice, letter or any other document or security delivered to any of them by or on behalf of the Company, and (2) be indemnified by the Company for acting as the Placement Agent hereunder pursuant to the indemnification provisions set forth in the applicable letter agreement between the Company and the Placement Agent.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.11	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Third Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Nothing in this Agreement, express or implied, is intended to confer on any Person other than the parties to this Agreement any rights, remedies, claims, benefits, obligations or liabilities under or by reason of this Agreement, and no Person that is not a party to this Agreement (including, without limitation, any partner, member, shareholder, director, officer, employee or other beneficial owner of any party to this Agreement, in its own capacity as such or in bringing a derivative action on behalf of a party to this Agreement) shall have any standing as a third party beneficiary with respect to this Agreement or the transactions contemplated hereby. Notwithstanding the foregoing, the Placement Agent is an intended third-party beneficiary of the representations and warranties of the Company and of each Purchaser set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 6.1(h)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 8.10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> respectively, of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.12	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Independent Nature of Purchasers&#x2019; Obligations and Right.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The obligations of each Purchaser under this Agreement are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance obligations of any other Purchaser under this Agreement. Nothing contained herein, and no action taken by any Purchaser pursuant hereto, shall be deemed to constitute the Purchasers as, and the Company acknowledges that the Purchasers do not so constitute, a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group, and the Company will not assert any such claim with respect to such obligations or the transactions contemplated by this Agreement. The Company acknowledges and each Purchaser confirms that it has independently participated in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Purchaser also acknowledges that Sidley Austin LLP has not rendered legal advice to such Purchaser. Each Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. The Company has elected to provide all Purchasers with the same terms and Transaction Agreements for the convenience of the Company and not because it was required or requested to do so by any Purchaser.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">34</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.13	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. This Agreement may be signed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.14	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Entire Agreement; Amendments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. This Agreement and the other Transaction Agreements (including all schedules and exhibits hereto and thereto), together with any side letter agreements with any of the Purchasers, which side letters the Company has shared with any Purchaser that has so requested, constitute the entire agreement between the parties hereto respecting the subject matter hereof and supersedes all prior agreements, negotiations, understandings, representations and statements respecting the subject matter hereof, whether written or oral.  No amendment, modification, alteration, or change in any of the terms of this Agreement shall be valid or binding upon the parties hereto unless made in writing and duly executed by the Company and the Purchasers of at least a majority in interest of the Securities then held by the Purchasers. Notwithstanding the foregoing, this Agreement may not be amended and the observance of any term of this Agreement may not be waived with respect to any Purchaser without the written consent of such Purchaser unless such amendment or waiver applies to all Purchasers in the same fashion.  The Company, on the one hand, and each Purchaser, on the other hand, may by an instrument signed in writing by such parties waive the performance, compliance or satisfaction by such Purchaser or the Company, respectively, with any term or provision hereof or any condition hereto to be performed, complied with or satisfied by such Purchaser or the Company, respectively. Notwithstanding the foregoing or anything else herein to the contrary, no amendment, modification, alteration, change or waiver of Section 8.10 shall be valid without the prior written consent of the Placement Agent, which consent may be granted or withheld in the sole discretion of the Placement Agent.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.15	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Survival</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The covenants, representations and warranties made by each party hereto contained in this Agreement shall survive the Closing and the delivery of the Securities in accordance with their respective terms. Each Purchaser shall be responsible only for its own representations, warranties, agreements and covenants hereunder.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.16	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Mutual Drafting.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> This Agreement is the joint product of each Purchaser and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8.17	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Additional Matters</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. For the avoidance of doubt, the parties acknowledge and confirm that the terms and conditions of the Securities were determined as a result of arm&#x2019;s-length negotiations.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">9.18	Further Assurances. The parties shall execute and deliver all such further instruments and documents and take all such other actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">[Remainder of Page Intentionally Left Blank.]</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">35</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the parties hereto have executed this Agreement as of the day and year first above written.</font></p>
  <p style="margin-left:48.333%;text-indent:-8.759%;padding-left:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">COMPANY:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.28%;"></td>
    <td style="width:1.34%;"></td>
    <td style="width:84.38%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">ACRIVON THERAPEUTICS, INC.</font></p></td>
   </tr>
   <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;text-indent:-7.452%;padding-left:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:24pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">36</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the parties hereto have executed this Agreement as of the day and year first above written.</font></p>
  <p style="margin-left:48.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">PURCHASER:</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.28%;"></td>
    <td style="width:1.36%;"></td>
    <td style="width:84.36%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">[NAME]</font></p></td>
   </tr>
   <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Address:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">[&#x25cf;]</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Email</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">[&#x25cf;]</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">37</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>acrv-ex10_2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html>
 <head>
  <title>EX-10.2</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.2</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">REGISTRATION RIGHTS AGREEMENT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">THIS REGISTRATION RIGHTS AGREEMENT</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> (this &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), dated as of April </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, 2024, is entered into by and among </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">ACRIVON THERAPEUTICS, INC., </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and the several investors signatory hereto (individually as an &#x201c;Investor&#x201d; and collectively together with their respective permitted assigns, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Investors</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Purchase Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">   </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Upon the terms and subject to the conditions of the Purchase Agreement, the Company has agreed to issue to the Investors, and the Investors have agreed to purchase, severally and not jointly, an aggregate of up to $130,000,440 of (x) shares (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Initial Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of the Company's common stock, par value $0.001 per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and/or (y) pre-funded warrants (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) to purchase shares of Common Stock, in each case, pursuant to the Purchase Agreement.  The Initial Shares and the shares of Common Stock issuable upon exercise of the Warrants are collectively referred to herein as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">.&#x201d;</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">To induce the Investors to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and applicable state securities laws.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="lastspot"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">NOW, THEREFORE,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">acknowledged, the Company and the Investors hereby agree as follows:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">DEFINITIONS.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">For purposes of this Agreement, the following terms shall have the following meanings:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any individual or entity including but not limited to any corporation, limited liability company, association, partnership, organization, business, individual, governmental or political subdivision thereof or a governmental agency.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Register</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Registered</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">,&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Registration</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; refer to a registration effected by preparing and filing one or more registration statements of the Company in compliance with the Securities Act and providing for offering securities on a continuous basis, and the declaration or ordering of effectiveness of such registration statement(s) by the United States Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Registrable Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Shares and any Common Stock issued or issuable with respect to the Shares as a result of any stock split or subdivision, stock dividend, recapitalization, exchange or similar event. Registrable Securities shall cease to be Registrable Securities upon the date on which the Investors shall have resold all the Registrable Securities covered by the Registration Statement. </font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Registration Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean all registration and filing fee expenses incurred by the Company in effecting any registration pursuant to this Agreement, including (i) all registration, qualification, and filing fees, printing expenses, and any other fees and expenses associated with filings required to be made with the SEC, FINRA or any other regulatory authority, (ii) all fees and expenses in connection with compliance with or clearing the Registrable Securities for sale under any securities or &#x201c;Blue Sky&#x201d; laws, (iii) all printing, duplicating, word processing, messenger, telephone, facsimile and delivery expenses, and (iv) all fees and disbursements of counsel for the Company and of all independent certified public accountants of the Company (including the expenses of any special audit and cold comfort letters required by or incident to such performance). </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any registration statement of the Company  filed with, or to be filed with, the SEC under the Securities Act, that Registers Registrable Securities, including the related prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits and all material incorporated by reference in such registration statement as may be necessary to comply with applicable securities laws. &#x201c;Registration Statement&#x201d; shall also include a New Registration Statement, as amended when each became effective, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a prospectus subsequently filed with the SEC.</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;Selling Expenses&#x201d; shall mean all underwriting discounts and selling commissions applicable to the sale of Registrable Securities and all similar fees and commissions relating to the Investors&#x2019; disposition of the Registrable Securities.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">REGISTRATION.</font></div></div>
  <p style="margin-left:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Mandatory Registration</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall, as promptly as reasonably practicable and in any event no later than May 11, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Filing Deadline</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), prepare and file with the SEC an initial Registration Statement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Initial Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) covering the resale of all Registrable Securities. Before filing the Registration Statement, the Company shall furnish to the Investors a copy of the Registration Statement. The Investors and their counsel shall have at least three (3) Business Days prior to the anticipated filing date of a Registration Statement to review and comment upon such Registration Statement and any amendment or supplement to such Registration Statement and any related prospectus (including any documents incorporated by reference therein), prior to its filing with the SEC. The Company shall (a) use its reasonable best efforts to address in each such document prior to being so filed with the SEC such comments as the Investor or its counsel reasonably proposed by the Investor, and (b) not file any Registration Statement or related prospectus or any amendment or supplement thereto containing information regarding the Investor to which Investor reasonably objects, unless such information is required to comply with any applicable law or regulation. The Investors shall furnish all information reasonably requested by the Company and as shall be reasonably required in connection with any registration referred to in this Agreement.  </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company shall use its reasonable best efforts to have the Initial Registration Statement and any amendment declared effective by the SEC at the earliest possible date but no later than the earlier of the seventy-fifth (75</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">) calendar day following the initial filing date of the Initial Registration Statement if the SEC notifies the Company that it will &#x201c;review&#x201d; the Initial Registration Statement and (b) the fifth (5</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">) Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the Initial Registration Statement will not be &#x201c;reviewed&#x201d; or will not be subject to further review (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Effectiveness Deadline</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The Company shall notify the Investor by e-mail as promptly as practicable, and in any event, within twenty-four (24) hours, after the Registration Statement is declared effective or is supplemented and shall provide the Investor with copies of any related Prospectus to be used in connection </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">2</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">with the sale or other disposition of the securities covered thereby. The Company shall use reasonable best efforts to keep the Initial Registration Statement continuously effective pursuant to Rule 415 promulgated under the Securities Act and available for the resale by the Investors of all of the Registrable Securities covered thereby at all times until the earliest to occur of the following events: (i) the date on which the Investors shall have resold all the Registrable Securities covered thereby; and (ii) the date on which the Registrable Securities may be resold by the Investors without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information requirement under Rule 144 under the Securities Act or any other rule of similar effect (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Registration Period</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The Initial Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Sufficient Number of Shares Registered</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. In the event the number of shares available under the Initial Registration Statement at any time is insufficient to cover the Registrable Securities, the Company shall, to the extent necessary and permissible, amend the Initial Registration Statement or file a new registration statement (together with any prospectuses or prospectus supplements thereunder, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">New Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), so as to cover all of such Registrable Securities as soon as reasonably practicable, but in any event not later than ten (10) Business Days after the necessity therefor arises (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">New Registration Filing Deadline</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The Company shall use its reasonable best efforts to have such amendment and/or New Registration Statement become effective as soon as reasonably practicable following the filing thereof but no later than the earlier of the seventy-fifth (75th) calendar day following the initial filing date of the New Registration Statement if the SEC notifies the Company that it will &#x201c;review&#x201d; the New Registration Statement and (b) the fifth (5th) Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the New Registration Statement will not be &#x201c;reviewed&#x201d; or will not be subject to further review (the earlier of such dates, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">New Registration Effectiveness Deadline</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  The provisions of Section 2(a) and (b) shall apply to the New Registration Statement, except as modified hereby.    </font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Liquidated Damages</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. If (i) the Initial Registration Statement has not been filed by the Filing Deadline, (ii) the Initial Registration Statement has not been declared effective by the Effectiveness Deadline, (iii) the New Registration Statement has not been filed by the New Registration Filing Deadline, (iv) the New Registration Statement has not been declared effective by the New Registration Effectiveness Deadline or (v) after any Registration Statement has been declared effective by the SEC, sales cannot be made pursuant to such Registration Statement for any reason (including without limitation by reason of a stop order, or the Company&#x2019;s failure to update such Registration Statement), but excluding any Allowed Delay (as defined below) or, if the Registration Statement is on Form S-1, for a period of twenty (20) days following the date on which the Company files a post-effective amendment to incorporate the Company&#x2019;s Annual Report on Form 10-K (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Maintenance Failure</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then the Company will make pro rata payments to each Investor then holding Registrable Securities, as liquidated damages and not as a penalty, in an amount equal to 1.0% of the aggregate amount paid pursuant to the Purchase Agreement by such Investor for such Registrable Securities then held by such Investor for each 30-day period or pro rata for any portion thereof during which the failure continues (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Blackout Period</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). Such payments shall constitute the Investors&#x2019; exclusive monetary remedy for such events, but shall not affect the right of the Investors to seek injunctive relief. The amounts payable as liquidated damages pursuant to this paragraph shall be paid in cash no later than five (5) Business Days after each such 30-day period following the commencement of the Blackout Period until the termination of the Blackout Period (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Blackout Period Payment Date</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). Interest shall accrue at the rate of 1.0% per month on any such liquidated damages payments that shall not be paid by the Blackout Period Payment Date until such amount is paid in full. Notwithstanding the above, in no event shall the aggregate amount of liquidated damages (or interest thereon) paid under this Agreement to any Investor exceed, in the aggregate, 5.0% of the aggregate purchase </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">3</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">price of the Shares purchased by such Investor under the Purchase Agreement.  Notwithstanding anything in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 2(d)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> to the contrary, during any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities because any Investor fails to furnish information required to be provided pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 2(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 4(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> within three (3) Business Days of the Company&#x2019;s request, any liquidated damages that would otherwise accrue as to such Investor only shall be tolled until such information is delivered to the Company.</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">On no more than two occasions and for not more than twenty (20) consecutive days or for a total of not more than forty-five (45) days in any twelve (12) month period, the Company may delay the effectiveness of the Initial Registration Statement or any other Registration Statement, or suspend the use of  any prospectus included in any Registration Statement, in the event that the Company determines in good faith that such delay or suspension is necessary to (A) delay the disclosure of material non-public information concerning the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best interests of the Company or (B) amend or supplement the affected Registration Statement or the related Prospectus so that such Registration Statement or Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the case of the Prospectus in light of the circumstances under which they were made, not misleading (an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Allowed Delay</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;); provided, that the Company  shall promptly (a) notify each Investor in writing of the commencement of an Allowed Delay, but shall not (without the prior written consent of an Investor) disclose to such Investor any material non-public information giving rise to an Allowed Delay, (b) advise the Investors in writing to cease all sales under the Registration Statement until the end of the Allowed Delay and (c) use commercially reasonable efforts to terminate an Allowed Delay as promptly as practicable.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Rule 415; Cutback</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">.  If at any time the SEC takes the position that the offering of some or all of the Registrable Securities in any Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the Securities Act (provided, however, the Company shall be obligated to use reasonable best efforts to advocate with the SEC for the registration of all of the Registrable Securities) or requires any Investor to be named as an &#x201c;underwriter,&#x201d; the Company shall (i) promptly notify each holder of Registrable Securities thereof and (ii) make commercially reasonable efforts to persuade the SEC that the offering contemplated by such Registration Statement is a valid secondary offering and not an offering &#x201c;by or on behalf of the issuer&#x201d; as defined in Rule 415 and that none of the Investors is an &#x201c;underwriter.&#x201d; The Investors shall have the right to have its legal counsel, at such Investor&#x2019;s expense, to review and oversee any registration or matters pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 2(f)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, including participation in any meetings or discussions with the SEC regarding the SEC&#x2019;s position and to comment on any written submission made to the SEC with respect thereto. No such written submission with respect to this matter shall be made to the SEC to which any Investor&#x2019;s counsel reasonably objects. In the event that, despite the Company&#x2019;s reasonable best efforts and compliance with the terms of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 2(f)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, the SEC refuses to alter its position, the Company shall (i) remove from such Registration Statement such portion of the Registrable Securities (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Cut Back Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and/or (ii) agree to such restrictions and limitations on the registration and resale of the Registrable Securities as the SEC may require to assure the Company&#x2019;s compliance with the requirements of Rule 415 (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">SEC Restrictions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;); provided, however, that the Company shall not name any Investor as an &#x201c;underwriter&#x201d; in such Registration Statement without the prior written consent of such Investor (provided that, in the event an Investor withholds such consent, the Company shall have no obligation hereunder to include any Registrable Securities of such Investor in any Registration Statement covering the resale thereof until such time as the SEC no longer requires such Investor to be named as an &#x201c;underwriter&#x201d; in such Registration Statement or such Investor otherwise consents in writing to being so named). Any cut-back imposed on the Investors pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 2(f)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> shall be allocated among the Investors on a pro rata basis and shall be applied first to any of the Registrable Securities of such Investor as such Investor shall designate, unless the SEC Restrictions otherwise require or provide or the Investors otherwise agree. No liquidated damages shall accrue as to any </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">4</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Cut Back Shares until such date as the Company is able to effect the registration of such Cut Back Shares in accordance with any SEC Restrictions applicable to such Cut Back Shares (such date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Restriction Termination Date</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). From and after the Restriction Termination Date applicable to any Cut Back Shares, all of the provisions of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> (including the Company&#x2019;s obligations with respect to the filing of a Registration Statement and its obligations to use reasonable efforts to have such Registration Statement declared effective within the time periods set forth herein and the liquidated damages provisions relating thereto) shall again be applicable to such Cut Back Shares; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, that the date by which the Company is required to file the Registration Statement with respect to such Cut Back Shares shall be the tenth (10</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">) day following the Restriction Termination Date and the date by which the Company is required to have the Registration Statement effective with respect to such Cut Back Shares shall be the fifty-fifth (55</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">) day immediately after the Restriction Termination Date.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">RELATED COMPANY OBLIGATIONS.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">With respect to the Registration Statement and whenever any Registrable Securities are to be Registered pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, including on the Initial Registration Statement or on any New Registration Statement, the Company shall use its reasonable best efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Notifications</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The Company will promptly notify the Investors promptly of the time when any subsequent amendment to the Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any prospectus or for additional information.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Amendments.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> The Company will prepare and file with the SEC any amendments, post-effective amendments or supplements to the Initial Registration Statement, any New Registration Statement or any related prospectus, as applicable, that, (a) as may be necessary to keep such Registration Statement effective for the Effectiveness Period and to comply with the provisions of the Securities Act and the Exchange Act with respect to the distribution of all of the Registrable Securities covered thereby, or (b) in the reasonable opinion of the Investors and the Company, as may be necessary or advisable in connection with any acquisition or sale of Registrable Securities by the Investors.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Investor Review</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The Company will not file any amendment or supplement to the Registration Statement, any New Registration Statement or any prospectus, other than documents incorporated by reference, relating to the Investors, the Registrable Securities or the transactions contemplated hereby unless (A) the Investors and their counsel shall have been advised and afforded the opportunity to review and comment thereon at least three (3) Business Days prior to filing with the SEC and (B) the Company shall have given reasonable due consideration to any comments thereon received from the Investors or their counsel.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Copies Available</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The Company will furnish to any Investor whose Registrable Securities are included in any Registration Statement and its counsel copies of the Initial Registration Statement, any prospectus thereunder (including all documents incorporated by reference therein), any prospectus supplement thereunder, any New Registration Statement and all amendments to the Initial Registration Statement or any New Registration Statement that are filed with the SEC during the Registration Period (including all documents filed with or furnished to the SEC during such period that are deemed to be incorporated by reference therein), each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">5</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">case relating to such Registration Statement (other than any portion thereof which contains information for which the Company has sought confidential treatment) and such other documents as Investor may reasonably request in order to facilitate the disposition of the Registrable Securities owned by Investor that are covered by such Registration Statement, in each case as soon as reasonably practicable upon such Investor&#x2019;s request and in such quantities as such Investor may from time to time reasonably request; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, that the Company shall not be required to furnish any document to the Investor to the extent such document is available on EDGAR.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Notification of Stop Orders; Material Changes</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall use best efforts to (i) prevent the issuance of any stop order or other suspension of effectiveness and, (ii) if such order is issued, obtain the withdrawal of any such order as soon as practicable. The Company shall advise the Investors promptly (but in no event later than 24 hours) and shall confirm such advice in writing, in each case: (i) of the Company&#x2019;s receipt of notice of any request by the SEC or any other federal or state governmental authority for amendment of or a supplement to the Registration Statement or any prospectus or for any additional information; (ii) of the Company&#x2019;s receipt of notice of the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness of the Initial Registration Statement or prohibiting or suspending the use of any prospectus or prospectus supplement, or any New Registration Statement, or of the Company&#x2019;s receipt of any notification of the suspension of qualification of the Registrable Securities for offering or sale in any jurisdiction or the initiation or contemplated initiation of any proceeding for such purpose; and (iii) of the Company becoming aware of the happening of any event, which makes any statement of a material fact made in any Registration Statement or any prospectus untrue or which requires the making of any additions to or changes to the statements then made in any Registration Statement or any prospectus in order to state a material fact required by the Securities Act to be stated therein or necessary in order to make the statements then made therein (in the case of any prospectus, in light of the circumstances under which they were made) not misleading, or of the necessity to amend any Registration Statement or any prospectus to comply with the Securities Act or any other law. The Company shall not be required to disclose to the Investors the substance of specific reasons of any of the events set forth in clause (i) to (iii) of the immediately preceding sentence (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Suspension Event</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), but rather, shall only be required to disclose that the event has occurred. If at any time the SEC, or any other federal or state governmental authority shall issue any stop order suspending the effectiveness of any Registration Statement or prohibiting or suspending the use of any prospectus or prospectus supplement, the Company shall use its reasonable best efforts to obtain the withdrawal of such order at the earliest practicable time. The Company shall furnish to the Investors, without charge, a copy of any correspondence from the SEC or the staff of the SEC, or any other federal or state governmental authority to the Company or its representatives relating to the Initial Registration Statement, any New Registration Statement or any prospectus, or prospectus supplement as the case may be.  In the event of a Suspension Event set forth in clause (iii) of the first sentence of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 3(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, the Company will use its commercially reasonable efforts to publicly disclose such event as soon as reasonably practicable, or otherwise resolve the matter such that sales under Registration Statements may resume; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, that if the Company has a bona fide business purpose for not making such information public, the Company may suspend the use of all Registration Statements for up to sixty (60) consecutive calendar days; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">further</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, that the Company may not suspend the use of all Registration Statements more than twice, or for more than ninety (90) total calendar days, in each case during any twelve-month period.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Confirmation of Effectiveness</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. If reasonably requested by an Investor at any time in respect of any Registration Statement, the Company shall deliver to such Investor a written confirmation from Company&#x2019;s counsel of whether or not the effectiveness of such Registration Statement has lapsed at any time for any reason (including, without limitation, the issuance of a stop order) and whether or not such Registration Statement is currently effective and available to the Company for sale of Registrable Securities.  </font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">6</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Listing</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall use best efforts to cause all Registrable Securities covered by a Registration Statement to be listed on the Nasdaq Global Market.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Compliance</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall otherwise use best efforts to comply with all applicable rules and regulations of the SEC under the Securities Act and the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), including, without limitation, Rule 172 under the Securities Act, file any final prospectus, including any supplement or amendment thereof, with the SEC pursuant to Rule 424 under the Securities Act, promptly inform the Investor in writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Investor is required to deliver a prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder, and make available to its security holders, as soon as reasonably practicable, but not later than the Availability Date (as defined below), an earnings statement covering a period of at least twelve (12) months, beginning after the effective date of each Registration Statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act, including Rule 158 promulgated thereunder (for the purpose of this subsection 3(h), &#x201c;Availability Date&#x201d; means the forty-fifth (45</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">) day following the end of the fourth fiscal quarter that includes the effective date of such Registration Statement, except that, if such fourth fiscal quarter is the last quarter of the Company&#x2019;s fiscal year, &#x201c;Availability Date&#x201d; means the ninetieth (90</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">) day after the end of such fourth fiscal quarter).</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Blue-Sky</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall use best efforts to register or qualify or cooperate with the Investor and their counsel in connection with the registration or qualification of such Registrable Securities for the offer and sale under the securities or blue sky laws of such jurisdictions reasonably requested by the Investor; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, that the Company shall not be required in connection therewith or as a condition thereto to (i) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 3(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, (ii) subject itself to general taxation in any jurisdiction where it would not otherwise be so subject but for this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 3(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, or (iii) file a general consent to service of process in any such jurisdiction.</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Rule 144</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. With a view to making available to the Investors the benefits of Rule 144 (or its successor rule) and any other rule or regulation of the SEC that may at any time permit the Investors to sell shares of Common Stock to the public without registration, the Company covenants and agrees to: (i) make and keep adequate current public information available, as those terms are understood and defined in Rule 144, until the earlier of (A) six (6) months after such date as all of the Registrable Securities may be sold without restriction by the holders thereof pursuant to Rule 144 or any other rule of similar effect or (B) such date as there are no longer Registrable Securities; (ii) file with the SEC in a timely manner all reports and other documents required of the Company under the Exchange Act; (iii) furnish electronically to each Investor upon request, as long as such Investor owns any Registrable Securities, (A) a written statement by the Company that it has complied with the reporting requirements of the Exchange Act, (B) a copy of or electronic access to the Company&#x2019;s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other information as may be reasonably requested in order to avail such Investor of any rule or regulation of the SEC that permits the selling of any such Registrable Securities without registration and (iv) provide any legal opinions.</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company shall cooperate with the holders of the Registrable Securities to facilitate the timely preparation and delivery of certificates or uncertificated shares representing the Registrable Securities to be sold pursuant to such Registration Statement or Rule 144 free of any restrictive legends and representing such number of shares of Common Stock and registered in such names as the holders of the Registrable Securities may reasonably request to the extent permitted by such Registration Statement or Rule 144 to effect sales of Registrable Securities ; for the avoidance of doubt, the Company </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">7</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">may satisfy its obligations hereunder without issuing physical stock certificates through the use of The Depository Trust Company&#x2019;s Direct Registration System.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company shall use reasonable best efforts to cause the Company&#x2019;s transfer agent to remove any restrictive legend from any Registrable Securities, as promptly as practicable following such request. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">OBLIGATIONS OF THE INVESTORS.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Investor Information</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. Each Investor shall provide a completed Investor Questionnaire in the form attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> in connection with the registration of the Registrable Securities.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Suspension of Sales</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">.  Each Investor, severally and not jointly with any other Investor, agrees that, upon receipt of any notice from the Company of the existence of Suspension Event as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 3(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, the Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement covering such Registrable Securities until the Investor's receipt of a notice from the Company confirming the resolution of such Suspension Event and that such dispositions may again be made.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Investor Cooperation</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. Each Investor, severally and not jointly with any other Investor, agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of any amendments and supplements to any Registration Statement or New Registration Statement hereunder, unless such Investor has notified the Company in writing of its election to exclude all of its Registrable Securities from such Registration Statement.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">EXPENSES OF REGISTRATION.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">All Registration Expenses incurred in connection with registrations pursuant to this Agreement shall be borne by the Company.  All Selling Expenses relating to securities registered on behalf of the Investors shall be borne by the Investors pro rata on the basis of the number of Registrable Securities so registered.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">INDEMNIFICATION.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investors, each Person, if any, who controls the Investors, the members, the directors, officers, partners, employees, members, managers, agents, representatives and advisors of the Investors and each Person, if any, who controls the Investors within the meaning of the Securities Act or the Exchange Act (each, an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Indemnified Person</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), against any losses, obligation, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges, costs (including, without limitation, court costs and costs of preparation, reasonable and documented attorneys&#x2019; fees, amounts paid in settlement (with the prior consent of the Company, such consent not to be unreasonably withheld, conditioned or delayed) or reasonable and documented expenses, (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Claims</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;)) reasonably incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory agency or body or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a party thereto (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Indemnified Damages</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement or omission or alleged omission of any material fact contained in any Registration Statement, any preliminary Prospectus or final </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">8</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Prospectus, or any amendment or supplement thereof, or (ii) any violation or alleged violation by the Company or any of its Subsidiaries of the Securities Act, Exchange Act or any other state securities or other &#x201c;blue sky&#x201d; laws of any jurisdiction in which Registrable Securities are offered or any rule or regulation promulgated thereunder applicable to the Company or its agents and relating to action or inaction required of the Company in connection with such registration of the Registrable Securities (the matters in the foregoing clauses (i) and (ii) being, collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Violations</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The Company shall reimburse each Indemnified Person promptly as such expenses are incurred and are due and payable, for any reasonable out-of-pocket legal fees or other reasonable and documented expenses incurred by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 6(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">: (A) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by the Investors or such Indemnified Person specifically for use in such Registration Statement or prospectus and was reviewed and approved in writing by such Investor or such Indemnified Person expressly for use in connection with the preparation of any Registration Statement, any prospectus or any such amendment thereof or supplement thereto, if such in each case if the foregoing was timely made available by the Company; (B) with respect to any superseded prospectus, shall not inure to the benefit of any such Person from whom the Person asserting any such Claim purchased the Registrable Securities that are the subject thereof (or to the benefit of any other Indemnified Person) if the untrue statement or omission of material fact contained in the superseded prospectus was corrected in the revised prospectus, as then amended or supplemented, and the Indemnified Person was promptly advised in writing not to use the outdated, defective or incorrect prospectus prior to the use giving rise to a violation; (C) shall not be available to the extent such Claim is based on a failure of the Investors to deliver, or cause to be delivered, if required the prospectus to the Persons asserting an untrue statement or omission or alleged untrue statement or omission at or prior to the written confirmation of the sale of Registrable Securities; and (D) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the Investor pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Initial Registration Statement, any New Registration Statement or any prospectus, the Investors, severally and not jointly, agree to indemnify, hold harmless and defend, the Company, each of its directors, each of its officers who signed</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">the Initial Registration Statement or signs any New Registration Statement, each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act (collectively and together with an Indemnified Person, an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Indemnified Party</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), against any losses, claims, damages, liabilities and expense (including reasonable attorney fees) resulting from any Violation, in each case to the extent, and only to the extent, that such Violation occurs in reliance upon and in conformity with information about the Investors furnished in writing by the Investor to the Company and reviewed and approved in writing by such Investor or such Indemnified Person expressly for use in connection with the preparation of the Registration Statement, any New Registration Statement, any prospectus or any such amendment thereof or supplement thereto. In no event shall the liability of Investor be greater in amount than the dollar amount of the proceeds (net of all expense paid by Investor in connection with any claim relating to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> and the amount of any damages Investor has otherwise been required to pay by reason of such untrue statement or omission) received by Investor upon the sale of the Registrable Securities included in such Registration Statement giving rise to such indemnification obligation. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of the Registrable Securities by any Investor pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Promptly after receipt by an Indemnified Person or Indemnified Party under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> of notice of the commencement of any action or proceeding (including any governmental action </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">9</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall, if a Claim in respect thereof is to be made against any indemnifying party under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be, and upon such notice, the indemnifying party shall not be liable to the Indemnified Person or the Indemnified Party for any legal or other expenses subsequently incurred by the Indemnified Person or the Indemnified Party in connection with the defense thereof; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, that an Indemnified Person or Indemnified Party (together with all other Indemnified Persons and Indemnified Parties that may be represented without conflict by one counsel) shall have the right to retain its own counsel with the reasonable fees and expenses to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation by such counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to actual or potential differing interests between such Indemnified Person or Indemnified Party and any other party represented by such counsel in such proceeding. The Indemnified Party or Indemnified Person shall cooperate with the indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person which relates to such action or claim. The indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of any action, claim or proceeding effected without its written consent, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the consent of the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise unless such judgment or settlement (i) imposes no liability or obligation on, (ii) includes as an unconditional term thereof the giving of a complete, explicit and unconditional release from the party bringing such indemnified claims of all liability of the Indemnified Party or Indemnified Person in respect to or arising out of such claim or litigation in favor of, and (iii) does not include any admission of fault, culpability, wrongdoing, or wrongdoing or malfeasance by or on behalf of, the Indemnified Party or Indemnified Person.. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, except to the extent that the indemnifying party is prejudiced in its ability to defend such action.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The indemnification required by this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or Indemnified Damages are incurred. Any Person receiving a payment pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> which person is later determined to not be entitled to such payment shall return such payment (including reimbursement of expenses) to the person making it.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">CONTRIBUTION.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">To the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect to any amounts for which it</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">10</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">would otherwise be liable under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> to the fullest extent permitted by law; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 11(f)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> of the Securities Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and (ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds (net of all expenses paid by such holder in connection with any claim relating to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 7</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> and the amount of any damages such holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by such seller from the sale of such Registrable Securities giving rise to such contribution obligation.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">ASSIGNMENT OF REGISTRATION RIGHTS.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company shall not assign this Agreement or any rights or obligations hereunder (whether by operation of law or otherwise) without the prior written consent of the Investors holding a majority of the Registrable Securities then outstanding; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, that in any transaction, whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby the Company is a party and in which the Registrable Securities are converted into the equity securities of another Person, from and after the effective time of such transaction, such Person shall, by virtue of such transaction, be deemed to have assumed the obligations of the Company hereunder, the term &#x201c;Company&#x201d; shall be deemed to refer to such Person and the term &#x201c;Registrable Securities&#x201d; shall be deemed to include the securities received by the Investor in connection with such transaction unless such securities are otherwise freely tradable by the Investor after giving effect to such transaction, and the prior written consent of the Investors holding a majority of the Registrable Securities then outstanding shall not be required for such transaction.  No Investor may assign its rights under this Agreement, other than to an affiliate of such Investor, without the prior written consent of the Company.  The provisions of this Agreement shall be binding upon and inure to the benefit of the Investor and its successors and permitted assigns.</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">AMENDMENTS AND WAIVERS.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:11pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The provisions of this Agreement, including the provisions of this sentence, may be amended, modified or supplemented, or waived only by a written instrument executed by (i) the Company and (ii) the holders of a majority of the then outstanding Registrable Securities (voting together as a single class), </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> that any party may give a waiver as to itself and provided further that any amendment, modification, supplement or waiver that  disproportionately and adversely affects the rights and obligations of any Investor relative to the comparable rights and obligations of the other Investors shall require the prior written consent of such adversely affected Investor or each Investor, as applicable. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of one or more Investors and that does not adversely directly or indirectly affect the rights of other Investors may be given by Investors holding all of the Registrable Securities to which such waiver or consent relates.</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">MISCELLANEOUS.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. Any notices or other communications required or permitted to be given hereunder shall be in writing and shall be deemed to be given (a) when delivered if personally delivered to the party for whom it is intended, (b) when delivered, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient&#x2019;s next business day, (c) three (3) days after having been sent by certified or registered mail, return-receipt requested and postage prepaid, or (d) one (1) business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt:</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">11</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;text-indent:14.286%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:10pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:2.8575102053935906%;text-indent:0;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">If to the Company, addressed as follows:</font></div></div>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Acrivon Therapeutics, Inc.</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">480 Arsenal Way, Suite 100</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Watertown, MA 02472<br>Attention: Peter Blume-Jensen; Rasmus Holm-Jorgensen; Mary-Alice Miller</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Email: pblumejensen@acrivon.com; rholmjorgensen@acrivon.com; mmiller@acrivon.com</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:26.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">with a copy (which shall not constitute notice):</font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Sidley Austin </font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">llp</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"><br>787 Seventh Avenue<br>New York, NY 10019 <br>Attention:  Asher Rubin, Istvan Hajdu<br>Email:  arubin@sidley.com, ihajdu@sidley.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;text-indent:14.286%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:10pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:2.8575102053935906%;text-indent:0;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">If to any Investor, at its e-mail address or address set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> to the Purchase Agreement or to such e-mail address, or address as subsequently modified by written notice given in accordance with this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Any Person may change the address to which notices and communications to it are to be addressed by notification as provided for herein.</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">No Waiver.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> No failure or delay on the part of either party hereto in the exercise of any power, right or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude any other or further exercise thereof or of any other right, power or privilege.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Governing Law</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The provisions of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Section 8.4</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> of the Purchase Agreement are incorporated by reference herein </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Integration</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. This Agreement and the other Transaction Agreements (including all schedules and exhibits hereto and thereto) constitute the entire agreement between the parties hereto respecting the subject matter hereof and supersedes all prior agreements, negotiations, understandings, representations and statements respecting the subject matter hereof, whether written or oral.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The titles, subtitles and headings in this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile or pdf signature including any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g., </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">www.docusign.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original, not a facsimile or pdf (or other electronic reproduction of a) signature.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">12</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">and documents as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of strict construction will be applied against any party.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted as if it were written so as to be enforceable to the maximum extent permitted by applicable law, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent permitted by applicable law, the parties hereby waive any provision of law which renders any provisions hereof prohibited or unenforceable in any respect.</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Non-Recourse</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. Notwithstanding anything that may be expressed or implied in this Agreement, the Company covenants, agrees and acknowledges that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or future director, officer, employee, stockholder, general or limited partner or member of the Investors or of any affiliates or assignees thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any current or future director, officer, employee, stockholder, general or limited partner or member of the Investors or of any affiliates or assignees thereof, as such for any obligation of the Investors under this Agreement or any documents or instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or their creation.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any remedies provided by law.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">[Signature Page Follows]</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">13</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> the parties have caused this Registration Rights Agreement to be duly executed as of date first written above.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:47.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">COMPANY:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.28%;"></td>
    <td style="width:1.34%;"></td>
    <td style="width:84.38%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">ACRIVON THERAPEUTICS, INC.</font></p></td>
   </tr>
   <tr style="height:12.25pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> the parties have caused this Registration Rights Agreement to be duly executed as of date first written above.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:47.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">INVESTOR:</font></p>
  <p style="margin-left:47.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12%;"></td>
    <td style="width:1%;"></td>
    <td style="width:87%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">[NAME]</font></p></td>
   </tr>
   <tr style="height:12.25pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Address:</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">[&#x25cf;]</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Email</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">[&#x25cf;]</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">15</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>acrv-ex10_3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html>
 <head>
  <title>EX-10.3</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.3</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[COMPANY LETTERHEAD]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">April [__], 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[__]</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Re:	Publicity and Board Observer Rights</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Ladies and Gentlemen:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Subject to and in consideration of an investment in Acrivon Therapeutics, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), by [__] and/or one or more of its Affiliates (as defined below) (each, an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Investor</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and together, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Investors</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), the parties to this letter hereby agree as follows:</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">No Publicity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company will not, without the prior written consent of the Investors, use in advertising, publicity, marketing communications regarding any Company financing (whether oral or written) or other public communication or filing, the &#x201c;[__]&#x201d; name or any other information that would reasonably be expected to identify the Investors or their Affiliates or, to the Company&#x2019;s knowledge, the name of any partner or employee thereof, nor any trade name, trademark, trade device, service mark, symbol or any abbreviation, or contraction thereof (</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">e.g.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, &#x201c;[__]&#x201d;) owned by the Investors, except that the Company may make any such disclosure if, upon the advice of counsel, there is no alternative to such disclosure because it is required by applicable law, rule or regulation (including the rules of the SEC, FINRA or any stock exchange on which the common stock of the Company is listed) and the Investors are notified reasonably in advance and given reasonable opportunity to review such disclosure and comment thereon (and the Company shall consider such comments in good faith and incorporate any such reasonable comments). Except as permitted by the immediately preceding sentence, the name and logo of the Investors or any their respective Affiliates will not be used by the Company or its representatives in any manner (orally or in writing) to market, sell securities of the Company or otherwise promote the Company, its products, services and/or business; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, that the Company may disclose the name of the Investors in connection with the provision of any details of agreements executed by Company and the Investors in connection with the investment and the transactions contemplated thereby to any of its executive officers, directors, accountants, counsel and financial advisors with a need to know such information, provided that such recipient agrees to abide by the foregoing confidentiality obligations. The Company understands that the Investors are frequently asked for permission publicly to use or list its name among holders of the stock of companies in which the Investors invest and that the Investors deny these requests except where such disclosure is legally required and there is no alternative to such disclosure, and the Company understands that given that the Investors deny these requests when made by other companies, even the inadvertent public use of an Investor&#x2019;s name by the Company will cause harm to the Investors. For the avoidance of doubt, the Company may respond to inquiries about any public disclosure that was required by law, rule or regulation and made in accordance with this Section 1, by confirming the accuracy of such disclosure. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Board Observer</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.7033333333333336%;display:inline-flex;justify-content:flex-start;">a.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Effective as of the Closing Date (as defined in that certain Securities Purchase Agreement dated as of even date herewith (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Purchase Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;)), the Company shall invite one designee of the Investors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Observer</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), as designated by the Investors from time to time, to attend and participate in all meetings of the Board of Directors of the Company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and each committee thereof in a nonvoting observer capacity. In this respect, the Company shall give the Observer (i) written notice of, agendas and participation details for such meetings and (ii) copies of all notices, minutes, consents, and other materials, in each case, that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such Observer shall agree to hold in confidence information so provided; provided further, that the Board of Directors and each committee shall have the right to withhold any information and exclude the Observer from any executive sessions of such meetings if only non-employee directors are present (in addition to any legal or other advisors or representatives requested by such non-employee directors); and provided further, that the Company reserves the right to withhold any information and to exclude the Observer any meeting or portion thereof if the Board of Directors determines in good faith that (i) based upon the advice of outside counsel, access to such information or attendance at such meeting is reasonably likely to (x) adversely affect the attorney-client privilege between the Company and its counsel or (y) result in a conflict of interest, (ii) the Observer is a competitor of the Company, or (iii) such withholding and exclusion is necessary to protect trade secrets (unless covered by an enforceable confidentiality agreement, in a form reasonably acceptable to the Company) and the Observer is notified in advance of any such withholding or exclusion. The Observer shall not, by virtue of his or her capacity as such, have or be deemed to have, or otherwise be subject to, any duties (fiduciary or otherwise) to the Company or any of its Affiliates or subsidiaries or its or their respective equityholders or any other person or entity or any duties (fiduciary or otherwise) otherwise applicable to the members of the Board of Directors in their capacity as such. With respect to the Observer, the Company&#x2019;s obligations under this Section 2(a) are contingent upon such Observer&#x2019;s (1) entering into a confidentiality agreement with the Company in a form that is reasonably acceptable to the Company and the Investors and (2) agreeing, solely in such individual&#x2019;s capacity as the Observer, to be bound by the Company&#x2019;s insider trading and window policies then in effect and applicable to members of the Board of Directors.</font></div></div>
  <div style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.7033333333333336%;display:inline-flex;justify-content:flex-start;">b.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">From time to time, the Company may invite additional designees of the Investors to attend meetings of the Board of Directors and committees thereof in a nonvoting observer capacity, subject to the mutual consent and agreement of the Company and the Investors; provided, however, that any such additional designee shall agree (i) to hold in confidence information so provided and (ii) to enter into and be bound by those agreements and policies set forth in Section 2(a)(1) and (2).</font></div></div>
  <div style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.7033333333333336%;display:inline-flex;justify-content:flex-start;">c.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The rights set forth in this Section 2 shall terminate and be of no further force or effect at such time as the Investors and/or their Affiliates cease to collectively </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.7033333333333336%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">beneficially own at least 50% of the number of pre-funded warrants purchased by the Investors under the Purchase Agreement (as adjusted for stock splits, recapitalizations and other similar events and including all shares of common stock issued upon the conversion of the pre-funded warrants to the extent still beneficially owned by the Investors and/or their Affiliates).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  When used in this letter, the following terms shall have the meanings assigned to them in this Section 3: </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">a.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with such Person, where &#x201c;control&#x201d; means the possession, directly or indirectly, of the power to direct the management and policies of a Person whether through the ownership of voting securities or otherwise. </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">b.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any individual, corporation, partnership, limited liability company, trust, unincorporated association, governmental entity or other legal entity.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Amendments; Waiver; Entire Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. This letter may not be amended or modified in any manner except by a written instrument signed by the Investors and the Company. Any waiver of any term or condition shall be in writing executed by the party entitled to waive such term or condition. Any waiver of any term or condition shall not be construed as a waiver of any subsequent breach or a subsequent waiver of the same term or condition, or a waiver of any other term or condition of this letter.  The failure of either party to assert any of its rights hereunder shall not constitute a waiver of such rights. This letter, together with the Investment Agreement and the other transaction documents entered into in connection therewith, constitutes the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Assignment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. No party may assign this letter or any of its rights, interests or obligations hereunder without the prior written consent of the other parties, and any purported assignment by a party without prior written consent of the other parties will be null and void and not binding on such other party; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, that notwithstanding the foregoing, an Investor may assign this letter or any of its rights, interests or obligations hereunder to its Affiliates.  Subject to the preceding sentence, all of the terms, agreements, covenants, representations, warranties and obligations of this letter are binding upon, and inure to the benefit of and are enforceable by, the parties and their respective successors and assigns.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Governing Law; Jurisdiction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. This letter shall be governed by the laws of the State of Delaware, without regard to conflict of law principles. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of the State of Delaware and to the jurisdiction of the United States District Court for the District of Delaware for the purpose of any suit, action or other proceeding arising out of or based upon this letter, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this letter except in the state courts of the State of Delaware or the United States District Court for the District of Delaware, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this letter or the subject matter hereof may not be enforced in or by such court.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">WAIVER OF JURY TRIAL</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS LETTER OR THE SUBJECT MATTER HEREOF OR THEREOF.  THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS LETTER, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS.  THIS SECTION 7 HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS.  EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  All notices under this letter must be in writing and given by personal delivery, by United States Express Mail or a nationally recognized overnight delivery service for next day delivery, or by electronic mail, as follows (or to such other Person or address as any party may give in a notice given in accordance with the provisions hereof):</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If to the Company:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Acrivon Therapeutics, Inc.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">480 Arsenal Way, Suite 100</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Watertown, Massachusetts</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Attention: Peter Blume-Jensen ; Rasmus Holm-Jorgensen ; Mary-Alice Miller<br>Email: pblumejensen@acrivon.com; rholmjorgensen@acrivon.com; mmiller@acrivon.com</font></p>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">with a copy (which shall not constitute notice):</font></p>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Sidley Austin LLP.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">787 Seventh Avenue</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">New York, NY 10019</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Attention:  Asher Rubin; Istvan Hajdu</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Email:  arubin@sidley.com; ihajdu@sidley.com</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If to the Investors:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[__]</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notice will be effective and deemed given only as follows:  (a) if given by personal delivery, up-on such personal delivery, (b) if sent for next day delivery by United States Express Mail or overnight delivery service, on the date of delivery as confirmed by written confirmation of delivery, or (c) if sent by electronic mail, upon acknowledgement of receipt other than by automatic means.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Equitable Relief; Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company acknowledges and agrees that the Investors may be damaged irreparably and may not have an adequate remedy at law if any provision of this letter is not performed in accordance with its specific terms or is otherwise breached.  Accordingly, in addition to any other remedy to which the Investors may be entitled, at law or in equity, the Investors will be entitled to seek an injunction or injunctions to prevent breaches or threatened breaches of the provisions of this letter and to seek to enforce specifically this letter and its provisions, without bond or other security being required and without any proof of actual damages.  The rights, obligations and remedies created by this letter are cumulative and in addition to any other rights, obligations or remedies otherwise available at law or in equity.  Nothing herein will be considered an election of remedies or a waiver of the right to pursue any other right or remedy to which the Investors may be entitled. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Headings; Construction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The section headings contained in this letter are inserted for convenience only and will not affect in any way the meaning or interpretation of this letter. Except as otherwise expressly provided herein, the following rules of interpretation apply hereto: (i) the singular includes the plural and vice versa; (ii) &#x201c;or&#x201d; and &#x201c;any&#x201d; are not exclusive; (iii) &#x201c;includes,&#x201d; &#x201c;include,&#x201d; &#x201c;included&#x201d; and &#x201c;including&#x201d; are deemed to be followed by &#x201c;without limitation&#x201d;; and (iv) the words &#x201c;hereby,&#x201d; &#x201c;herein,&#x201d; &#x201c;hereunder,&#x201d; &#x201c;hereof&#x201d; and words of similar import refer to this letter as a whole and not merely to the specific section or clause in which any such word appears. No presumption or burden of proof shall arise favoring or disfavoring a party by virtue of the authorship of any provision of this letter.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  This letter may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute one and the same instrument.  This letter will become effective when one or more counterparts have been signed by each of the parties and delivered to the other party, it being understood that all parties need not sign the same counterpart.  The exchange of copies of this letter and of executed signature pages by facsimile transmission or by electronic mail in &#x201c;portable document format&#x201d; (&#x201c;.pdf&#x201d;) or by a combination of such means, will constitute effective execution and delivery of this letter as to the parties and may be used in lieu of an original letter for all purposes.  Signatures of the parties transmitted by facsimile or by .pdf shall be deemed to be their original signatures for all purposes.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">12.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The provisions of this letter will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or enforceability of the other provisions hereof.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">[Signature Page Follows]</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:24pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Very truly yours,</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.28%;"></td>
    <td style="width:1.34%;"></td>
    <td style="width:84.38%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">COMPANY</font></p></td>
   </tr>
   <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.28%;"></td>
    <td style="width:1.34%;"></td>
    <td style="width:84.38%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">AGREED AND ACCEPTED:</font></p></td>
   </tr>
   <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>6
<FILENAME>acrv-ex10_4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html>
 <head>
  <title>EX-10.4</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.4</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[COMPANY LETTERHEAD]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">April [__], 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[__]</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Re:	Affiliate Registration Rights Agreement</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Ladies and Gentlemen:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Subject to and in consideration of an investment in Acrivon Therapeutics, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), by [__] (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Investor</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), the parties to this letter hereby agree as follows:</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Affiliate Registration Rights Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company agrees, upon a written request from the Investor, to enter into a Registration Rights Agreement, in substantially the form attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, with the Investor following such time that Investor reasonably determines that it may be deemed an &#x201c;affiliate&#x201d; (as defined for this purpose in Rule 144 of the Securities Act of 1933, as amended) of the Company. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Amendments; Waiver; Entire Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. This letter may not be amended or modified in any manner except by a written instrument signed by the Investors and the Company. Any waiver of any term or condition shall be in writing executed by the party entitled to waive such term or condition. Any waiver of any term or condition shall not be construed as a waiver of any subsequent breach or a subsequent waiver of the same term or condition, or a waiver of any other term or condition of this letter.  The failure of either party to assert any of its rights hereunder shall not constitute a waiver of such rights. This letter, together with the Investment Agreement and the other transaction documents entered into in connection therewith, constitutes the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. This rights and obligations under this letter shall automatically terminate and be of no further force of effect upon such time as the Investor no longer holds securities of the Company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Assignment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. No party may assign this letter or any of its rights, interests or obligations hereunder without the prior written consent of the other parties, and any purported assignment by a party without prior written consent of the other parties will be null and void and not binding on such other party; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, that notwithstanding the foregoing, an Investor may assign this letter or any of its rights, interests or obligations hereunder to its affiliates.  Subject to the preceding sentence, all of the terms, agreements, covenants, representations, warranties and obligations of this letter are binding upon, and inure to the benefit of and are enforceable by, the parties and their respective successors and assigns.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Governing Law; Jurisdiction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. This letter shall be governed by the laws of the State of Delaware, without regard to conflict of law principles. The parties (a) hereby irrevocably and </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">unconditionally submit to the jurisdiction of the state courts of the State of Delaware and to the jurisdiction of the United States District Court for the District of Delaware for the purpose of any suit, action or other proceeding arising out of or based upon this letter, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this letter except in the state courts of the State of Delaware or the United States District Court for the District of Delaware, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this letter or the subject matter hereof may not be enforced in or by such court.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">WAIVER OF JURY TRIAL</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS LETTER OR THE SUBJECT MATTER HEREOF OR THEREOF.  THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS LETTER, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS.  THIS SECTION 6 HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS.  EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  All notices under this letter must be in writing and given by personal delivery, by United States Express Mail or a nationally recognized overnight delivery service for next day delivery, or by electronic mail, as follows (or to such other person or address as any party may give in a notice given in accordance with the provisions hereof):</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If to the Company:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Acrivon Therapeutics, Inc.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">480 Arsenal Way, Suite 100</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Watertown, Massachusetts</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Attention: Peter Blume-Jensen</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Email: pblumejensen@acrivon.com</font></p>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">with a copy (which shall not constitute notice):</font></p>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Sidley Austin LLP.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">787 Seventh Avenue</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">New York, NY 10019</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Attention:  Asher Rubin; Istvan Hajdu</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Email:  arubin@sidley.com; ihajdu@sidley.com</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If to the Investors:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[__]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notice will be effective and deemed given only as follows:  (a) if given by personal delivery, up-on such personal delivery, (b) if sent for next day delivery by United States Express Mail or overnight delivery service, on the date of delivery as confirmed by written confirmation of delivery, or (c) if sent by electronic mail, upon acknowledgement of receipt other than by automatic means.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Equitable Relief; Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company acknowledges and agrees that the Investors may be damaged irreparably and may not have an adequate remedy at law if any provision of this letter is not performed in accordance with its specific terms or is otherwise breached.  Accordingly, in addition to any other remedy to which the Investors may be entitled, at law or in equity, the Investors will be entitled to seek an injunction or injunctions to prevent breaches or threatened breaches of the provisions of this letter and to seek to enforce specifically this letter and its provisions, without bond or other security being required and without any proof of actual damages.  The rights, obligations and remedies created by this letter are cumulative and in addition to any other rights, obligations or remedies otherwise available at law or in equity.  Nothing herein will be considered an election of remedies or a waiver of the right to pursue any other right or remedy to which the Investors may be entitled. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Headings; Construction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The section headings contained in this letter are inserted for convenience only and will not affect in any way the meaning or interpretation of this letter. Except as otherwise expressly provided herein, the following rules of interpretation apply hereto: (i) the singular includes the plural and vice versa; (ii) &#x201c;or&#x201d; and &#x201c;any&#x201d; are not exclusive; (iii) &#x201c;includes,&#x201d; &#x201c;include,&#x201d; &#x201c;included&#x201d; and &#x201c;including&#x201d; are deemed to be followed by &#x201c;without limitation&#x201d;; and (iv) the words &#x201c;hereby,&#x201d; &#x201c;herein,&#x201d; &#x201c;hereunder,&#x201d; &#x201c;hereof&#x201d; and words of similar import refer to this letter as a whole and not merely to the specific section or clause in which any such word appears. No presumption or burden of proof shall arise favoring or disfavoring a party by virtue of the authorship of any provision of this letter.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  This letter may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute one and the same instrument.  This letter will become effective when one or more counterparts have been signed by each of the parties and delivered to the other party, it being understood that all parties need not sign the same counterpart.  The exchange of copies of this letter and of executed signature pages by facsimile transmission or by electronic mail in &#x201c;portable document format&#x201d; (&#x201c;.pdf&#x201d;) or by a combination of such means, will constitute effective execution and delivery of this letter as to the parties and may be used in lieu of an original letter for all purposes.  Signatures of the parties transmitted by facsimile or by .pdf shall be deemed to be their original signatures for all purposes.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The provisions of this letter will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or enforceability of the other provisions hereof.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">[Signature Page Follows]</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">3</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:24pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Very truly yours,</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.28%;"></td>
    <td style="width:1.34%;"></td>
    <td style="width:84.38%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">COMPANY</font></p></td>
   </tr>
   <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:37.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.28%;"></td>
    <td style="width:1.34%;"></td>
    <td style="width:84.38%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">AGREED AND ACCEPTED:</font></p></td>
   </tr>
   <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[Signature page to Affiliate Registration Rights Agreement]</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">EXHIBIT A</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">REGISTRATION RIGHTS AGREEMENT</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This Registration Rights Agreement (this &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is made as of [  ], 20[  ] by and between Acrivon Therapeutics, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and the persons listed on the attached </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Schedule A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> who are signatories to this Agreement (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Investors</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  Unless otherwise defined herein, capitalized terms used in this Agreement have the respective meanings ascribed to them in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">RECITALS</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the Company and the Investors wish to provide for certain arrangements with respect to the registration of the Registrable Securities (as defined below) by the Company under the Securities Act (as defined below).</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">NOW, THEREFORE,</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> in consideration of the mutual promises and covenants set forth herein, and other consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"><br>Definitions</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Certain Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  In addition to the terms defined elsewhere in this Agreement, as used in this Agreement, the following terms have the respective meanings set forth below:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Block Trade</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean an offering of Registrable Securities which requires both the Investors and the Company to enter into a sale agreement and is limited in scope of selling efforts as compared to an Underwritten Offering.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the Board of Directors of the Company.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the common stock of the Company, par value $0.001 per share.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the Securities Exchange Act of 1934, as amended, or any similar successor federal statute and the rules and regulations thereunder, all as the same shall be in effect from time to time.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Governmental Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean any federal, state, local or foreign government, or any department, agency, or instrumentality of any government; any public international organization, any transnational governmental organization; any court of competent jurisdiction, arbitral, administrative agency, commission, or other governmental regulatory authority or quasi-governmental authority, any political party; and any national securities exchange or national quotation system.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">5</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Other Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean securities of the Company, other than Registrable Securities (as defined below).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean any individual, partnership, corporation, company, association, trust, joint venture, limited liability company, unincorporated organization, entity or division, or any government, governmental department or agency or political subdivision thereof.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Registrable Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the shares of Common Stock and any Common Stock issued or issuable upon the exercise or conversion of any other securities (whether equity, debt or otherwise) of the Company now owned or hereafter acquired by any of the Investors. Registrable Securities shall cease to be Registrable Securities upon the earliest to occur of the following events: (i) such Registrable Securities have been sold pursuant to an effective Registration Statement; (ii) such Registrable Securities have been sold by the Investors pursuant to Rule 144 (or other similar rule), (iii) at any time after any of the Investors become an affiliate of the Company, such Registrable Securities may be resold by the Investor holding such Registrable Securities without limitations as to volume or manner of sale pursuant to Rule 144; or (iv) ten (10) years after the date of this Agreement.  For purposes of this definition, in order to determine whether an Investor is an &#x201c;affiliate&#x201d; (as such term is defined and used in Rule 144, and including for determining whether volume or manner of sale limitations of Rule 144 apply) the parties will assume that all convertible securities (whether equity, debt or otherwise) have been converted into Common Stock.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The terms &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">register</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">registered</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">registration</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall refer to a registration effected by preparing and filing a Registration Statement in compliance with the Securities Act, and such Registration Statement becoming effective under the Securities Act.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Registration Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean all expenses incurred by the Company in effecting any registration pursuant to this Agreement, including, without limitation, all registration, qualification, and filing fees, printing expenses, escrow fees, fees and disbursements of counsel for the Company, up to $50,000 of reasonable legal expenses of one special counsel for Investors (if different from the Company&#x2019;s counsel and if such counsel is reasonably approved by the Company) in connection with the preparation and filing of the Resale Registration Shelf (as defined below), and up to $50,000 of reasonable legal expenses of one special counsel for the Investors (if different from the Company&#x2019;s counsel and if such counsel is reasonably approved by the Company) per Underwritten Offering, blue sky fees and expenses, and expenses of any regular or special audits incident to or required by any such registration, but shall not include Selling Expenses.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any registration statement of the Company filed with, or to be filed with, the Commission under the Securities Act, including the related prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits and all material incorporated by reference in such registration statement as may be necessary to comply with applicable securities laws other than a registration statement (and related prospectus) filed on Form S-4 or Form S-8 or any successor forms thereto.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">6</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Rule 144</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean Rule 144 as promulgated by the Commission under the Securities Act, as such rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the Securities Act of 1933, as amended, or any similar successor federal statute and the rules and regulations thereunder, all as the same shall be in effect from time to time.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Selling Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean all underwriting discounts and selling commissions applicable to the sale of Registrable Securities, the fees and expenses of any legal counsel (except as provided in the definition of &#x201c;Registration Expenses&#x201d;) and any other advisors any of the Investors engage and all similar fees and commissions relating to the Investors&#x2019; disposition of the Registrable Securities.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Underwritten Offering</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean a public offering of Registrable Securities pursuant to an effective registration statement under the Securities Act (other than pursuant to a registration statement on Form S-4 or S-8 or any similar or successor form) which requires the Investors and the Company to enter into an underwriting agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"><br>Resale Registration Rights</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Resale Registration Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Following demand by any Investor the Company shall file with the Commission a Registration Statement on Form S-3 (except if the Company is not then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in accordance with the Securities Act) covering the resale of the Registrable Securities by the Investors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Resale Registration Shelf</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and the Company shall file such Resale Registration Shelf as promptly as reasonably practicable following such demand, and in any event within sixty (60) days of such demand.  Such Resale Registration Shelf shall include a &#x201c;final&#x201d; prospectus, including the information required by Item 507 of Regulation S-K of the Securities Act, as provided by the Investors in accordance with Section 2.7.  Notwithstanding the foregoing, before filing the Resale Registration Shelf, the Company shall furnish to the Investors a copy of the Resale Registration Shelf and afford the Investors an opportunity to review and comment on the Resale Registration Shelf.  The Company&#x2019;s obligation pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.1(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> is conditioned upon the Investors providing the information contemplated in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.7</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company shall use its reasonable best efforts to cause the Resale Registration Shelf and related prospectuses to become effective as promptly as practicable after filing.  The Company shall use its reasonable best efforts to cause such Registration Statement to remain effective under the Securities Act until the earlier of the date (i) all Registrable Securities covered by the Resale Registration Shelf have been sold or may be sold freely without limitations or restrictions as to volume or manner of sale pursuant to Rule 144 or (ii) all Registrable Securities covered by the Resale Registration Shelf otherwise cease to be Registrable Securities pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the definition of Registrable Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company shall promptly, and within two (2) business</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">7</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">days after the Company confirms effectiveness of the Resale Registration Shelf with the Commission, notify the Investors of the effectiveness of the Resale Registration Shelf.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding anything contained herein to the contrary, the Company shall not be obligated to effect, or to take any action to effect, a registration pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.1(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">if the Company has and maintains an effective Registration Statement on Form S-3ASR that provides for the resale of an unlimited number of securities by selling stockholders (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company Registration Shelf</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;);</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">during the period forty-five (45) days prior to the Company&#x2019;s good faith estimate of the date of filing of a Company Registration Shelf; or</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">if the Company has caused a Registration Statement to become effective pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> during the prior twelve (12) month period.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If the Company has a Company Registration Shelf in place at any time in which the Investors make a demand pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.1(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the Company shall file with the Commission, as promptly as practicable, and in any event within fifteen (15) business days after such demand, a &#x201c;final&#x201d; prospectus supplement to its Company Registration Shelf covering the resale of the Registrable Securities by the Investors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;); </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, that the Company shall not be obligated to file more than one Prospectus pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.1(d)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> in any six month period to add additional Registrable Securities to the Company Registration Shelf that were acquired by the Investors other than directly from the Company or in an underwritten public offering by the Company.  The Prospectus shall include the information required under Item 507 of Regulation S-K of the Securities Act, which information shall be provided by the Investors in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.7</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Notwithstanding the foregoing, before filing the Prospectus, the Company shall furnish to the Investors a copy of the Prospectus and afford the Investors an opportunity to review and comment on the Prospectus.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Deferral and Suspension</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  At any time after being obligated pursuant to this Agreement to file a Resale Registration Shelf or Prospectus, or after any Resale Registration Shelf has become effective or a Prospectus is filed with the Commission, the Company may defer the filing of or suspend the use of any such Resale Registration Shelf or Prospectus, upon giving written notice of such action to the Investors with a certificate signed by the [Principal Executive Officer] of the Company stating that in the good faith judgment of the Board, the filing or use of any such Resale Registration Shelf or Prospectus covering the Registrable Securities would be seriously detrimental to the Company or its stockholders at such time and that the Board concludes, as a result, that it is in the best interests of the Company and its stockholders to defer the filing or suspend the use of such Resale Registration Shelf or Prospectus at such time.  The Company shall have the right to defer the filing of or suspend the use of such Resale Registration Shelf or Prospectus for a period of not more than one hundred twenty (120) days from the date the Company notifies the Investors of such deferral or suspension; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> that the Company shall not exercise the right contained in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.1(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> more than once in any twelve month period.  In the case of the suspension of use of any effective Resale Registration Shelf or Prospectus, the Investors, immediately upon receipt of notice thereof from the Company, shall discontinue any offers or sales of Registrable Securities pursuant to such Resale Registration</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">8</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Shelf or Prospectus until advised in writing by the Company that the use of such Resale Registration Shelf or Prospectus may be resumed.  In the case of a deferred Prospectus or Resale Registration Shelf filing, the Company shall provide prompt written notice to the Investors of (i) the Company&#x2019;s decision to file or seek effectiveness of the Prospectus or Resale Registration Shelf, as the case may be, following such deferral and (ii) in the case of a Resale Registration Shelf, the effectiveness of such Resale Registration Shelf.  In the case of either a suspension of use of, or deferred filing of, any Resale Registration Shelf or Prospectus, the Company shall not, during the pendency of such suspension or deferral, be required to take any action hereunder (including any action pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof) with respect to the registration or sale of any Registrable Securities pursuant to any such Resale Registration Shelf, Company Registration Shelf or Prospectus.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Other Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> below, any Resale Registration Shelf or Prospectus may include Other Securities, and may include securities of the Company being sold for the account of the Company; provided such Other Securities are excluded first from such Registration Statement in order to comply with any applicable laws or request from any Government Entity, Nasdaq or any applicable listing agency.  For the avoidance of doubt, no Other Securities may be included in an Underwritten Offering pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> without the consent of the Investors.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Sales and Underwritten Offerings of the Registrable Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding any provision contained herein to the contrary, the Investors, collectively, shall and subject to the limitations set forth in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, be permitted (i) one Underwritten Offering per calendar year, but no more than three Underwritten Offerings in total, and (ii) no more than two Underwritten Offerings or Block Trades in any twelve month period, to effect the sale or distribution of Registrable Securities.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If the Investors intend to effect an Underwritten Offering or Block Trade pursuant to a Resale Registration Shelf or Company Registration Shelf to sell or otherwise distribute Registrable Securities, they shall so advise the Company and provide as much notice to the Company as reasonably practicable (and, in either case, not less than fifteen (15) business days prior to the Investors&#x2019; request that the Company file a prospectus supplement to a Resale Registration Shelf or Company Registration Shelf).</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">In connection with any offering initiated by the Investors pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> involving an underwriting of shares of Registrable Securities, the Investors shall be entitled to select the underwriter or underwriters for such offering, subject to the consent of the Company, such consent not to be unreasonably withheld, conditioned or delayed.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">In connection with any offering initiated by the Investors pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2 </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">involving an Underwritten Offering of Registrable Securities, the Company shall not be required to include any of the Registrable Securities in such underwriting unless the Investors (i) enter into an underwriting agreement in customary form with the underwriter or underwriters, (ii) accept customary terms in such underwriting agreement with regard to representations and warranties relating to ownership of the Registrable Securities and authority and power to enter into such underwriting agreement and (iii) complete and execute all questionnaires, powers of attorney,</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">9</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">custody agreements, indemnities and other documents as may be requested by such underwriter or underwriters.  Further, the Company shall not be required to include any of the Registrable Securities in such underwriting if (Y) the underwriting agreement proposed by the underwriter or underwriters contains representations, warranties or conditions that are not reasonable in light of the Company&#x2019;s then-current business or (Z) the underwriter, underwriters or the Investors require the Company to participate in any marketing, road show or comparable activity that may be required to complete the orderly sale of shares by the underwriter or underwriters.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If the total amount of securities to be sold in any offering initiated by the Investors pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> involving an underwriting of shares of Registrable Securities exceeds the amount that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities (subject in each case to the cutback provisions set forth in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">), that the underwriters and the Company determine in their sole discretion shall not jeopardize the success of the offering.  If the Underwritten Offering has been requested pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof, the number of shares that are entitled to be included in the registration and underwriting shall be allocated in the following manner: (a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">first</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, shares of Company equity securities that the Company desires to include in such registration shall be excluded and (b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">second</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, Registrable Securities requested to be included in such registration by the Investors shall be excluded.  For the avoidance of doubt, no other person besides the Investors shall be entitled to participate in any Block Trade.  To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round down the number of shares allocated to any of the Investors to the nearest 100 shares.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Fees and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  All Registration Expenses incurred in connection with registrations pursuant to this Agreement shall be borne by the Company.  All Selling Expenses relating to securities registered on behalf of the Investors shall be borne by the Investors.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Registration Procedures</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  In the case of each registration of Registrable Securities effected by the Company pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof, the Company shall keep the Investors advised as to the initiation of each such registration and as to the status thereof.  The Company shall use its reasonable best efforts, within the limits set forth in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, to:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">prepare and file with the Commission such amendments and supplements to such Registration Statement and the prospectuses used in connection with such Registration Statement as may be necessary to keep such Registration Statement effective and current and comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statement;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">furnish to the Investors such numbers of copies of a prospectus, including preliminary prospectuses, in conformity with the requirements of the Securities Act, and such other documents as the Investors may reasonably request in order to facilitate the disposition of Registrable Securities;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">use its reasonable best efforts to register and qualify the Registrable Securities covered by such Registration Statement under such other securities or blue sky laws of such jurisdictions in the United States as shall be reasonably requested by the Investors, provided that the Company shall</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">10</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">in the event of an Underwritten Offering or Block Trade, and subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.2(d),</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> enter into and perform its obligations under an underwriting agreement or Block Trade sale agreement, in usual and customary form (including any &#x201c;lock-ups&#x201d; on behalf of the Company and its directors and officers), with the managing underwriter of such offering and take such other usual and customary action as the Investors may reasonably request in order to facilitate the disposition of such Registrable Securities;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">notify the Investors at any time when a prospectus relating to a Registration Statement covering any Registrable Securities is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing.  The Company shall use its reasonable best efforts to amend or supplement such prospectus in order to cause such prospectus not to include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provide a transfer agent and registrar for all Registrable Securities registered pursuant to such Registration Statement and, if required, a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">if requested by an Investor, use reasonable best efforts to cause the Company&#x2019;s transfer agent to remove any restrictive legend from any Registrable Securities, within two business days following such request;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">cause to be furnished, at the request of the Investors, on the date that Registrable Securities are delivered to underwriters for sale in connection with an Underwritten Offering or Block Trade, (i) an opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, and (ii) a letter or letters from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters; and</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">cause all such Registrable Securities included in a Registration Statement pursuant to this Agreement to be listed on each securities exchange or other securities trading markets on which Common Stock is then listed.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Investors Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Discontinuance of Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Investors agree that, upon receipt of any notice from the Company of the occurrence of any event of the kind described in Section </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2.4(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof, the Investors shall immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement covering such Registrable Securities until the Investors&#x2019; receipt of the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">11</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">copies of the supplemented or amended prospectus contemplated by  Section </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2.4(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof or receipt of notice that no supplement or amendment is required and that the Investors&#x2019; disposition of the Registrable Securities may be resumed.  The Company may provide appropriate stop orders to enforce the provisions of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.5(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Compliance with Prospectus Delivery Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Investors covenant and agree that they shall comply with the prospectus delivery requirements of the Securities Act as applicable to them or an exemption therefrom in connection with sales of Registrable Securities pursuant to any Registration Statement filed by the Company pursuant to this Agreement.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notification of Sale of Registrable Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Investors covenant and agree that they shall notify the Company following the sale of Registrable Securities to a third party as promptly as reasonably practicable, and in any event within thirty (30) days, following the sale of such Registrable Securities.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Indemnification</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">To the extent permitted by law, the Company shall indemnify the Investors, and, as applicable, their officers, directors, and constituent partners, legal counsel for each Investor and each Person controlling the Investors, with respect to which registration, related qualification, or related compliance of Registrable Securities has been effected pursuant to this Agreement, and each underwriter, if any, and each Person who controls any underwriter within the meaning of the Securities Act against all claims, losses, damages, or liabilities (or actions in respect thereof) to the extent such claims, losses, damages, or liabilities arise out of or are based upon (i) any untrue statement (or alleged untrue statement) of a material fact contained in any prospectus or other document (including any related Registration Statement) incident to any such registration, qualification, or compliance, or (ii) any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law applicable to the Company and relating to action or inaction required of the Company in connection with any such registration, qualification, or compliance; and the Company shall pay as incurred to the Investors, each such underwriter, and each Person who controls the Investors or underwriter, any legal and any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability, or action; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, that the indemnity contained in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> shall not apply to amounts paid in settlement of any such claim, loss, damage, liability, or action if settlement is effected without the consent of the Company (which consent shall not unreasonably be withheld); and provided, further, that the Company shall not be liable in any such case to the extent that any such claim, loss, damage, liability, or expense arises out of or is based upon any violation by such Investor of the obligations set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof or any untrue statement or omission contained in such prospectus or other document based upon written information furnished to the Company by the Investors, such underwriter, or such controlling Person and stated to be for use therein.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">To the extent permitted by law, each Investor (severally and not jointly) shall, if Registrable Securities held by such Investor are included for sale in the registration and related qualification</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">12</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and compliance effected pursuant to this Agreement, indemnify the Company, each of its directors, each officer of the Company who signs the applicable Registration Statement, each legal counsel and each underwriter of the Company&#x2019;s securities covered by such a Registration Statement, each Person who controls the Company or such underwriter within the meaning of the Securities Act against all claims, losses, damages, and liabilities (or actions in respect thereof) arising out of or based upon (i) any untrue statement (or alleged untrue statement) of a material fact contained in any such Registration Statement, or related document, or (ii) any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by such Investor of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof, the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law applicable to such Investor and relating to action or inaction required of such Investor in connection with any such registration and related qualification and compliance, and shall pay as incurred to such persons, any legal and any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability, or action, in each case only to the extent that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in (and such violation pertains to) such Registration Statement or related document in reliance upon and in conformity with written information furnished to the Company by such Investor and stated to be specifically for use therein; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, that the indemnity contained in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> shall not apply to amounts paid in settlement of any such claim, loss, damage, liability, or action if settlement is effected without the consent of such Investor (which consent shall not unreasonably be withheld); provided, further, that such Investor&#x2019;s liability under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> (when combined with any amounts such Investor is liable for under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6(d)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) shall not exceed such Investor&#x2019;s net proceeds from the offering of securities made in connection with such registration.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Promptly after receipt by an indemnified party under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against an indemnifying party under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, notify the indemnifying party in writing of the commencement thereof and generally summarize such action.  The indemnifying party shall have the right to participate in and to assume the defense of such claim; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, that the indemnifying party shall be entitled to select counsel for the defense of such claim with the approval of any parties entitled to indemnification, which approval shall not be unreasonably withheld; provided further, however, that if either party reasonably determines that there may be a conflict between the position of the Company and the Investors in conducting the defense of such action, suit, or proceeding by reason of recognized claims for indemnity under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, then counsel for such party shall be entitled to conduct the defense to the extent reasonably determined by such counsel to be necessary to protect the interest of such party.  The failure to notify an indemnifying party promptly of the commencement of any such action, if prejudicial to the ability of the indemnifying party to defend such action, shall relieve such indemnifying party, to the extent so prejudiced, of any liability to the indemnified party under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, but the omission so to notify the indemnifying party shall not relieve such party of any liability that such party may have to any indemnified party otherwise than under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If the indemnification provided for in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage, or</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">13</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">expense referred to therein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage, or expense as well as any other relevant equitable considerations.  The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties&#x2019; relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission.  In no event, however, shall (i) any amount due for contribution hereunder be in excess of the amount that would otherwise be due under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, as applicable, based on the limitations of such provisions and (ii) a Person guilty of fraudulent misrepresentation (within the meaning of the Securities Act) be entitled to contribution from a Person who was not guilty of such fraudulent misrepresentation.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with an Underwritten Offering, or the Block Trade sale agreement, are in conflict with the foregoing provisions, the provisions in the underwriting agreement or Block Trade sale agreement shall control; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, that the failure of the underwriting agreement to provide for or address a matter provided for or addressed by the foregoing provisions shall not be a conflict between the underwriting agreement or the Block Trade sale agreement and the foregoing provisions.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The obligations of the Company and the Investors under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> shall survive the completion of any offering of Registrable Securities in a Registration Statement under this Agreement or otherwise.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Information</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Investors shall furnish to the Company such information regarding the Investors and the distribution proposed by the Investors as the Company may reasonably request and as shall be reasonably required in connection with any registration referred to in this Agreement.  The Investors agree to, as promptly as practicable (and in any event prior to any sales made pursuant to a prospectus), furnish to the Company all information required to be disclosed in order to make the information previously furnished to the Company by the Investors  not misleading.  The Investors agree to keep confidential the receipt of any notice received pursuant to Section </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">2.4(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> and the contents thereof, except as required pursuant to applicable law.  Notwithstanding anything to the contrary herein, the Company shall be under no obligation to name the Investors in any Registration Statement if the Investors have not provided the information required by this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.7</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> with respect to the Investors as a selling securityholder in such Registration Statement or any related prospectus.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Rule 144 Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  With a view to making available to the Investors the benefits of Rule 144 and any other rule or regulation of the Commission that may at any time permit the Investors to sell Registrable Securities to the public without registration, the Company agrees to use its reasonable best efforts to:</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">14</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">make and keep public information available, as those terms are understood and defined in Rule 144 at all times after the date hereof;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">file with the Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">prior to the filing of the Registration Statement or any amendment thereto (whether pre&#x2011;effective or post&#x2011;effective), and prior to the filing of any prospectus or prospectus supplement related thereto, to provide the Investors with copies of all of the pages thereof (if any) that reference the Investors; and</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">furnish to any Investor, so long as the Investor owns any Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of Rule 144, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested by an Investor in availing itself of any rule or regulation of the Commission which permits an Investor to sell any such securities without registration.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Limitations on Subsequent Registration Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  From and after the date of this Agreement, the Company shall not enter into any agreement with any holder or prospective holder of any securities of the Company which would provide to such holder rights with respect to the registration of such securities under the Securities Act or the Exchange Act that would conflict with or adversely affect any of the rights provided to the Investors in this Section 2; it being understood and agreed that any subsequent agreement of the Company with any holder or prospective holder of any securities of the Company of the same class (or convertible into or exchange for securities of the same class) as the Registrable Securities granting such Person rights under this Section 2 equivalent to the rights of the Investors under this Section 2 will not be prohibited by the terms of this Section 2.9.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"><br>Miscellaneous</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  No amendment, alteration or modification of any of the provisions of this Agreement shall be binding unless made in writing and signed by each of the Company and the Investors.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Injunctive Relief</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  It is hereby agreed and acknowledged that it shall be impossible to measure in money the damages that would be suffered if the parties fail to comply with any of the obligations herein imposed on them and that in the event of any such failure, an aggrieved Person shall be irreparably damaged and shall not have an adequate remedy at law.  Any such Person shall, therefore, be entitled (in addition to any other remedy to which it may be entitled in law or in equity) to injunctive relief, including, without limitation, specific performance, to enforce such obligations, and if any action should be brought in equity to enforce any of the provisions of this Agreement, none of the parties hereto shall raise the defense that there is an adequate remedy at law.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">15</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  All notices required or permitted under this Agreement must be in writing and sent to the address or facsimile number identified below.  Notices must be given: (a) by personal delivery, with receipt acknowledged; (b) by email followed by hard copy delivered by the methods under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">clause (c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(d)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">; (c) by prepaid certified or registered mail, return receipt requested; or (d) by prepaid reputable overnight delivery service.  Notices shall be effective upon receipt.  Either party may change its notice address by providing the other party written notice of such change.  Notices shall be delivered as follows:</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:30.76%;"></td>
    <td style="width:69.24%;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.08in;vertical-align:top;padding-right:0.08in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">If to the Investors:</font></p></td>
    <td style="padding-left:0.08in;vertical-align:top;padding-right:0.08in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">At such Investor&#x2019;s address as set forth on Schedule A hereto</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.08in;vertical-align:top;padding-right:0.08in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">If to the Company:</font></p></td>
    <td style="padding-left:0.08in;vertical-align:top;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">[           ]</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Attention: [       ]</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">E-mail: [     ]<br></font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.08in;vertical-align:top;padding-right:0.08in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">with a copy to:</font></p></td>
    <td style="padding-left:0.08in;vertical-align:top;padding-right:0.08in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">[             ]</font></p><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Attention: [         ]</font></p><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">E-mail: [               ]</font></p><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Governing Law; Jurisdiction; Venue; Jury Trial</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This Agreement shall be governed by, and construed in accordance with, the law of the State of New York without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of New York.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Each of the Company and the Investors irrevocably and unconditionally submits, for itself and its property, to the nonexclusive jurisdiction of the courts of the State of New York sitting in the Borough of Manhattan, New York and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement and the transactions contemplated herein, or for recognition or enforcement of any judgment, and each of the Company and the Investors irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York state court or, to the fullest extent permitted by applicable law, in such federal court.  Each of the Company and the Investors hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Each of the Company and the Investors irrevocably and unconditionally waives, to the fullest extent permitted by applicable law, any objection that it may now or hereafter have to the laying of venue of any action or proceeding arising out of or relating to this Agreement and the transactions contemplated herein in any court referred to in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b) hereof.  Each of the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">16</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company and the Investors hereby irrevocably waives, to the fullest extent permitted by applicable law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">EACH OF THE COMPANY AND THE INVESTORS HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).  EACH OF THE COMPANY AND THE INVESTORS (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT EACH OF THE COMPANY AND THE INVESTORS HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Successors, Assigns and Transferees</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Any and all rights, duties and obligations hereunder shall not be assigned, transferred, delegated or sublicensed by any party hereto without the prior written consent of the other party; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, that the Investors shall be entitled to transfer Registrable Securities to one or more of their affiliates and, solely in connection therewith, may assign their rights hereunder in respect of such transferred Registrable Securities, in each case, so long as such Investor is not relieved of any liability or obligations hereunder, without the prior consent of the Company.  Any transfer or assignment made other than as provided in the first sentence of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 3.5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> shall be null and void.  Subject to the foregoing and except as otherwise provided herein, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the successors, permitted assigns, heirs, executors and administrators of the parties hereto.  The Company shall not consummate any recapitalization, merger, consolidation, reorganization or other similar transaction whereby stockholders of the Company receive (either directly, through an exchange, via dividend from the Company or otherwise) equity (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Other Equity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) in any other entity (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Other Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) with respect to Registrable Securities hereunder, unless prior to the consummation thereof, the Other Entity assumes, by written instrument, the obligations under this Agreement with respect to such Other Equity as if such Other Equity were Registrable Securities hereunder.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Entire Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  This Agreement, together with any exhibits hereto, constitute the entire agreement between the parties relating to the subject matter hereof and all previous agreements or arrangements between the parties, written or oral, relating to the subject matter hereof are superseded.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Waiver</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  No failure on the part of either party hereto to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of either party hereto in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver thereof; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">17</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  If any part of this Agreement is declared invalid or unenforceable by any court of competent jurisdiction, such declaration shall not affect the remainder of the Agreement and the invalidated provision shall be revised in a manner that shall render such provision valid while preserving the parties&#x2019; original intent to the maximum extent possible.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Titles and Subtitles</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.  All references in this Agreement to sections, paragraphs and exhibits shall, unless otherwise provided, refer to sections and paragraphs hereof and exhibits attached hereto.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Counterparts.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the parties that execute such counterparts (including by facsimile or other electronic means), and all of which together shall constitute one instrument.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Term and Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Investors&#x2019; rights to demand the registration of the Registrable Securities under this Agreement, as well as the Company&#x2019;s obligations hereunder other than pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> hereof, shall terminate automatically once all Registrable Securities cease to be Registrable Securities pursuant to the terms of this Agreement.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Remainder of Page Intentionally Left Blank; Signature Page Follows</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">]</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">18</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement effective as of the day, month and year first above written.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.28%;"></td>
    <td style="width:1.36%;"></td>
    <td style="width:84.36%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">ACRIVON THERAPEUTICS, INC.</font></p></td>
   </tr>
   <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[Signature Page to Registration Rights Agreement]</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement effective as of the day, month and year first above written.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.28%;"></td>
    <td style="width:1.34%;"></td>
    <td style="width:84.38%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">[NAME]</font></p></td>
   </tr>
   <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="margin-left:46.667%;font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[Signature Page to Registration Rights Agreement]</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>acrv-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><img src="img28311487_0.jpg" alt="img28311487_0.jpg" style="width:336px;height:104px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Acrivon Therapeutics Announces $130 Million Private Placement Financing</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">WATERTOWN, Massachusetts, April 9, 2024</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> &#x2013; Acrivon Therapeutics, Inc. (&#x201c;Acrivon&#x201d; or &#x201c;Acrivon Therapeutics&#x201d;) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics (AP3), today announced that it has entered into a securities purchase agreement with certain existing and new accredited investors to issue and sell an aggregate of 8,235,000 shares of its common stock at a price of $8.50 per share, a premium to the closing price on April 8, 2024, and pre-funded warrants to purchase up to an aggregate of 7,060,000 shares of common stock at a purchase price of $8.499 per pre-funded warrant, through a private investment in public equity (&#x201c;PIPE&#x201d;) financing. The pre-funded warrants will have an exercise price of $0.001 per share of common stock, be immediately exercisable and remain exercisable until exercised in full.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Acrivon anticipates the gross proceeds from the oversubscribed PIPE to be approximately $130 million, before deducting fees to the placement agent and other offering expenses payable by the company. The closing of the financing is expected to occur on April 11, 2024, subject to customary closing conditions.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The private placement is being led by a new US-based healthcare and life sciences investor and includes other new and key existing investors, including RA Capital Management, Perceptive Advisors, Paradigm BioCapital, Surveyor Capital (a Citadel company), Sands Capital, and Acorn Bioventures.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;We are excited to announce this financing and thank our new and key existing investors who have shown their support for and confidence in Acrivon,&#x201d; said Peter Blume-Jensen, M.D., Ph.D., chief executive officer, president, and founder of Acrivon Therapeutics. &#x201c;With this funding, we are well positioned to continue the advancement of our lead clinical asset, ACR-368, currently in registrational-intent Phase 2 trials, as well as our preclinical pipeline including ACR-2316, our internally-discovered, novel WEE1/PKMYT1 inhibitor and our recently declared cell cycle regulatory program with an undisclosed target. I am particularly excited about the enthusiasm for the broad potential of Acrivon&#x2019;s differentiated AP3 platform and their support for our compelling long-term strategy aiming to transform precision medicine for the benefit of patients.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Acrivon currently expects to use the net proceeds from the private placement, together with its existing cash, cash equivalents and investments, to fund the continued advancement of its pipeline, including ACR-368, ACR-2316, and its undisclosed cell cycle regulatory program, to fund research and development to broaden its use and applications of its AP3 platform, to leverage its vast proprietary data sets through artificial intelligence and machine learning, and for other general corporate purposes.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Acrivon believes its cash, cash equivalents and investments, including the expected net proceeds from the private placement, will provide sufficient funding of planned operations into the second half of 2026 with flexibility to extend further.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Jefferies acted as the exclusive placement agent in the private placement.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The securities sold in this PIPE are being made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements. Pursuant to the securities purchase agreement, the company has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the securities sold in the PIPE.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. Any offering of the common stock described above under the resale registration statement will only be by means of a prospectus.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">About Acrivon Therapeutics </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Acrivon is a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing Acrivon&#x2019;s proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics, or AP3. The AP3 platform is engineered to measure compound-specific effects on the entire tumor cell protein signaling network and drug-induced resistance mechanisms in an unbiased manner. These distinctive capabilities enable AP3&#x2019;s direct application for drug design optimization for monotherapy activity, the identification of rational drug combinations, and the creation of drug-specific proprietary OncoSignature companion diagnostics that are used to identify the patients most likely to benefit from Acrivon&#x2019;s drug candidates. Acrivon is currently advancing its lead candidate, ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 in a potentially registrational Phase 2 trial across multiple tumor types. The company has received Fast Track designation from the Food and Drug Administration, or FDA, for the investigation of ACR-368 as monotherapy based on OncoSignature-predicted sensitivity in patients with platinum-resistant ovarian or endometrial cancer. Acrivon&#x2019;s ACR-368 OncoSignature test, which has not yet obtained regulatory approval, has been extensively evaluated in preclinical studies, including in two separate, blinded, prospectively-designed studies on pretreatment tumor biopsies collected from past third-party Phase 2 trials in patients with ovarian cancer treated with ACR-368. The FDA has granted Breakthrough Device designation for the ACR-368 OncoSignature assay for the identification of ovarian cancer patients who may benefit from ACR-368 treatment. In addition to ACR-368, Acrivon is also leveraging its proprietary AP3 precision medicine platform for developing its co-crystallography-driven, internally-discovered preclinical stage pipeline programs. These include ACR-2316, a potent, selective WEE1/PKMYT1 inhibitor development candidate with single-agent activity, and a cell cycle program with an undisclosed target.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Forward-Looking Statements </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">This press release includes certain disclosures that contain &#x201c;forward-looking statements&#x201d; within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding the expected closing of the PIPE, our anticipated use of proceeds from the PIPE, whether the conditions for the closing of the PIPE will be satisfied, the filing of a registration statement to register the resale of the securities to be issued and sold in the PIPE, our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as &#x201c;anticipate,&#x201d; &#x201c;believe,&#x201d; &#x201c;contemplate,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;estimate,&#x201d; &#x201c;expect,&#x201d; &#x201c;intend,&#x201d; &#x201c;may,&#x201d; &#x201c;plan,&#x201d; &#x201c;potential,&#x201d; &#x201c;predict,&#x201d; &#x201c;project,&#x201d; &#x201c;should,&#x201d; &#x201c;target,&#x201d; &#x201c;will,&#x201d; or &#x201c;would&#x201d; or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Acrivon&#x2019;s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties that are described more fully in the section titled &#x201c;Risk Factors&#x201d; in our reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Acrivon undertakes no duty to update such information except as required under applicable law.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Investor and Media Contacts: <br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Adam D. Levy, Ph.D., M.B.A.<br>alevy@acrivon.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Alexandra Santos<br>asantos@wheelhouselsa.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img28311487_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img28311487_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "P CT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-4?8VT.(E\?2"]/EV:&U#8&6.\CU]!6KJ7A'P[XHEM]3OK 2R-&I5P[(67J
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M+_A60OP8U_?AK[3 OJ))"?RV5LW0EJS/]ZM#%\2?$/7/$D36TLB6UFW6"W!
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M1%"J/0"GT5R4J%.E?D6YUUL34K6YWL9'B:PGU'1)H+89ER&"YQNP>E<;X?\
M#^I-K5O++:S01P2!W>12O0YP,]<XQQ5C4O&>HKJ4JVGEQP1N5"E,EL'J:[/2
MM0.IZ1#>K&%:13\N>,@D']17):CB:UTW=';>OA*%FE:7X7//OB)\.]3\1:RF
MJ:9+$Y:-8Y(I7VXQG!!]*[/PCH+>&O#5KI<DRS21;F=U& 69B3CVYQ7AMCXE
M\4R>-H93=W37[W0C:W+';][!39T ZCVKZ.KV*O-&*BV>+3Y9-R04445@;!3)
MIH[>%YI7"1H"S,>PI]9NO6,NHZ)<VL!Q*X!49QD@@X_'%3-M1;6Y4$G)*3LC
M,35O#FN:@D4D*23]$>6+&[VS_0UH>(]&&N^'+W2ED$/GQ[48#A2""./3(%<)
MI/A_4Y=6A1[2:%8Y SNZD  '/7O^%)\8M6U;3[;3K>SFE@M)RQEDB8J688PI
M([=\=_PK# 2J56W)6=SIS&%.C90E=6[D7@/X::IH7B6/5=3EMU6W5Q$D3EB[
M,"N>@P,$UZM7!?";4M3U+PM*VHR23+%.4@EE8EF7 R,GJ ?\\5WM=M5R<O>.
M"FDHZ!117!>+_B5_PBNN?V;_ &3]J_=+)YGVG9USQC:?3UJ(Q<G9%MI*[.]H
MKR3_ (7?_P!2]_Y._P#VNC_A=_\ U+W_ ).__:ZU]A4[$>UAW/6Z*H:)J7]L
M:)9ZCY7D_:8ED\O=NVY[9P,_E5^LFFG9EIW5T%%<S;>+OM/CNZ\,_8=OD1>9
M]I\W.[A3C;MX^]Z]JZ:AIJU^H7N%%%%(84444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9MYX@TJPU2UTRZO
M8XKRZ_U,1!RW.!SC R>!GK0E?1 :5%%% !1110 4444 %%%% !1110 5G:_-
M=VWA[49[!<W<=M(T( R=P4XP.YK1HIK<&?/_ ,-M8UJ3QU;1I=7$Z7!;[4LC
ME@5P26.>XXY_#O7K7C32[G4+&"6V1I&@8EHUY)!QR!WZ55\?:T_A+PX^H:9:
MP)>7$PA$OECY2P+%CZ_=[]S6%\+_ !MK'B._O+#59%N#'$)DF$80CD J=H [
M\<=C5XBE]8IM[(G#5GAZB:U9H^#M&OH=3^VSPR01(A WC:6)]CVKMH;RUN79
M(+F&5T^\J.&*_7%9OBDSKX<NS 2&P-VWKMR,_I7GWA\W(UVT^RAC)Y@R!_=_
MBS[8S7D^T6$E&C%7N>O[)XR,J\G:WZ'K-%96J>(M/TB58KAV:4C.R-<D#WJ[
M97MOJ%JES;2!XV[]P?0^]=ZJ0<N5/4\UTIJ*FUHRQ15<7UH;DVPNH3..L?F#
M=^55M9UB#1;/SY@79CM2,=6/]*;G&*<F]$$:<I244M6:-<]<>,]*M[TVY\UP
MIVM*B@J#^>33M$\46^MS/;&%X)MI(&[((]CQS7&7/A75H;YK>.U>5=V%D7[I
M'J3V_&N.OB9\JE0U3.[#86'/*&(T:.DO/!5M?W1N[6],44Q\S;LW#GG@Y%8_
MC3QLW@-;'1M*M8I9O)$A:XR5"Y(Z C))#>E;FM^(K3P'X:L_M:O<2X$4<:'!
M=@.3D] /\*PHH/#GQ=LOM4L=U:7ED?+8(Z[@IY'8@J<'L#D'\>W#8>%-^U<;
M7W.'$XFI47LN:]MCH/!>LVGBK25UO[!!!?!VAF95!8, .C=<$$5T]9NAZ%8^
M'=+33]/C9(5)8EFRS,>I)]:TJN33>FQG%-+4**B>Y@BD6.2:-)&^ZK, 3]!6
M9XDUAM&TSSHE#32-L3=T!ZY/Y5E.<81<GT-(4Y3DHK=FE=S_ &:SGN-N[RHV
M? [X&:\P7Q/JXO/M)O)"<Y\LGY,>FWI6[X?\57E[J:65^$ECGRH(0#!Q[=16
MNO@O21>_:-LI3.?)+?)_CC\:X*CGB4I479+Y'I4E3PCE#$1NWMU-*\U6.QT"
M;59D/EQ6YG9!UX7./Z5YMX=^*+>(]?BTC5M)M/LEV^R/ +;6[;MW#<\=!UJ[
M+\6-$O-7ET:XT^1M.E8VS7.\$,I^4DK_ '?QSCMVK:T'X:Z%X?UC^T[8W,LR
MY\I9G#+'GTP!S]:]B,5"/OK4\64G.7N/0ZZ*&.")8H8TCC485$4 #Z 4^BBL
M34**** /)_C)_P ?F@?[\G\TKU<=!7E'QD_X_- _WY/YI7JXZ"M7_"CZLA?Q
M'Z(6BBBLBSR^RFBM_C?J\T\B1Q):;G=VP% 2/DFNOL?'/AG4K\65KJT+W!.U
M5964,?0$@ GZ&N"FT6TU[XU:C:7P=K=8ED>-6P),(F%/MGG\*N_%+PQI%AX;
MBU'3[&"SN()U7=;QB/<ISU ZG..:WM%J"EV1E=IR:/4:*HZ+/)=:%I]Q*<R2
MVT;L?4E035ZL6K.QHG=7*]]?VFFVK75]<Q6\"]7E8*/I]:Q;#QYX8U.[%K:Z
MO"TS'"JZM'N/H"P )K@O&U\NI_$JWTN^M+^^TZRC#&SLHR[R,5W$X!'J 3Z
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M21XC),TD,,G#(A ZCMDY./>NTHK1S7*TEN1RNZ;84445F6%%%% !1110 4@
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G "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>acrv-20240408.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-04-09T07:03:23.4175+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://acrivon.com/20240408" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:acrv="http://acrivon.com/20240408" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="acrv-20240408.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10150.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140117705196480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  08,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Acrivon Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001781174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-5125532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">480 Arsenal Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Watertown<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">207-8979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not Applicable <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACRV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MP<;HW?N0W8E56?$.8JZL54EQN!(<$L%= /\OE+(?)^ZU1OE6:O0?4$L#!!0
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MDUM)Z.#<@V#OX96,'<V/'W?W U!+ P04    " "N.(E8)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ KCB)6&60>9(9 0
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M<',O87!P+GAM;%!+ 0(4 Q0    ( *XXB5@F,TE[[P   "L"   1
M      "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( *XXB5B9
M7)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N
M>&UL4$L! A0#%     @ KCB)6(CD.F&X!   H1(  !@              ("!
M#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( *XXB5B?
MH!OPL0(  .(,   -              "  ?P,  !X;"]S='EL97,N>&UL4$L!
M A0#%     @ KCB)6)>*NQS     $P(   L              ( !V \  %]R
M96QS+RYR96QS4$L! A0#%     @ KCB)6#JJHN=  0  / (   \
M     ( !P1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *XXB5@D'INB
MK0   /@!   :              "  2X2  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( *XXB5AED'F2&0$  ,\#   3
M  "  1,3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  %T4
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="acrv-20240408.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="acrv-20240408.htm">acrv-20240408.htm</File>
    <File>acrv-20240408.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "acrv-20240408.htm": {
   "nsprefix": "acrv",
   "nsuri": "http://acrivon.com/20240408",
   "dts": {
    "inline": {
     "local": [
      "acrv-20240408.htm"
     ]
    },
    "schema": {
     "local": [
      "acrv-20240408.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 25
   },
   "report": {
    "R1": {
     "role": "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_89b67c7e-1d96-4982-8bed-140402994bc6",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "acrv-20240408.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_89b67c7e-1d96-4982-8bed-140402994bc6",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "acrv-20240408.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://acrivon.com/20240408/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000950170-24-042789-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-042789-xbrl.zip
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M*=Y=L/BZ/ZKV@!=!515?&]>'Y13F&\D3/$6ZY2A/Q5',5\91[K7^&>?."P7
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M2?1O8E#BS_/T3F?#_3@P8H^(]& 3-%.UB H8F5EQ0QGPIX$!>TF<!Z.#9\^
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M?^JDU(?>[RJ"GS!T5*1B;[+$YP;F'9BW5X3]>A-@,X@5-Y7SAI86_:3*UQN
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MH4C]WQ(T.6#FI=D*=]C_Q:8?^-11F67H-&T^\QK?',48O,J\:9DE48X:&^H
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MXK8-L69..]<8B9P$H0T&F3ZG=C!"=35-6 D6EW=]HI*;K%P4 >'?YFE\JY.
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M,;9FB'$\G5(V$H;/\.^\*^S&0(ZD@=D"_2AS&&PU^0FHT+*+XO%C,RU+2_B
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MY8PTN6+>&C@"1RX2(C>E8QR#OHUZD+?WD^_M_?SS3^[*<$)4&&/>=I1F6;G
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MH+7^DK)6=YVU&@96H4?]T9HVT/G63^"D)IPU49M+1WUVR'GD+B-? H?/!/6
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M1QA"HIX6:!]20TZI":2L<K<2GP>Q/0LYY;UVB>(LX<32^):6!$= ^,\5++:
MX"XT]J5:D(N0:DD,<#Z"]+,3=P+[[V$AH%>/ZM7(LW #DF['RU6V:JL+9H[<
MA0:O#2X.5W<_&\6=TC]Z="\#YTBDH4.PY&FL3?YP1;$&*]SGGKDKB!2EM @>
MFW5L0_CR.6+<(,](*3@^P@+<NXU@*;:HW'2A#Q'D,YJ4KJ>^5N@-G%^K-&R+
M%:>$MZ&@>\)4PI$F>*MC=CC/2*>2/CA-W'R_'ENMYBE[2K'KQR=G_?HPE3_*
M,$)_]G5ZAXG<MK] ESR@8$2M*!6]W%@OT9R6O4OX.[N!1MK4HTPMG),6H+LC
M4AMR&5M2I07^S*:!U6IW2)EKAKT?(D8J6 )96H+:D'&<EC)(D:BHU%4:0QD-
MQU!9[C=?@^<]+>.XYH2,<M"1BBXW)(6P&&:=1ZQHB$99D<\SQSIVIO9Z/T._
M+<#-G2I%MYP?4LMUX#@:=L*R?[E3:NO;=9HF54:Z,AG::.PO1^>+ZRPM9UP3
MT.POWGJ)JQ=89< 9<HY1I0EJ\'%( 2=0.B)RQI8)Q>R;-(>N7)AQLX^UJC<5
MMJG"CR@/#W8F1H6)05]CC36D=&T[J<=R"/FUXL2?$$\GI*FXAT>!2U84E]TN
M4$QO:DYQ:G@/-(HT-!'.X=+N9\<_Q]X^L5;,H3>6"!R<L6#4>*? O1_NI#T(
MF2?(VF\18MO" EZ 9= GR[Q=HDEXD"A\E#3X-E,GHX93S;G.WT:^&R&==JM[
M8QD^;A0BKI7]G8]@ER; ;<?/'?3QU;;CD^TT7H$SNES.-Q'BY-?+L%M9A!W)
M$JMTC&N%:6)>NL :[C(1VLFUOJDJ!W.4OH5?$^YT6TJR696L3% I]]C!';,E
MC-%=?Z.3\53#3J&[B<QD#!-;MT M'+=.D+^5*'_/4.H]RH[-?)EHFYNSY.GB
M&K/N.?QFU![?82JB6?Y"DMP(U:9P6BD2L;<[9IITSS;_.)3"O(/W$IK"&@L*
M?<K0H0H 2=JSO6,X58^N<U0^7(N;BP;LN'1'PUV]3@?F4%;X':.5/P_1RJ&L
M\(N6[?KKJLX,65.DD;?\FOQEV&"$6PU8\66SS2@=V!%YJSKEK<[1?(*6U;9]
M%356,8:4- /-RPE:6 0D9@1N0$@"QB-@9T%*T9U-WVO.J=YV#AT!#1B/#GAA
M1/NQ+4<%A&;DC6,PN'U.?YQQRK4M)%]DZ92[*Z#P#ZF%X5:^W6F$FRXZF/</
MCR__+;U@T*Q>NLH+9XJ+IO:(>Y]&"#6G?-)OVX8I-;"!&44%W7#.<,9%Y=05
MM#QF/J<9P8E18YRJN01Y-T"?8P])61 (JPEAJ"E\RTLQ6O,JWQF:VYE^?)6-
M+:W1F/1L#2B!D/9 4>>+J,H;+%+L*T>387BDP0#M9T/C4T=&.<;HL6CJ/<IU
M:'F$$G&L/-PXN 9*;!)?<Z^6%$%NOD;UC\E@,$F]M0J:KFR)![+JW=H>,;;0
MOJK[OMG:ZDSQH'3[&"=+4W&&:*BW(A3)4HUL.G&4D;O=<41R-9;XG2KS#??*
M0<;L6"C=5ZNOIHUG\KU^MD1V:/$LQ=0.$R,]]-YK,*?"/B4UU>Z:KIAPX[;E
M\"S%4$WYE6,"-F.NJ$<THZX1"A)QWZA$D%=7!7CR1\12*SA]JS\I.HUU%)*X
M7_5T1I@G"I8T$,A:JV6_-#NE.<+E.*8E":OFB>J.8:UPN$O[,BUN,'*^<X>]
MI:S1G(,OSO8**9X^7-"QAIW!(W)6M_W<XL]7I*YB\W4.J< O(M,F5I)XGAK[
MC_+:-@E(F[-/HG91*(1*,3K*HIH)!(W4 0DA"H@T;W6MF>W(>_2"*Z[KV02M
M0 /K?7R'F90C1@.VU4!YU8@7>04Y*V$4V.U:/M#*_9)D!*FYSN'%^5198(5;
ME4E[QB2,>)J/=&ZFQ$*CVX)<D+ 3QF'Y2PQJ4!=C#F H?GF-=)O8X#;;T*XS
M+0M4\!_2A$V]%7F1;*=B,Y1#T;:VA]:^K%B$D\8L#?C5&>"O':6\ D#$9<*1
M) 1U:_=%S2F:^&F24!)\2*S0O<_)E:(KV#+K,LFU;3J1&@1&[E0\930NV7O;
MT6$A3>:S&I_5^QN[]NA#LQ9-S09U<0^()S#"&G")-G:.TISOPA%!1!X6TTS\
MZ::FS8CLMO B=,E0TQRG7"R=<W6@4Z$G'GRRIU245<B/D1MCV'# O,<BL;C#
M 9:P46<?WOI)FMZ@;9D1UTCL6=]2\8X-N%\KQHA><OS'C:S'K(4@4SA>B7@I
MIJ]IXTB59WP)TT/!:IPAV6!TD#WCLS)9>5>_GJ#_Y./%Z=7IR:5W<7)^<7)Y
M<G9U<NS]>G)Q\O9?WJ_C?YYX9Q^NO+<G)V?PP"^GEU?PS;'W\>SXY,+]\?CH
MROOPSMO[^># ]\;P]V\G\,BQMX4O,2^L/V_1U7WOPX77F,S[\>^7..#X[%_>
MY=7XZ@3_P&<^GIWB!.FSRU'S9S1AFNSXZ'\_GN)4W\'@IV?_/+F\@BE=P8#'
MWF_C?\FJO,L/[X]][^IB?';Y[N0"GX?'QY>7I[^<T3+?GUQ>>ENGV][EQZ-?
MN]_D; N^ZW+\_L0[_WAQ^7$,K[OZT)PBK-R'$3N&Q&G)E&H#7'R$$>&&H)_!
M[W# HP^_G>/>_#K&@SLZ.?TGO'Y\YGTX/ST[_7"&NW7TX>/9Y<E[^'I\^>%L
M_/8][.3XZO3R'<S@P\6_<.33JR&BL0D1C?W=(:+Q/2,:FW&/7/TZOF(A9N0G
MB3 0W>\^OG]/LNRW\?&)]_OIU:\?/EZ)H+P &00"BF^0+MD(,G3K])_;K>\N
M3FIRVHQZ].'L\A3&XF%!J($4'+][=_K^5&X-FN&O(%3A?2C<O:./EU<?CD_'
M[^$2^.WT[.3$V_K]UU-XZ)W<0^-_?C@]'I\=T<^//WQ\"\O\=?P>12E=*M[9
M";P<AL-WXZ5R)C\\/GD/@AAD*]U<1AAOC\Q5M]DZXBG:'&SQ^2U/@5J:9#=&
M,M+<>D[:S2G3YX&!%JQN[\)1N&;5X%3<ZR>49 -OM4=Y9U(1]J#YC)5'1'8-
MU%@,EC*&E*2HHX%JG^&\X!41@"\'[#')7=;=U[9S,26P,K4QM5U'4AS27DQB
MHA^<1J>J%BODEE0$"**HOH=(XPY>(J@EB1,VL>AL4A##P&NA9+"*FX2"'%DI
M ];3J9V:+(Y0=.3WU_M[U7M)-K*%O^,!T,]7!CQ C9]TDY&I21*?1.B%J3:?
MW+"78G6VKV_AQJ3XADX$$^;1ARJ.&$HAQ%Y+8%;C0684-3?OK5I%H9^2$_D(
MN@:!%4 @VV2#;[./@KFT&G+#)]J,<E/%5J$)X<GS?&N!J5#G$;F0MX+N';<P
M4DS:M,'Y @/]$I9N3L@@)S52YGUS# :BIUJ5Z0'2E<$N'M1T97SPBS>5LR+J
M(Y&7CRI6"2I04E,:^'1;S957\]\V[G/?5GR2PU)207T4&2K"*IJ*A:VOUS<@
M3K1K=6 C^$LZY,G8M2 L"AD8)M!98KQ#%A>1DFG"IYXQB#.3=9"YX(A;#_4$
MY?*B#AJE$=.<*I""6$6(@QBJ.;;2]EVT(UBM3E3,A&Q2>W"W@'3"W+>SHN^#
M-&>(IP4"3^7B5YV462YD!5,M,3RR"J_M23)QNQ(:3( %2@6L[<F*6KC%;X>T
M?0,W5M$UK9[/AJLV))QL-DLH]2L0M:"_U.(M]G8@1-1ZY=<LPZR21,_@-#3E
M="-53,L8&\8)P#*Y)%6(3M[BFMIX55WJ!#>(_<@&%:URI8,L@)<:C(,V":Z\
M45>P/;WJ@>I5F-WG7^"FW]ZJ.Z5R=U,9.W,)9I]U:18VL[PQ!],0M3$!5/-%
MBQ!H!VR4*K%55Z!W703UB(VCT+"&EF@=&KW"WF04M1JL@;U^(F<#CYG>RI?4
M"+58.X;V5:U,XM&T@B<6"[(S$VM738S=H% Y(TQT@'69G'9I(DP/1*_$U@"9
M@QD(9!-+JT&RI ,GHM\AD%9.R9-6;!01)!1)W&&#J.]7L1;$MG0:'5;BR[E[
M.E[N&U1>SE)P8 YM)M+6(]B2H RD6:*7>'MR38JB:P&!@[G[(0<TE5'/6[8$
M9H"27<8/4U"7;[%&/>2M9H5&))C?W7L1: I&<T##[2*=5JG5LIMOL"%GF0*3
MH8LUIS.;)5&WYBHB:)R]:2U9-_QJ6M,*P=UY-JU^KM6X863D+M@)3Z=?UN9I
M9<VP;,=",<-E"%9L1+!B;PA6#.477[1LQV[$F]' .216@_T:(K#RA+63:7T'
M+RW4H,-G-6'65#/$/?8(V(!S)2<5"CW:S:P_YXX*1>C3IN0-VX4744[7J7T<
M<7PCL%HIS077(4\95&6L+\$4GPK^6OQZ%F23LP.-B[XQ8WI)?EUU\T[T74Z@
MSWA;SM2_HZ36A82 4<D$RU(5@D$'"\6FE86.-6>EP;VLPB@U6@5!+B6:8:)M
M8K:DFO"RLKKU:_;CL7TR[2FL,\!)89J#M9R&>;T,U[3>>KF+<$4M;*I5:7*#
M6;+73T3_<8 ^1.38T\HD7:=1<IJ8'#RTIRU ,0*1&3=S4[>J%P,@_A16 K"R
M2$ES;J&9U.2*&\QX+!W=RS9#=IM^*\&;:FFT38<HUZ7?ZH3T\:K*2["A/M_F
MXJ4%&L1QV'8*2^\81U'5>NZV\$%0DRS46;T$_5.!H%M(^"O\%B/O=]>4,3)3
MI(^I@:ICTNC'JO:"="&=7_&7^[O[+^I'A(5E!E8$4V)/CG\97Z"4O+N[&^4Z
M&,W2VR\X@!:P0.5V6UEX1^B 2Y_]0(A!0!ZO.@B!RF_X//\LD3#%*J.#%BB"
M)+\S$*OIA,+&K?-O&;;UR\KJ /6F:[*BJG>%DZ;\>$9IB^;:V?^?ND6MBILO
MHM9ZKGZ=E6JE\X)=)P"'5 ^91Z::L1) /(-&P6;EGY1#(:1 BF6Y%W)88AZ_
MN&0;0LAVO>O([N<0XCP-(\RL)F[J:B:T&K". *I@\MCKW62IMVI-NU"1'*'6
M[@IJ'=3#Q;[7S[X%1]CN X[K"C5)X-\Q*O;1NJ%I/X@G7R5.CQP14FZ93B>T
M2YN+J=-'(F%=9+9SCLY(AD*M:)&L 0?8*EDZJ=LF#M8*_%C7(04N[5_2'2V4
M>BE^G$)75,'@:M27UQAANN2/18KFK@.H)K?#TL*,2H$'!Z0I2[Q"YZ4*D:Y:
M=NS4,(VRW#K'JDA-9YA,-JQ^73QR$HP?Q)OFMGFP110XAH,?/'H4CJ[>U46Y
M*%Y4RH$FX1P,PFB'O8^UHLY;?8WF&X;W:'8Y!J@(:04V?@H&4&I]EO*/^B/F
MNELE0KD'C;TM.T:5&C;CEJR EMJ8H^8^J8+E*\:D?T06VO3I$_4[=%1'$563
M%!4+NE:HS@8SR=K!?S,K!S!1]L&<P*JI\Y'1ZE:L_0%EGG1G&UVL732N[$#
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MF'_@4AH&(K;ZE@W6._7P7VK XC)\,H$.>M.K:6YZ'W%K@EM?T)94GFAX8[)
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MB@,GK,G,BX8RC">D5!VW@>I^7!_W=$$][YMMTF4?9#Y$+-'?1_+'N>0., N
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MM<,^!G*XQ"LWNT^*&TF4\AU!5J*AD2OI=XKZGT7KOKSC:DO60,.I>]B X<_
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M)S#H((KQ#E74$5;9LML,/S:+H8U>L(T1 !W!)96NF,7_-\<RRR 3%>A=9X/
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M:<FZAY/=XP!H,:DCK<:T=N]*DIW$?*-HF4?]W3&.#(1SZ@+4NQ_XA/-0GQ=
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M3XP,%<$$U@<#,47)P:XH24J<=DVP0J^G1V<?/!$$P2PZXB/\$S7%4C.?Z)U
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MIOFE)YDIR956(&]A?VG[F6T9$XU=<SNA"J42:5[?<7G]Y75-SH  B!:%ZT&
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M;(/IQE WI2$:YDUH@Z%WN64_I*-;?&HJ@UO44O^P;S/30J8ON,O]^]]A39V
M"G(+.1-(GZ^ ]N%C;WDDD5=@#%B"W9,KC4O\%F[4?Q5F<ZJBL"IH[,0$=<C8
M1I?]X'*$M&$+II?DFF9KD>@2-!E,P?.M2RI\JQ=DN*P8S38[%:!9G+CD"9IP
M>)($''AJ6ZT;:T\$?+,=(&0R707.19,'U[XHY\'%SG[(+XTN;UH0 P7GH8.M
M W!6$O11?+NQ'>_7AA=N-@0(]]5 ,R[0(%R[I^@DSVLZ0 ODI- #W=_;^2]X
MVT%;0:^C%/^D+,%/O- #L'C(>LR]=2*#E +"8 <%,!6P9-'2E+P3]-?B7/'7
MLR*C'=@77H%MF%DIG["4-XU?B7]O 3.3(6D,.<G8IKV&.1%(?(,/W=_=^XMV
M/VQS6'75(DJ3-?H\XHFD\V0&3]PQ*_QZ?CG!Z:CV3VDFGNWMH/.DST=I)TU+
M"]RI+F5[4A-0WQX0?>Q53O(IN/0_9%'\ 07>@+(X%\0^HW>JHE0$&[Y*J?.<
METXT9;\D/B7*H7F1BPHC?)B92Y9V<W#RE*6MS=A$G'.C'*&;'/'Z^$DA/L".
M?E_G+.M* ?[;E(,-O'F1O6#)54J=AZ3%&K6(RN@*)F]F =FT_S$-&<E9(Q P
MQ:=N/>\.*UD0O[^)?8'.:/W88^IH++^3C,:^*VGN]?EJ7OS4-G?PEO<43%TU
M!)&-072,XTN]':,XQH2A"DF4*E)#(A/[-L/&1CHM#C[2<G?M,R/A,;1AM[G>
M7LJ&6C4U:A>H<!A)9MJOO#FG=9;M!N=%A:82Y@Y-S40T*9CF _<N!T?Y^9W"
M'MZL8_A;%,%1L\*"-M_F9^LL@EMMH%$"1IRC?X[=U]+<?VH8/._4/*8)\8AJ
M>_2#\&Q$M3U]5-OJT,MP86V+,HU-(%QE5K4PZ# 3;0JSL^]X4QR"3$*L[Y6I
MCQJB>K3Q4!MXV@"H0]GY^$D)9ENH[6HRN4D[21NG=X+_=:[)9>9"5)3A*2:P
M 14FS&11.RG#O:SM:O0>$EEA"LG3,VCJ2Q7>IX*\#ER8QNPH$+;OV@Q[0T2;
MW! PO4.>G</-SHZN(NBIHO8I^&R\156%AK2-.PPO.F$W19VIQKPW*6YY99!:
MBCQ;XIMG2^NY5-@,/'$-QT85K.)1Y3/A#' D6AM3)E\ZU^@;<HBH;Q(G]6\(
MWQTIGC3DVD 8)Z(LG6ML<!9C'Z".*/! @5H5MHK@+%%OP6GCQPAK0(  A@P.
MGZOHK@*MP(TS_'S_8%LYE*QC?>P48K@3"CU3NKK90&D]D)3%.?=E4RDR(Q<:
M=X5:%N[> $MI$DI33M5WM]2'I#4LAD1P2(.1KM1V')0X@;S14:8T/+VQ&914
MLLL#V&Z=;#LS@S1X62$QZ <#-\C=O,AW.O#BL)"Q*'/M+[_2?2;;=U)=S?D-
M-!P.%MF\I#/^8I'FCA5C[JJN)*B+=JE;5-*8EOEA6V'?6GP)*C@&4]^_RFQ-
MM<K'9.%,;/^OW5^86(5A'<T? 4-]9P@U&:N1-,[#6W>GK@)8*VMT#8QUL 6O
M/N3(FI>>&D H[=@8V6'[Y-M:2*[41/B'JNOT<R 6.F06L!$SA67Q7KT93-YR
M2TZ82 7OB*! DN+F+OJ9V_K@B[:)Q8)XM4BY2J]QN @@Y%A8<WR(<8F2:_K>
MBVH[+XL026I91/2;E%BU_F[/V77*EIC0'O_TLY8$L8F9D88FLD1:^FSI O$<
M#)Z..(O66ZRHLWW"))ZCK?BED?(^;,V5JF(\#E[5U22*/VP278/P&A>L;_"4
MH#L9*&J*0XTX-DT]$?58<$W?[;63*VT^914%X%Q>I2H8I+$@U"^4+#7N(-=L
M'>J(.!\F:,I%>VOXMJRRF8&4NJ8.(BW8,0Q$Q:/8\KBEX!6$=!&C]/-XMFS]
MJ1^ONG7BMIE-B@P?Z<>N>))RL/F(#\HQ-0S%,[R1!^-MT(REVU8>NYH4\0,,
M:^U/Q%/JW%26DK&UAG( )T764>+LM-:VHOTY7V2:5&V5Y9DB5.$:1!ER5\,/
M$[3]S)T,H"&WG^DIXF8I" L2,!=3O0C4J;"T/8DM7@<VL-E13) 7(<H[=[AC
MC$KN6XQ=<^/+OA)?F[_6<'8,B&;B*LHT#UL8:'M<W\&&AU0/F;!!HH>%$U*(
M-@<8U>-R'YE69GN(!JL-;4XW&+SS6DE$I:(X)#>3Q1Q&LJE[4T$5]G&M:,\]
MF> SU<$G=AF-U*6=5A@21)4TUK:HK">Z:3')2MU'$V[N!\NY!A;3O;QQ.F[0
MCJZG4NT-*PB;3S&L>JY@LJ_101RHJ/9:A6<1^,0)/#WM YKUB5S%$=FJ]T8S
M5+G)XUY>N9?M?IQ221LJL0R7'26/WHE=FA'U1RGF(%R"*:B1E9*:6U$IY-5J
M4V'P>!0PW((?P')3^<8!^,VZR(D[O&%"TVF& U.<QI4)4KJ$"ZIY;8O#P1+6
MKE@GQ1:*6P?CC,I(H>TC*0#6>8Z[SJI#P.";;ELQ)B0H9IDMAU]8@U/QSIGO
M >P,-Z+B&+F-T(J-?* YZ9N9O::E,6;2U<2\:\52_)")L<R59O!"PD[8A>Z-
MUJK43+9TPRYA1;947CBY92>U7#DMDAPOI;'A6\-<[=1T44!KP]G)L)'CY9PE
M! P6V,[0FOW^4]>R^]==' VJM E!DS54D]D,,1DZ81K!]FYP E,0U]4..K-!
M.F=>8"59K(T[FI?KYX:-O07_(6<R0;1=@])8LFMLX,WL#5O../PY\A(3\W8I
M#<9NM5!O[?&HN?WX[F"KI5<Y(?(4:;+>OZX =':35@^,R"8VNZ)LOI#-6*,.
M(WNU(\?MHRRE?K$1^O?H._5PA/Z-T+]-Y>,;9KBK4ZGH*?)+W5$XJMBB<&H%
M&@$Y^GGSSJCG8] XB35;\8XM:>?W2NN\U989W_#-6>?=@DNGCF PN/N?T.LD
MHC^'<[5_S(WUP25L+$_H!F3]</+P;98-&BR-3M8MI\\%=';!.!6IQ:JN(,3#
MV\"&MJ/QG5P@/7?LJ$PUH#R%UM"X52FHV!0&KL &JD5*9^6&W3:VRR$'X Q-
MP15RRTV:&[)+8!P/<L]I]VR38:LASHORL#<;S5.^/?<26'84_C:ZF1 )U@J(
M0// =NHU"R&EV"L"TK;V]T;6>H^UOLWJLUI=*2&S]DJ:#%+/2OJ"[FYKBM0^
MAJWH^=B/H+VRZ7PNDA3F.ENN:9!L O4RI-:58U?7^^KJ^NQI=G7]]>3R],?@
MU9O7;T_._Q&\^>'7LY^IQ^O%5WDRS,NM[#OUT/BWQQ&9OW=X 2LL_YN9R(D
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MJ^Z'>^Q_]^R0N0KFS&\U^)9)[AL,(NUYB^M#'8CV7QST+E-HRYFG*4*'?$B
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MP7$Q%Y:_()?%-"I-12"?+*J<U51\W)%+[4)I%Y1Z/>4Q"QMWQ1W&?E6GN1W
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MF:U"6)8L&T5VQML936;MH;_U5OI.$>5=<$5(B-%.KJPU-H\H\DE)+)1G,1M
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M-<WDI%T9>P_&_N)P,-941_FH-=3Y5@@M58*#_.VONT]VVL\?X;<OGC^:P/^
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MIJD*!<!:X/^?%"V"*<*1  X6QJDI0.G1L,+%A!< =Q8N'BQ#F!:P"^. UT6
MW$E B8U!\B2P?I<*J:S9U4"%DK9HCNTS]9]"9PRHG$P S4#;2H#^&HBLB&E3
MP,8L8JO$ZB2,"]JD" FV,(X%G'4/ O'JZ*37<:0$,PX_X81',KF KA(!BP#0
M8&O<H_" F]@>'"I0?FH#^VJ3]9+:AD*]&GB3'FI5VX[,<H!7*/KH J:?E.]A
M] GZAX$M@"4(:$$:A[5M8@<_1="0M3&QPZ0=$ X^,Y+ ()V5P'W8CPS"<9&F
MD1A*X)W6HG!V0&5Q*Y"Y3S>W19>) S2%B<K&R-X\"6EH%"'_@+D"_8:*5@%Y
ML$K"*K? (>/T(KW"FMVR,#_*E$'FA51284V.]2-W RKQH[NI0Q>H?6<*0,"Q
MB<QHTDS#"3*H#>30,3=.B$T#J)N(=6;^R(!@&*/" M^5)%09A;CP5!N4.^DX
MS56U04! P(NH"'/C^9EQ]L*@ +&CC&F+5>)3 .\E$$RT3%ZU2O@8I5,%.L(R
MT3&7"UMVH&H"N+Z3V$F0*):*J"59%0E6V'BG 72E<JECHF^R 9A%J,] ^79K
MNX&O,KH%8U0<$>X;BAVPA#8DKE$]D*276 .$?!LS9SOS^+CS4]CYH4*Q%($4
M"%E"R1#E"H;2X(<5,326U<5 ^T(19!!( DN*1+$2A-H+\[>*_A0(1_F,;\O_
M0CW1- M$#%E.<@"-',>!S]5%RGIB,F3M"L@)N'<*2MX%*XUUO95L3+ /DLB4
M*UN7'$,4>.CX HR;3P 1#,.\UM"ZL089$\902L);%$6$-N:N(+4NQ CL 95Y
MON6E6$B0:.:(I;"K+BK^95?N"H0P29H\#$QP&EHL$@E3DO!7] *T-"^(V7I)
M;JGBFOI ()K2[0H6691>$UR ,X%=Q.O(JK1'"B@_W!-2,=L'2 !6:R=TDZ_-
MC5!JQ83ZAB@B4<6ZS$AF8Z=1>_"VQ2M6OH6\3'5$F@'T'Z7%( ^N;'H4AVG"
MFGR"F"0WZ0"-']*]&<8*ZMDHD'45:I'>A#@FI*"@A.V5,3AV4\,ZG=EMODN^
M+Z)XH$FK9L$7!6C@M'\;R[?M.3K%<.\FDOLM\9R=VXSG5"Q^\@DP\T(W$PB.
M8IQXXY_<""[B[Z8R+^@_U]6@DNA!9P.,LC)IXD)M@5TH/VW)(;"3EHRG<F;6
MV177P>?]G9FGE+4#\^8.S+W[X<"L1U27Z,)<( @KR*T&Q7<K&*:UNBYA$KUM
MP1S&IC60H!KCXGR16O>W]_?WETFM^]M/=_:K_SUI4M<UR%7>";G^R;2NX="Z
M-&3I4P!%"16I0W2_5$.%VNJT8/^ D9:@"N;<$>^*+!S!VHJ.,]I$1/84=TM:
M+#Z@^ XI<2L?W;TZI16(G6W6]7#VJX&)!,-2S#=2!K:+FF. KSR^E\\0*Q%*
MHGI$I<SG^*3!*$[!?()NR8;2%#H NQ&#*VQ.4G03['4D>;1@8)7&BH(X?INQ
M&( ?A\Z1T'3JK?R279W""BP>X1^S&<A-C!YA'_2AI0 +/[E,*9Z6NJRF4 (\
M.I]MPQJS>6F=O?.VVP7Y!>"Q3XK:T)L^S(>>=K*;@8@N@!RD:1 $&JW.RX6^
M%+)//7%@VPT-_87IQ/IY)3N8T5T;")A^D2MR,U$XT; [@OT&8R"W3,L8'L),
M&0? P:S73N?.K42^(W30>!^6L*X*@VX#(FR;V>,?6D^U-!7?E/>-V%[:_ET@
MK*\RJ'BP/+X8CQSCAT[0-V2==^2V"E4MF&A2WVTY@!@6F4N]L+#/V5!S2(''
M'DF[AI1CC4"@4") *)Y2&9[Z^(Q!G,:J$Q/ UJ5WT"ARBAGO=_#KJH? G^,9
M$M^6CT56T)^A+Y0"!!@R$F@4<OR0_9#DLRK#MMZ;2$Z3>F3!.I:8;1$0\\?<
MY!R6+R#4D3UVGV'7UT<8O)^+,W(>,4X0=@PP5:.D>B%KA!V#/L=$->-%!"UN
M0%0MHWDQO[3(,>Q4QOYD"%O)>/*MPHX!'^+B'!;+:ZO(X3\?/XOU)\5^SXW/
MFQR]-_A DD[%0(!VFR4*%,28/+>33%]J6$L,*N9395U[58\V[DKG009@-F:;
MB/XBSIEWX18!VX*R"#2FQL-*!\PP:G@&2"6Y$0'P',FF)EDH2@T?P5<T/[>4
MG$I@R9V\N^@058@MF=%,@5IRFAQ%QXT*,P4 ;Q1)C!@-4QC;AD:!_R!>0V4C
M=G6/M/?M!SPO7($J;G&))CE]6H_[EP'.ZEQ]>+,2T[0!A2L3Q&0 -S_VAC?X
M$N5QP!0N=987U \*A)1RD[RD0$:(70?,2C"$AMH7S(F('Q\&]:C< )W1+G$R
MX&!'0<KS!J"F"#6BN/K%9F/J/MWB2CX?29$!$#GTH?DWMO"9%)7();I>\YGW
MQE<3.";PA+< KE/NQ_L:E.44*_%P"_I8C0<5M_^<C<TR1E_%[+9XC_O;PNXZ
M=&M5$\REV[L2Z6"W?-U9O+<A-P7GF2:XHW%/$L>HR:>RNXW=34$G4&CW)\B,
M%Y-R&7'R87E/VBR S;5(?%X('[6"O4T>BQ)S3!HKCN%;'@8V)JR/C$O@JPAM
MH"Y%:AP FVF&J\NOM8W5XTYW?&$*PZ13X-J8FL3R("%-@SD>-JF3P%>7?^V#
M^+X^B,$/X(-X-<>8:L2:K(7KM")0A9RA:ZY:NJ4E=@V3RZ6OD')HKFTH!!5>
MSHRNR&'S^20_V@J>,33LNBO[>['>["78G*G7U&C4@&ZD2I>6!NIJR.,L@T.>
M4&,.&-BOQ.)):70<P*@<&5R.'*C&99%S6JZUWN/?=X^'/\ >[SO+H4$R=>EL
M*9HU?4[^(F*$_9.DSD 1I%62FF+%CM72V6PU5T7GHWDII:"8&N(X@("8E2.0
MIU\GU7L9/IU_S/9N2&/O@47^UC'B=8SXQC'BM8 L!20F# XTVEZMD8Y R;FY
MR%Q]@3E0B1IJ3!W$M.!I@E(N!I&5BU]V?G8*95*@>86_<.@A&KQ@I,DLPTQ$
M,;$!K#GQ"V<:JWF!.PSYR0CQ9[/].%D/<*+1W0R23TXHQ/U?:VB7#FBC89(R
MHWB?517+_'<4[2#@,];9:^GLVIBBZKP#/* WS>:%<J+HU0E:U1N(4]'R8'I;
M$V_S9K] );B.HKK.U;CF#MN_'[D:AQCZ)L-KB:&M;2'>HZ>%CA<XI9G/2P8V
M\Q</25+R(ZC.IAGC&"N9<'#)D.48V9TSOJ*![[>NH0%7*6/72HA;WP2[2Q<]
MC[>?_>E=\".D@*QR@-DSY^7'E6D7&3[@675*HX?F'7G.@XHOG9_88)L[V.-_
MT0%!V+/DR74_6%)!0Q;.5C[:MSPLF;EN,,YO=ZMGV]6A9<F9&AN6#!; $W@A
MFTY1+4AM.V8>,@$SQ9^>\)X?#*^X:;ISIODH2XL+]H&C[,W,2$^PI76C5<\O
M54(("U.RUTSG6YC.C^#S7>FT%J;J56$Y-K[NXCM!M49*X(XXXT8+1 SJ-RKM
MP#+90+(G269XG+G 2'&15,Y68G:>24-W<OD"H[<)[G095T* S- X 8&?KO7D
MV].3']\//;D#9!-1?* MWDL-A-0672"6;"72)S',7Y88P8"2/; K$6S8!U0J
M)RI3",J3N?8P&68T^!0OG1C83B02K3X]S\2LAGRV10?/7Q%B7&("JNJV6H#-
M]6&U?: J9X!K)Q]S6S9EQOLP9D6>>K4>\&:7-QG7H@0C6# [3MV5C6\QRX"/
M PKT6\*0F"-0?5RV+]/)F@,&_%6]:V8S5X&CGOSB@2F$H82AU''!I8V4YN0%
MP@OJ8Z#M9'DU4<+&'5!=8M6JG"]-5N<%AAHJ\/!Y2_JL1CJ!K_A3QOJ/RM.E
MI0O%+;^=5'G:5$1I6-@SK92^$W'4K7YT-7=9TD$%0M;FAD7,1TL5[Z[R[*$+
MTI=AQVJ.D2NWTU1?:95L*',L?0D>2E],HLK*..)/;3F1<IA,X9D]-#Z_T!T0
MLC;4:AY4&D]M8AJ;0>T8TW> N&&MUX+FU@3-+_=$T) +8]GBY"2U# =E"7M5
MJERJD:G%G"3P"7ML_50RE4K6=.WR0:GG>G1,V.W528&ZG57M+*)8>#&\KO_K
M]\VGA@?H;+:<!\\&TQ\D,31S'I=#57X[6]>26->2^'HM"2 B)$HOPFJ5#(+J
MX?9;WVPV";Z, (#$.:NG]<RK&X/*@]TIY&X-*MDQ >7 )EP)HIJ9G9+OB",7
MKIYH%:JZFD,YBFYK850DL+$4.D?/H'&D(V?]*:(OJAFW@UF]SIY52>K9H+!E
M,;G7::R,W.LDY:W%[C7%[I/[(79?DV\ J?%83MOBMR+3)M*DK:Z*6>>M)_9C
ME"93+*=ER:T<TXHP ]!6G"TK]G$U/<X(*I/LH14*RR34DUC9ZBEN2V$RL2T7
MH[-,7:8A)_;"3BH2;\%0)!)TXK'V7.5C!7UE112$+$R++%\,K3M;L:B3\X3\
M/_2=$8>@<6<XCP/LE4*YV,@_KG;L7I("82K9\SK' Q/N<(05[UD:*F:+,J."
MA7C(@LY:9/5S&!73:6-@\Y=);R T8Q6O4-WN0,YB=V>7KH56._EO1A^SYXW0
MTP/9DD%IC[DYLW5*QPNFDF36.&63F*SM2 U58AHG!P+GDB %JXFH$D4<?PAC
MJ5V^>6[/1GB3C%/\B2*_0$7K)+@[9V7[#RRU:9T$=ROXO+\SF\MU[E3#7-W@
MF1R AK.%%;XB*]G\"5\ZG0M</I^Q3TV-011BL!?K^RI[9#7/93CB@PF9.[R*
M(L@?_%PL8[#7 05Y^4!B0K4ZP4!+Z'PCR,AB7.D(GA>^%L&7>]5CAIQE,7U?
M,_$6>Q8K_GQK )$3'S6$F2LU"DA:6S6W9]4\O1]6S?O.T>_=GCA])7X[[WT0
M_=Y1YWB9YDRW<_!&O.OT^A_$FVZO^_*#( C/Q%'_3/2.7K^!?_JGHE,!%X''
MFZ<.CCM';\5I3QQTSL^Z]/2@?W1Z(EYVSKJ'XOP=_ EO.[VCLZ.3U^+TO(]M
M^F^.SNRE5?BV_Z8KSLY?_M8]Z(NW'7J*<$!#?HE_8@0&FQV<ONOZ+BPBX:^C
MDW[WY!!&!#A?=D7G^'BK>T+78YWQP QNY^00WXG#H[-WYWV88?]-!\?\@!^]
M.CJ&#HY.>&*GY[T^M:<FO>YQI]_%WN< 6Y]1 %T<')\?PK"!>'_4?X.3/CYZ
M>]3O(&8"Z/JDWP,T,?+. NBUYWZ(#?^Q..F^/CYZ#=/H;@;B98]6"88Z/.]_
M\)^Z"9TBFJ#GMV\!X<>=]_3B#$8\A\Y=<\(AP'G6Y35Z*MYTSF#FW1/QZOSX
M^ .BY>#\#!<.:,"-AQ-&XC@"=.%:("406KJPX.]ZI[_#TIZ>P&(< 1PGIWU$
MI4,0M86N_GG0?8=#(@@-:H,FENA> <9Q%N\[O5[G!&@.A^EUW_5@(/Q)"W%V
M7GX-P/>ZOQ]UW^.Z5^@!D4ZT>]Q]#:0*2WERUCT.RM6L=/)_)Z?O =G'3!N_
MGQZ?G_2!6H]K>Z!"]W8[O#H]/J8/<37/SH]Y;7GDVJAK]G][[/_9_6#_)UQ4
M9:F)O9VRN$OUP+I+58!5:"0$E*7:0;MQ]KR(5(S!ZQEY%NINC"X'5L5;J?G*
M I%([Y<""SZ]2& 2D6 /'RIVKC-_ZP&Z/A(@&1%AL6<_%&M8"D_/96FB0]#$
M=!Q4;FW!NN:^S$8M,1+AB"*"2QI_5P/'TZB^CCV 2[5T>+IS"\%6*D@;JP]N
MMA;L]&^[ZNV'O:7K:-BH*]!:'J&+BFEW-Q>F[:S,.BR^^>P!(^7QLQW1R8Q"
MWO5> B\Y*_" /TB/!XR4]UB^*T^G8(J_E<: D5X8D ,+;UO\;GQL1:[K[&!R
M CF806R@.'P9%V.U]1NZR!/1%CUI0$"*-VD\WOHMS2[<\[<RFVUU8A0=;W4<
MJ^SY('O11>'4$I,!]O&1FOY#\M;<#M-Q6V0CZ.>CZZ;^;CRF?JH/;[ HM=SU
MQ]M[SY[<)>TNY][8![!=[4T.83J9X55;>'7!W,Q"UF(V%UX:NJ:8AT(Q9SJ*
MU4QT$(9$'!^_>\@JP--G3\49'10>B0XYBA\P,K#%AQ3OECOY@%K0[J\/&!D5
MN2\Z!JW&7C'025L<F?Q2)N*-_!@5#Q@_5I41,D.T_,,05V%%18\0-Y5'=ZX[
M7M,&7HZ,6?:L[]KR]P=25M'V?QB+@7=</K#+>):92//X@:5'K!-I;@6?]W=F
MW^M^LY5BLAS)\4=55'FK21*YJLP<1: B[)5[Y05E\>KA%V,JQ63+G6^9\Q83
M6Z$#8Q-@KD9*OAZ361Q["80MB139G%7?0!IWZQVG.E<.\^!#Z3(Z:_$:3%%U
ML,Z+W5 VK0S]G=JN?"D>@]"82F3K/$A"E2R $F"@D$^J+_%.:='4,M9AW9N'
M=7^]'V'=+I8XIS,P/2!]-6S#OW@3])(CO?UJ!>!RAYDR27SN':P8$<72\G(,
M\CVB@P83F?F#!B[YC8H]2:Q^K_Y3(*O(<,XS*ALGI[CG*<A:O6ZW&FBV>>+
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MOZN_]$\FXNW<IA?EOJ?'KDBFX_4R1Y\_&J31[,5?GC\:Y>/XQ?\#4$L#!!0
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M^SC8QXWGVYO> KNJJ<6[7:S+J0E;GO<.N;1J>6,>"$Q&!K60)0L+7QA(3%X
MSN/I:P&;9U8<HF/0MNC3>VJ;$\'2:#=P$"^TNAE>8IT[H=?DJSZGJM4>9<CI
MU^/?>@*M&^7N*8;%->U0A\+-4K(2M3<!B8H#F<Y0S!SRD&"GKL<0+$VK06AI
ML'\NEWHRTF]D\FC660YR4J5,5Y@S6NO7N,[[)-<A2<#MRKF^F\4CK\%VL29A
M6GN*<B8Q"W-64.;4[)PZ:L(6(R.GYIK-4IZ34F=SX/:F9WD]*,X,O20-*\.0
M/%9Y0TJM:,M.?C+,<YVINW2,_>]S&6?K9CG@/Z2:&2H319K*H)H";P*33.^+
M\K5P%:YJ8J=13_P&58Y#H>Y8/@9?(NI%KP-'YG)-I<S \H<[1]/0DP9S/)ND
M8%'P]_B_W(8QS,8P,54E0)&D IZ/2$\J:;#%'&?^7S]N^[#YW*==9$E,JF@D
M3X6S0=B[/E9=?$54&M)JS1OA%-Z.*7MX9SF4:]_'A_#+7F9^36J<ZC6I/X-=
M-+-8H$:6)N>U<]E4R>ZQ*B8R?(69DS M*=4.FDH(4O_*/.9,1M,&=R"?P.WL
M4-FVN,==PN20QGQ*WQMC#DGV;6'IQM*5^Y<V?SEFB/TQS1(%T'=.=R?$[H]D
M4J8ZC]08LS3O,JEC(UF^B=@X4#74!C;.J:&:772,?-T8N9'':\#)J3=MG25G
M1F6HN%Z $P!-(J,@EZ7JQ>Y\J![6"7]MZH7#V56.?D2.4KB!E*Q?X/W!'!IF
MOZS8@%VIV#&\MW8A[*3=P7'7Z.=@?^?/K-YC!^>+RG+L+!R'ZG4DX01F( KL
M$.PX<\<+UO DZF*8E=T^$_0U*"<&,%F992*EM&]2YA;,<-%<!GE5L8(C<9&Y
M 1C1]H8-3A6J;M^F.A5X]EV2SKSALQT\,/7OGTU>DLU'2M" S+FLJ,HTNIC^
MW=W%5UU,OXOI=S']!R;0E;-S#42X8XQ9%VQ&A:I%=*HEUI7ELG8AH[]?RRZ5
MS5I/*UV2WTJ_)U^O&F3IA#HM=0V(NDP*ZT7:#?7SG&_]LLNW[NBYC9[+IO!Z
M433^H]!>!9PFZ-#HF-#FCIJ\S4/.7%-!E4^3)Z:U)E451E==$]H9P:X7[0S9
MD-\G<IXKV8&@&:K46CK12ORI/O)&[Z3%]]*) VS$B. \S+@(MB%0+.-3Q+#4
M=I>^O6;F[B:0K4-V8U(>1?M\<"/!VC/S;4?OZ&[I&MS21L_:FEU57:-PA3+P
MU@2.%ON]'1[&L?Y+@[:Z:LJFOFOEJ_N4I!6#?[-:M7ZM@O6XS+],Y?H3R@%=
M._R3)N<\(U4^"%YWQU[8R_;F_@GVR8B@=R8S+I S0O?DP(9);G(9#?->]&#:
MH)1CO;;&R2T+?&GTF;#LP0XS"I? 1\"<84]"I4WIM L*-:5,*4MPOYPW4087
M\]$)IA V^(.UQ4#Q-*408;1IGE).'+)B'$1,@/"#93'^3<*<2JW;7"N 2Z9:
MR_A;>W#4U@CCZM4"!RZU@5A5\D5;?%2Y9>8Y1AM+L<=Y*B:Y4NUM#BD-Q]=%
M9^O1G:'<4B(1##^$W_.%M_%J>],+Q(*4>^=W6YXW7#XIGKX.'PI#&*#RB\AH
M0VY@IARZ"6,D7Q[1C5H>P)WT?MS^2>E*RK2&"_-W3:\-KB=C>=2(MN%Z:!#,
M%UL_P3*/DAP_!7TH-G/#FM73A".U$O_0H>RE<6R_Z7B+-%:0@A4="6[D?'%Y
M;)QL&X3KJ2(5(KK0?)ZD>1%C50"QHO,0"%(;/HJQ+1T>UC]JBGXGH+:>MJ19
MK./-MT?Z?$-LKA(&$#,'8L8JDX'-_';RIHE4FVX!#3.;<TANS0%DX>ZL@?+S
M^ V%U68'EWE9 4H*AKF=+)PQ%C-H-#$,4 M\Z'*.5@\\RXRS BCSWXFWET6?
M*^\XAYX9<YF/77>^RW(?B:_.1!A?(?D1OLC#R*GT,/4=E.6/)1TXKQ9]BS0T
M*\+:-[!2F4$9]A0JH3^G8$VK'(%J!0-KJ'G*8 8WJFC@@H9;6HA%Y;Y"$8T[
MFW7DC'6'Y[I5<#5>$GV[6%%4NF%^D7@;+S:]<9'![F0KG'.'$G%_>_U3EU'2
M991T&27U-9-];$OV- .%!Z8A9K\9S2"F7A.7F70-KBD?G4O A2JV@AKJ>N,_
M&==@U7*',T'I=4J&E'"Z?&CK&S]/1;IH,M31N8>>-C9\&0^7]UUGK.;BFR0W
MBIAH)&K]0"6VLNZJRKI8RT\&/KOB2SX3'"-#LP()-;M*R;;K.NX-!YPCI?Q>
MF2ETL)Y="K-IJ(FXF(V59E]R\.IL 8*[Q,)HB7Y>L=9>7KV+:^GFO>F.W8&J
M_&AO4U"80,9<IF$2$"3_XMD4+\_&SH_*H3V'KU+-^FL>SM,$?R=0%(.P#6<.
MQH NR;?E2\)K)SJL\7\J.]_ Q\B#$K2'UIJ<.@_-I;S".^W2.M/SA8R0S)^#
M>3Z#Y\[4'7@R6M]!@RQ=<CW1D3Z/8!(E\!$3>2WKVS-2\72DN5/CKHB/<(T8
MO+_$H]L>JYR&8'P1@LJ/UBGE.699.>)Y:2S2*0K#PT4G\1(*>@JA\T]F;]9!
MB5K+ZZ9CS*N\:.NX+V?)!5S65>*SL"UT-9N>&-,,0_J4(8E%XY;V'YQFLA&L
M--@=JS31[R55A+)-@\#T[!*MD:*R<M[$>^ED+["SEPO35O&2V817#@> 9*D6
M]C.N>"GW%/.&J_FYY1)^%3!QZ*.<]-*:QL(!PNMGLK!.X@YI4L"NE>&RWE2[
MRLR!&^3[?')2F&Z<X./0T*UD]-CQ'H;B?Z>D]1;+ZJDE$&S4L,BPI&2EP$Y
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MC:*"VLV5/3G!VC,2BR[09F<'I1O!M*H]9#0#]G44&JC!%#O,@$;))4(QA[C
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MK8\#];S1X*!WB+_YV\D WG=$SQ[VW\.'GP;'^_W^VX.C]][;@T%_?P23.![
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MN_K7'\9)L'C][[_^<);/HM?_'U!+ P04    " "N.(E8)6Y79N)!   ._@$
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M*)(@RI/@*LJ::)HA<?,J!>9!Y T#)&\I8I&N:KJN:F:S-$Y%'J]1;,'HXT6
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M5>1V&,!V\L)$T@L-6R<&*YP=)FF-RK3G)F@[!D)MR)-/&^XMFPPU4U!4I<K
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M,'0M8[DV"1>XDS@0U,-5U7KI/:KJM.:T)Q;2"9\1)X-)N1A8DP=UNV%6TO$
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M;(ZYCFX4OBAP/9E2%?TR1$+02)2DMB.31*%;V:6K;0F#<7IJ==CN^I 0W%A
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MR)JK2=1-F=NBW]'Z=F[#7?LMYNA!U2)4&IJ:G7'UD5A8B1*!$<6JYBQ-#>3
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MK"H+1Y+?#)S:K=W,EZQ&)/9^;SV*-"H*0W9-_<[<S5&[;N5NWF2>K;7B+VU
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M 4Q4])ZT9-6&;CAI^A,Z8?'"09,FP'T8KBXK.$_R,'+)"@(_R38;_7?4W63
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MFVSXO6;#)W?H7YIX\-G)'?XW*OX'4$L! A0#%     @ KCB)6!P)M4XC(@
M@P\! !$              ( !     &%C<G8M,C R-# T,#@N:'1M4$L! A0#
M%     @ KCB)6-%'-H;^"   /6D  !$              ( !4B(  &%C<G8M
M,C R-# T,#@N>'-D4$L! A0#%     @ KCB)6*X_ +"#I@  O0 &  \
M         ( !?RL  &%C<G8M97@Q,%\Q+FAT;5!+ 0(4 Q0    ( *XXB5B1
M/_(@ 4D  -%[ @ /              "  2_2  !A8W)V+65X,3!?,BYH=&U0
M2P$"% ,4    " "N.(E8=*:!650=   STP  #P              @ %=&P$
M86-R=BUE>#$P7S,N:'1M4$L! A0#%     @ KCB)6"G;&OK[2@  :H4"  \
M             ( !WC@! &%C<G8M97@Q,%\T+FAT;5!+ 0(4 Q0    ( *XX
MB5@E;E=FXD$   [^ 0 .              "  0:$ 0!A8W)V+65X-%\Q+FAT
M;5!+ 0(4 Q0    ( *XXB5C_9*0 .!   *I"   /              "  13&
G 0!A8W)V+65X.3E?,2YH=&U02P4&      @ " #K 0  >=8!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>acrv-20240408_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="acrv-20240408.xsd" xlink:type="simple"/>
    <context id="C_89b67c7e-1d96-4982-8bed-140402994bc6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781174</identifier>
        </entity>
        <period>
            <startDate>2024-04-08</startDate>
            <endDate>2024-04-08</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_f5ec1587-dd91-4b31-9c42-e65b566258a3">0001781174</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_b0cb3a43-bf84-42e6-9042-b90497e8083b">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_098315aa-39d0-4866-9654-ab55aa43a0f0">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_5b3c9fee-7c48-4eaf-b60f-ecf82de0dc26">2024-04-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_7cff70b9-fb9f-4085-be6b-20f8258c2bed">Acrivon Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_2d587c30-14eb-482d-bc06-745a52700127">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_d6522c86-197d-4e33-ab28-78d8b617806b">001-41551</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_208dde73-cf07-4d09-9a55-5211d63f15a1">82-5125532</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_fc9bbd50-a7c6-4cc9-8b3b-3d1dac9358e4">480 Arsenal Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_3664105e-3b82-447c-a2cc-10debf06f2f8">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_2bdebbe3-da97-47c7-b961-9a1e403b766c">Watertown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_1bdb1305-1b99-4918-ae90-c9e8dcc2b97d">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_4d181283-b8e3-442e-9e4e-19ff832ad227">02472</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_77f61c6a-5a20-4544-a29d-66b415eb9357">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_2fa84d5d-ba5b-4be9-9ca6-b03cfd1a681b">207-8979</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_1feffdb5-2bd5-4b39-a33a-024aa435efda">Not Applicable </dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_792a9a6f-5c1b-4d6a-b9cd-9c705937ade2">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_f615747f-9948-47f1-a50f-45bc89924b08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_520f8bc8-5291-4722-9b8a-021a7de447e8">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_fce15ef6-181d-4b12-ae9c-75f58340829c">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_602a7d44-3c14-4ef2-89fc-e2387329a03f">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_87b6409f-5135-4b0e-b1c7-c10192852a7b">ACRV</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_dd3140f1-77d0-4b36-a4a5-1cbd6b1b071a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_7365e258-d46e-4dd7-a45a-4273449da500">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_89b67c7e-1d96-4982-8bed-140402994bc6"
      id="F_946617d4-d309-4495-8862-b535794bf58a">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
